{"questions": [{"id": "58ec6eb5eda5a5767200000c", "body": "Is Enlimomab effective for stroke treatment?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/11673584"], "snippets": [{"offsetInBeginSection": 1434, "offsetInEndSection": 1630, "text": "CONCLUSIONS: The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for ischemic stroke in the model studied and, indeed, may significantly worsen stroke outcome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 1149, "offsetInEndSection": 1242, "text": "The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 135, "offsetInEndSection": 283, "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 284, "offsetInEndSection": 385, "text": "The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 385, "offsetInEndSection": 545, "text": "METHODS: A total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 1243, "offsetInEndSection": 1358, "text": "There were significantly more adverse events with enlimomab treatment than placebo, primarily infections and fever.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 729, "offsetInEndSection": 906, "text": "The primary efficacy endpoint was the response to therapy at 90 days on the Modified Rankin Scale; other endpoints included Barthel Index (BI) and NIH Stroke Scale and survival.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "BACKGROUND: There has been recent interest in the possible role of reperfusion-induced inflammation with neuronal injury after stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 906, "offsetInEndSection": 1033, "text": "RESULTS: At day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}]}, {"id": "5a885add61bb38fb24000017", "body": "What is the H4S47C cleavage mapping method used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24737863", "http://www.ncbi.nlm.nih.gov/pubmed/25491770", "http://www.ncbi.nlm.nih.gov/pubmed/26275423"], "snippets": [{"offsetInBeginSection": 113, "offsetInEndSection": 349, "text": "To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}, {"offsetInBeginSection": 164, "offsetInEndSection": 327, "text": "To map fission yeast centromeres, we applied H4S47C-anchored cleavage mapping and native and cross-linked chromatin immunoprecipitation with paired-end sequencing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423"}, {"offsetInBeginSection": 439, "offsetInEndSection": 707, "text": "Micrococcal nuclease (MNase) sequence-based profiles of asymmetric nucleosome positions revealed a corresponding asymmetry in MNase protection near the dyad axis, suggesting that the loss of DNA contacts around H4S47 is accompanied by protection of the DNA from MNase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}, {"offsetInBeginSection": 708, "offsetInEndSection": 939, "text": "Chromatin immunoprecipitation mapping of selected nucleosome remodelers indicated that asymmetric nucleosomes are bound by the RSC chromatin remodeling complex, which is required for maintaining nucleosomes at asymmetric positions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}, {"offsetInBeginSection": 328, "offsetInEndSection": 569, "text": "H3 nucleosomes are nearly absent from the central domain, which is occupied by centromere-specific H3 (cenH3 or CENP-A) nucleosomes with two H4s per particle that are mostly unpositioned and are more widely spaced than nucleosomes elsewhere.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "Nucleosomes in active chromatin are dynamic, but whether they have distinct structural conformations is unknown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}, {"offsetInBeginSection": 570, "offsetInEndSection": 768, "text": "Inner kinetochore proteins CENP-A, CENP-C, CENP-T, CENP-I, and Scm3 are highly enriched throughout the central domain except at tRNA genes, with no evidence for preferred kinetochore assembly sites.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423"}, {"offsetInBeginSection": 861, "offsetInEndSection": 990, "text": "CENP-A nucleosomes protect less DNA from nuclease digestion than H3 nucleosomes, while CENP-T protects a range of fragment sizes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423"}, {"offsetInBeginSection": 991, "offsetInEndSection": 1193, "text": "Our results suggest that CENP-T particles occupy linkers between CENP-A nucleosomes and that classical regional centromeres differ from other centromeres by the absence of CENP-A nucleosome positioning.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423"}, {"offsetInBeginSection": 940, "offsetInEndSection": 1155, "text": "These results imply that the asymmetric nucleosome-RSC complex is a metastable intermediate representing partial unwrapping and protection of nucleosomal DNA on one side of the dyad axis during chromatin remodeling.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}]}, {"id": "5ac725250340b9f058000006", "body": "Which miRNA is associated with the circular RNA ciRS-7?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24014594", "http://www.ncbi.nlm.nih.gov/pubmed/23446346", "http://www.ncbi.nlm.nih.gov/pubmed/25873049", "http://www.ncbi.nlm.nih.gov/pubmed/27929395"], "snippets": [{"offsetInBeginSection": 107, "offsetInEndSection": 299, "text": "The identification of competing endogenous RNA and circular RNA (circRNA) as important regulators of miRNA activity underscores the increasing complexity of ncRNA-mediated regulatory networks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 0, "offsetInEndSection": 158, "text": "Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer's Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27929395"}, {"offsetInBeginSection": 451, "offsetInEndSection": 578, "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}, {"offsetInBeginSection": 300, "offsetInEndSection": 484, "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 358, "offsetInEndSection": 450, "text": "We previously identified a highly expressed circular RNA (circRNA) in human and mouse brain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}, {"offsetInBeginSection": 579, "offsetInEndSection": 747, "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}, {"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "The emerging landscape of circular RNA ciRS-7 in cancer (Review).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049"}, {"offsetInBeginSection": 331, "offsetInEndSection": 394, "text": "Also, ciRS-7 acts as a natural competing endogenous RNA, a.k.a.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049"}, {"offsetInBeginSection": 0, "offsetInEndSection": 33, "text": "Circular RNA and miR-7 in cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 364, "offsetInEndSection": 592, "text": "Conventional methods of ssRNA, microRNA (miRNA), or messenger RNA (mRNA) detection and quantitation requiring free ribonucleotide ends may have considerably underestimated the quantity and significance of CNS circRNA in the CNS.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27929395"}]}, {"id": "5aae6a86fcf456587200000e", "body": "What are the 3 types of ultraviolet (UV) solar radiation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25040832", "http://www.ncbi.nlm.nih.gov/pubmed/20519675", "http://www.ncbi.nlm.nih.gov/pubmed/17204418", "http://www.ncbi.nlm.nih.gov/pubmed/12821280", "http://www.ncbi.nlm.nih.gov/pubmed/9577442", "http://www.ncbi.nlm.nih.gov/pubmed/22268421", "http://www.ncbi.nlm.nih.gov/pubmed/21192130", "http://www.ncbi.nlm.nih.gov/pubmed/11920550", "http://www.ncbi.nlm.nih.gov/pubmed/22163847", "http://www.ncbi.nlm.nih.gov/pubmed/16897517"], "snippets": [{"offsetInBeginSection": 777, "offsetInEndSection": 1065, "text": "In addition, mutations induced by solar UV radiation in p53, ras and patched genes of non-melanoma skin cancer cells, and the role of ROS as both a promoter in UV-carcinogenesis and an inducer of UV-apoptosis, are described based primarily on the findings reported during the last decade.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12821280"}, {"offsetInBeginSection": 512, "offsetInEndSection": 1119, "text": "It had two fixed radiation sensors total solar and ultraviolet A radiation sensor manual ultraviolet calibrated according to the erythemal response of skin measuring human ultraviolet index and the maximum exposure timer ecommended for different skin types (Safesun from Optix Tech, Inc.).The aim of this study was to measure the rate and exposure ultraviolet (UV) to evaluate the erythemal effect on most sensitive areas of the face and neck to noon fotoexposici\u00f3n solar in the four annual seasons, and thus promote extending protection regulations to prevent the effects harmful UV non-ionizing radiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21192130"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "OBJECTIVE: To determine the value of shade in protecting humans from solar ultraviolet (UV) radiation.DESIGN AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9577442"}, {"offsetInBeginSection": 390, "offsetInEndSection": 594, "text": "The purpose of the current study was to determine how many types of cancer are affected by solar radiation and how many premature deaths from cancer occur due to insufficient ultraviolet (UV)-B radiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11920550"}, {"offsetInBeginSection": 194, "offsetInEndSection": 371, "text": "Among types of solar radiation, ultraviolet B (290-320 nm) radiation is highly mutagenic and carcinogenic in animal experiments compared to ultraviolet A (320-400 nm) radiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12821280"}, {"offsetInBeginSection": 0, "offsetInEndSection": 259, "text": "Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Epidermal UV-A absorbance and whole-leaf flavonoid composition in pea respond more to solar blue light than to solar UV radiation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832"}, {"offsetInBeginSection": 126, "offsetInEndSection": 415, "text": "We have shown that patients that have to protect themselves against solar UV radiation for medical reasons, including patients with xeroderma pigmentosum (XP), basal cell nevus syndrome (BCNS), lupus erythematodes (LE) or transplant recipients, are at risk to develop vitamin D deficiency.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Solar ultraviolet (UV) radiation is widely known as a genotoxic environmental agent that affects Earth ecosystems and the human population.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22163847"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "Ultraviolet (UV) radiation is an important environmental factor for plant communities; however, plant responses to solar UV are not fully understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519675"}]}, {"id": "5ac08fe7d0c506ce46000003", "body": "Of what origin is the MCF-7 cell line?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21116879", "http://www.ncbi.nlm.nih.gov/pubmed/176383", "http://www.ncbi.nlm.nih.gov/pubmed/15183541", "http://www.ncbi.nlm.nih.gov/pubmed/16158200", "http://www.ncbi.nlm.nih.gov/pubmed/25725141", "http://www.ncbi.nlm.nih.gov/pubmed/7604203", "http://www.ncbi.nlm.nih.gov/pubmed/25733816"], "snippets": [{"offsetInBeginSection": 1405, "offsetInEndSection": 1658, "text": "These results indicate that DHAQC (2) is a synthetic, cytotoxic, and selective anthraquinone, which is less toxic than the natural product damnacanthal, and which demonstrates potential in the induction of apoptosis in the breast cancer MCF-7 cell line.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25733816"}, {"offsetInBeginSection": 636, "offsetInEndSection": 877, "text": "DHAQC (2) showed a slightly higher IC50 (inhibitory concentration with 50% cell viability) value in the MCF-7 cell line compared to damnacanthal, but it is more selective in terms of the ratio of IC50 on MCF-7 cells and normal MCF-10A cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25733816"}, {"offsetInBeginSection": 944, "offsetInEndSection": 1182, "text": "The flow cytometry cell cycle analysis on the MCF-7 cell line treated with the IC50 dose of DHAQC (2) for 48 hours showed that DHAQC (2) arrested MCF-7 cell line at the G2/M phase in association with an inhibited expression of PLK1 genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25733816"}, {"offsetInBeginSection": 129, "offsetInEndSection": 332, "text": "Previous studies in our laboratory showed that MCF-7/ADR has a unique cytosolic protein expression pattern when compared to that of the parental MCF-7 cell line and other drug resistant MCF-7 cell lines.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15183541"}, {"offsetInBeginSection": 1277, "offsetInEndSection": 1352, "text": "MCF-7/ADR and the breast cancer cell line MCF-7 are not of the same origin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 222, "offsetInEndSection": 327, "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25733816"}, {"offsetInBeginSection": 0, "offsetInEndSection": 128, "text": "The adriamycin resistant breast cancer cell line (MCF-7/ADR) is a subject of ongoing debate concerning its origin and or source.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15183541"}, {"offsetInBeginSection": 993, "offsetInEndSection": 1122, "text": "Cell death assay and DNA fragmentation analysis using the TUNEL test confirmed the induction of apoptosis in the MCF-7 cell line.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25725141"}, {"offsetInBeginSection": 383, "offsetInEndSection": 635, "text": "Results from the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed that DHAQC (2) exhibited potential cytotoxicity and selectivity in the MCF-7 cell line, comparable with the naturally occurring anthraquinone damnacanthal.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25733816"}]}, {"id": "589a247078275d0c4a000035", "body": "Dinutuximab is used for treatment of which disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26917818", "http://www.ncbi.nlm.nih.gov/pubmed/28389455", "http://www.ncbi.nlm.nih.gov/pubmed/25940913", "http://www.ncbi.nlm.nih.gov/pubmed/26934530", "http://www.ncbi.nlm.nih.gov/pubmed/26891967", "http://www.ncbi.nlm.nih.gov/pubmed/25851859", "http://www.ncbi.nlm.nih.gov/pubmed/28549783", "http://www.ncbi.nlm.nih.gov/pubmed/27456981"], "snippets": [{"offsetInBeginSection": 934, "offsetInEndSection": 1338, "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 981, "offsetInEndSection": 1324, "text": "Computer-based randomisation with sequence generation defined by permuted block randomisation (block size two) was used to randomly assign patients (1:1) to irinotecan and temozolomide plus either temsirolimus or dinutuximab, stratified by disease category, previous exposure to anti-GD2 antibody therapy, and tumour MYCN amplification status.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28549783"}, {"offsetInBeginSection": 188, "offsetInEndSection": 286, "text": "GD2 is a glycolipid found on the surface of tumour cells, which is overexpressed in neuroblastoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913"}, {"offsetInBeginSection": 1588, "offsetInEndSection": 1870, "text": "CONCLUSIONS: Dinutuximab is the first anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 636, "offsetInEndSection": 797, "text": "The marketing authorization application for dinutuximab is under regulatory review in the EU, and phase I-III development is underway in several other countries.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913"}, {"offsetInBeginSection": 825, "offsetInEndSection": 988, "text": "CONCLUSION: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455"}, {"offsetInBeginSection": 0, "offsetInEndSection": 200, "text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967"}, {"offsetInBeginSection": 184, "offsetInEndSection": 466, "text": "SUMMARY: Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455"}, {"offsetInBeginSection": 1871, "offsetInEndSection": 2047, "text": "Ongoing research will determine if dinutuximab could be used earlier in treatment, in nonresponders to initial therapies, in combination with chemotherapy, or in other cancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 775, "offsetInEndSection": 825, "text": "The recommended dosage of dinutuximab is 17.5 mg/m", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455"}]}, {"id": "5ac24c9495d0062724000002", "body": "What is the ChIP-exo method used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28060339", "http://www.ncbi.nlm.nih.gov/pubmed/23026909", "http://www.ncbi.nlm.nih.gov/pubmed/24373287", "http://www.ncbi.nlm.nih.gov/pubmed/25249628", "http://www.ncbi.nlm.nih.gov/pubmed/27246337"], "snippets": [{"offsetInBeginSection": 1103, "offsetInEndSection": 1444, "text": "When applied to published human CTCF, yeast Reb1 and our own mouse ONECUT1/HNF6 ChIP-exo data, MACE is able to define TFBSs with high sensitivity, specificity and spatial resolution, as evidenced by multiple criteria including motif enrichment, sequence conservation, direct sequence pileup, nucleosome positioning and open chromatin states.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25249628"}, {"offsetInBeginSection": 123, "offsetInEndSection": 324, "text": "We describe an Illumina-based ChIP-exo method which provides a global improvement of the data quality of estrogen receptor (ER) ChIP and insights into the motif structure for key ER-associated factors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287"}, {"offsetInBeginSection": 160, "offsetInEndSection": 306, "text": "ChIP coupled to high throughput sequencing (ChIP-seq) is commonly used to determine the genomic location of proteins that interact with chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 1065, "offsetInEndSection": 1264, "text": "In this chapter, we provide a brief commentary on these methodological changes and describe a detailed ChIP-exo method able to generate narrower peaks and greater peak coverage from ChIPped material.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27246337"}, {"offsetInBeginSection": 986, "offsetInEndSection": 1138, "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "Mapping Protein-DNA Interactions Using ChIP-exo and Illumina-Based Sequencing.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27246337"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909"}, {"offsetInBeginSection": 0, "offsetInEndSection": 88, "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 432, "offsetInEndSection": 544, "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "ChIP-exonuclease (ChIP-exo) is a modified ChIP-seq approach for high resolution mapping of transcription factor DNA sites.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287"}]}, {"id": "5a74acd80384be9551000006", "body": "Are AAV vectors considered for the treatment of retinal dystrophies?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21818300", "http://www.ncbi.nlm.nih.gov/pubmed/28596937", "http://www.ncbi.nlm.nih.gov/pubmed/21880665", "http://www.ncbi.nlm.nih.gov/pubmed/19373675", "http://www.ncbi.nlm.nih.gov/pubmed/24327302", "http://www.ncbi.nlm.nih.gov/pubmed/27416076", "http://www.ncbi.nlm.nih.gov/pubmed/27653967", "http://www.ncbi.nlm.nih.gov/pubmed/26609316", "http://www.ncbi.nlm.nih.gov/pubmed/15960597", "http://www.ncbi.nlm.nih.gov/pubmed/26015954"], "snippets": [{"offsetInBeginSection": 442, "offsetInEndSection": 682, "text": "In the sheltered environment of the retina, AAV vectors are able to maintain high levels of transgene expression in the retinal pigmented epithelium (RPE), photoreceptors, or ganglion cells for long periods of time after a single treatment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "BACKGROUND: Gene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300"}, {"offsetInBeginSection": 1313, "offsetInEndSection": 1495, "text": "Our results provide important considerations for viral vectors to be used in future gene therapy clinical trials targeting a wider severity spectrum of inherited retinal dystrophies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665"}, {"offsetInBeginSection": 0, "offsetInEndSection": 260, "text": "Despite their physiological roles, M\u00fcller glial cells are involved directly or indirectly in retinal disease pathogenesis and are an interesting target for therapeutic approaches for retinal diseases and regeneration such as CRB1 inherited retinal dystrophies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26015954"}, {"offsetInBeginSection": 468, "offsetInEndSection": 654, "text": "Using this model, we evaluated if gene replacement therapy using recent advancements in adeno-associated viral vectors (AAV) provides advantages in preventing rapid retinal degeneration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665"}, {"offsetInBeginSection": 888, "offsetInEndSection": 1078, "text": "The benefits of sc-Y733F-AAV were evident following viral administration during the active phase of retinal degeneration, where only sc-Y733F-AAV treatment achieved functional vision rescue.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665"}, {"offsetInBeginSection": 0, "offsetInEndSection": 148, "text": "Gene therapy using adeno-associated viral (AAV) vectors for the treatment of retinal degenerations has shown safety and efficacy in clinical trials.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076"}, {"offsetInBeginSection": 0, "offsetInEndSection": 202, "text": "Recombinant adeno-associated viral (AAV) vectors have become powerful gene delivery tools for the treatment of retinal degeneration in a variety of animal models that mimic corresponding human diseases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597"}, {"offsetInBeginSection": 826, "offsetInEndSection": 1049, "text": "The focus of this review is on examples of AAV-mediated gene therapy in those animal models of inherited retinal degeneration caused by mutations directly affecting the interacting unit formed by photoreceptors and the RPE.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597"}, {"offsetInBeginSection": 287, "offsetInEndSection": 595, "text": "In animal models of RPE65 deficiency, subretinal injection of recombinant adeno-associated virus (AAV) 2/2 vectors carrying RPE65 cDNA improves rod photoreceptor function, and intervention at an early stage of disease provides sustained benefit by protecting cone photoreceptors against retinal degeneration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27653967"}]}, {"id": "5ab2cc66fcf4565872000015", "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18799805", "http://www.ncbi.nlm.nih.gov/pubmed/15726657", "http://www.ncbi.nlm.nih.gov/pubmed/10620362", "http://www.ncbi.nlm.nih.gov/pubmed/23071008", "http://www.ncbi.nlm.nih.gov/pubmed/23974699", "http://www.ncbi.nlm.nih.gov/pubmed/11090943", "http://www.ncbi.nlm.nih.gov/pubmed/9413920", "http://www.ncbi.nlm.nih.gov/pubmed/10628745", "http://www.ncbi.nlm.nih.gov/pubmed/16432264", "http://www.ncbi.nlm.nih.gov/pubmed/26910068"], "snippets": [{"offsetInBeginSection": 646, "offsetInEndSection": 769, "text": "First, PXR is selectively expressed in the liver and intestine, the same tissues in which CYP3A gene expression is induced.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11090943"}, {"offsetInBeginSection": 1573, "offsetInEndSection": 1746, "text": "CYP2H1, a well-characterized inducible chicken cytochrome P450, also was induced by the same compounds, suggesting similar regulation of CYP3 and CYP2 genes in this species.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10620362"}, {"offsetInBeginSection": 858, "offsetInEndSection": 995, "text": "Consistent with CYP3A expression, hepatic CYP3A activity increased approximately 5-fold in TgCYP3A4/hPXR mice pretreated with rifampicin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805"}, {"offsetInBeginSection": 782, "offsetInEndSection": 956, "text": "The induced CYP2C19 and CYP3A activities remained elevated at 4 days after rifampicin discontinuation and returned to baseline levels 8 days after rifampicin discontinuation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23974699"}, {"offsetInBeginSection": 996, "offsetInEndSection": 1232, "text": "Most antihuman immunodeficiency virus protease inhibitors are CYP3A substrates and their interactions with rifamycins are a source of major concern in patients coinfected with human immunodeficiency virus and Mycobacterium tuberculosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805"}, {"offsetInBeginSection": 131, "offsetInEndSection": 311, "text": "CYP3A is of key importance in human drug metabolism, being involved in presystemic extraction of more than 50% of all drugs currently available and of various endogenous compounds.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657"}, {"offsetInBeginSection": 1233, "offsetInEndSection": 1534, "text": "By using TgCYP3A4/hPXR mice, human PXR-CYP3A4-mediated rifampicin-protease inhibitor interactions were recapitulated, as the metabolic stability of amprenavir, nelfinavir, and saquinavir decreased 52, 53, and 99%, respectively, in the liver microsomes of TgCYP3A4/hPXR mice pretreated with rifampicin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805"}, {"offsetInBeginSection": 352, "offsetInEndSection": 660, "text": "In this investigation, we tested the hypothesis that induction of cytochrome P450 (Cyp)3a11 gene by paclitaxel is downregulated by the inflammatory mediator, lipopolysaccharide (LPS), and that the pro-inflammatory cytokine, tumor necrosis factor (TNF)-\u03b1, attenuates human CYP3A4 gene induction by rifampicin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Transcription of genes encoding cytochrome P450 3A (CYP3A) monooxygenases is induced by a variety of xenobiotics and natural steroids.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10628745"}, {"offsetInBeginSection": 1483, "offsetInEndSection": 1604, "text": "The cells were then treated with the pro-inflammatory cytokine, TNF\u03b1, followed by the prototype CYP3A inducer rifampicin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068"}]}, {"id": "5ac0fccf19833b0d7b000007", "body": "What is the dardarin protein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/16750377"], "snippets": [{"offsetInBeginSection": 103, "offsetInEndSection": 204, "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 858, "offsetInEndSection": 1000, "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 0, "offsetInEndSection": 75, "text": "Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 393, "offsetInEndSection": 480, "text": "First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 312, "offsetInEndSection": 392, "text": "In this study, we noted two cellular phenotypes associated with mutant dardarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 205, "offsetInEndSection": 311, "text": "However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 481, "offsetInEndSection": 577, "text": "Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 724, "offsetInEndSection": 857, "text": "This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 578, "offsetInEndSection": 723, "text": "Manipulating activity by replacing the kinase domain with a 'kinase-dead' version blocks inclusion body formation and strongly delays cell death.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}]}, {"id": "58ec709aeda5a5767200000e", "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18637642", "http://www.ncbi.nlm.nih.gov/pubmed/22691567", "http://www.ncbi.nlm.nih.gov/pubmed/23600725", "http://www.ncbi.nlm.nih.gov/pubmed/27234918", "http://www.ncbi.nlm.nih.gov/pubmed/11706098", "http://www.ncbi.nlm.nih.gov/pubmed/19351232", "http://www.ncbi.nlm.nih.gov/pubmed/27072975", "http://www.ncbi.nlm.nih.gov/pubmed/10582983", "http://www.ncbi.nlm.nih.gov/pubmed/9305321", "http://www.ncbi.nlm.nih.gov/pubmed/12468781"], "snippets": [{"offsetInBeginSection": 68, "offsetInEndSection": 455, "text": "In humans, although a recent trial International Citicoline Trial on Acute Stroke (ICTUS) has shown that global recovery is similar in CDP-choline and placebo groups, CDP-choline was shown to be more beneficial in some patients, such as those with moderate stroke severity and not treated with t-PA. Several mechanisms have been proposed to explain the beneficial actions of CDP-choline.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23600725"}, {"offsetInBeginSection": 0, "offsetInEndSection": 213, "text": "The International Citicoline Trial in acUte Stroke is a sequential phase III study of the use of the drug citicoline in the treatment of acute ischaemic stroke, which was initiated in 2006 in 56 treatment centres.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642"}, {"offsetInBeginSection": 0, "offsetInEndSection": 52, "text": "Efficacy of citicoline as an acute stroke treatment.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232"}, {"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "BACKGROUND: Citicoline is approved in some countries for the treatment of acute ischaemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 0, "offsetInEndSection": 81, "text": "A randomized efficacy trial of citicoline in patients with acute ischemic stroke.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10582983"}, {"offsetInBeginSection": 1902, "offsetInEndSection": 2054, "text": "INTERPRETATION: Under the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 1607, "offsetInEndSection": 1722, "text": "CONCLUSIONS: This systematic review supports some benefits of citicoline in the treatment of acute ischemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918"}, {"offsetInBeginSection": 629, "offsetInEndSection": 1177, "text": "This approach was previously used in the analysis of the influential National Institute of Neurological Disorders and Stroke trial of recombinant tissue plasminogen activator in stroke.The purpose of this paper is to describe how this trial was designed, and in particular how the simultaneous objectives of taking into account three assessment scales, performing a series of interim analyses and conducting treatment allocation and adjusting the analyses to account for prognostic factors, including more than 50 treatment centres, were addressed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "BACKGROUND: Citicoline is a drug approved for the treatment of acute ischemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918"}, {"offsetInBeginSection": 1421, "offsetInEndSection": 1606, "text": "CONCLUSIONS: The results of this study indicate that citicoline was safe but ineffective in improving the outcome of patients with acute ischemic stroke who were enrolled in this trial.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10582983"}]}, {"id": "5ace238e0340b9f05800000d", "body": "Which human chromosome is the product of fusion?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27423248", "http://www.ncbi.nlm.nih.gov/pubmed/3325883", "http://www.ncbi.nlm.nih.gov/pubmed/7284984", "http://www.ncbi.nlm.nih.gov/pubmed/28333343", "http://www.ncbi.nlm.nih.gov/pubmed/9310467", "http://www.ncbi.nlm.nih.gov/pubmed/15815621", "http://www.ncbi.nlm.nih.gov/pubmed/8364539", "http://www.ncbi.nlm.nih.gov/pubmed/3289649", "http://www.ncbi.nlm.nih.gov/pubmed/7786792", "http://www.ncbi.nlm.nih.gov/pubmed/10470089"], "snippets": [{"offsetInBeginSection": 632, "offsetInEndSection": 961, "text": "We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28333343"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621"}, {"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 205, "offsetInEndSection": 372, "text": "We hypothesize that the near tetraploid chromosome number present in the tumor cells in both patients may be the product of fusion of two near diploid malignant cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7284984"}, {"offsetInBeginSection": 842, "offsetInEndSection": 1239, "text": "By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Fragments of human chromosome 8 were introduced into cells derived from murine scid mice via X-irradiation and somatic cell fusion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8364539"}, {"offsetInBeginSection": 257, "offsetInEndSection": 571, "text": "Alu-PCR products from these hybrids were used for chromosome painting using the technique of chromosome in situ suppression hybridization, allowing assignment of the human HYRC (hyper-radiosensitivity of murine scid mutation, complementing) gene, a candidate for a V(D)J recombinase gene, to human chromosome 8q11.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8364539"}, {"offsetInBeginSection": 339, "offsetInEndSection": 705, "text": "Unlike the site of fusion, which is enriched for sequences that are shared elsewhere in the human genome, the region of the nonfunctioning and degenerate ancestral centromere appears to share limited similarity with other sites in the human genome, thereby providing an opportunity to study this genomic arrangement in short, fragmented ancient DNA genomic datasets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 372, "offsetInEndSection": 592, "text": "The results also demonstrate that the product of the activated met gene is a fusion protein and that the amino terminal end of this fusion protein, which is encoded by human chromosome 1, exhibits homology to laminin B1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883"}, {"offsetInBeginSection": 0, "offsetInEndSection": 265, "text": "The ABL proto-oncogene on the Philadelphia chromosome is 'activated' by its translocation in a manner similar to its activation by the murine Abelson leukemia virus--with the formation of a fusion protein with a new N-terminus and enhanced tyrosine kinase activity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3289649"}]}, {"id": "5a7d5580faa1ab7d2e00001a", "body": "What in vivo tau tracers are being used?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24833492", "http://www.ncbi.nlm.nih.gov/pubmed/28219440", "http://www.ncbi.nlm.nih.gov/pubmed/28587897", "http://www.ncbi.nlm.nih.gov/pubmed/24924676", "http://www.ncbi.nlm.nih.gov/pubmed/28750496", "http://www.ncbi.nlm.nih.gov/pubmed/27683159", "http://www.ncbi.nlm.nih.gov/pubmed/27334944", "http://www.ncbi.nlm.nih.gov/pubmed/26697966", "http://www.ncbi.nlm.nih.gov/pubmed/26802556", "http://www.ncbi.nlm.nih.gov/pubmed/25239654"], "snippets": [{"offsetInBeginSection": 659, "offsetInEndSection": 798, "text": "An overview of the tau-PET radiotracer development scenario, focusing on tracers that are presently being examined in humans, is presented.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492"}, {"offsetInBeginSection": 526, "offsetInEndSection": 658, "text": "Selective PET radiotracers for amyloid-\u03b2 are already available, and potential tau tracers are emerging as new-generation biomarkers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492"}, {"offsetInBeginSection": 348, "offsetInEndSection": 496, "text": "Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654"}, {"offsetInBeginSection": 283, "offsetInEndSection": 384, "text": "The particularities of tau present some unique challenges for the development of tau imaging tracers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28750496"}, {"offsetInBeginSection": 325, "offsetInEndSection": 536, "text": "The advances of molecular imaging in the recent years have now led to the recent development of promising tau-specific tracers for positron emission tomography (PET), such as THK5317, THK5351, AV-1451, and PBB3.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}, {"offsetInBeginSection": 583, "offsetInEndSection": 717, "text": "Tau positron emission tomography radiolabelled probes such as T807, THK-5117, and PBB3 can image the pathology of the disease in vivo.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27334944"}, {"offsetInBeginSection": 1170, "offsetInEndSection": 1556, "text": "Recent progress in the development of these tracers is enabling the noninvasive assessment of the extent of tau pathology in the brain, eventually allowing the quantification of changes in tau pathology over time and its relation to cognitive performance, brain volumetrics, and other biomarkers, as well as assessment of efficacy and patient recruitment for antitau therapeutic trials.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24924676"}, {"offsetInBeginSection": 151, "offsetInEndSection": 560, "text": "The considerable evidence pointing at the accumulation of tau aggregates and its recognition as a risk factor in neurodegenerative conditions such as Alzheimer's disease have led to a major effort to develop selective tau ligands that would allow research into the physiopathologic underpinnings of traumatic brain injury and chronic traumatic encephalopathy in military personnel and the civilian population.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24924676"}, {"offsetInBeginSection": 1055, "offsetInEndSection": 1169, "text": "A worldwide effort has focused on the development of imaging agents that will allow selective tau imaging in vivo.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24924676"}, {"offsetInBeginSection": 257, "offsetInEndSection": 344, "text": "In the past decade, we developed 2-arylquinoline (2-AQ) derivatives as PET tau tracers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26697966"}]}, {"id": "5ab90a79fcf456587200001b", "body": "What drug treatment can cause a spinal epidural hematoma?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22175167", "http://www.ncbi.nlm.nih.gov/pubmed/15043358", "http://www.ncbi.nlm.nih.gov/pubmed/11707724", "http://www.ncbi.nlm.nih.gov/pubmed/21082060", "http://www.ncbi.nlm.nih.gov/pubmed/28614233", "http://www.ncbi.nlm.nih.gov/pubmed/27495842", "http://www.ncbi.nlm.nih.gov/pubmed/23351908", "http://www.ncbi.nlm.nih.gov/pubmed/18685937", "http://www.ncbi.nlm.nih.gov/pubmed/8447556", "http://www.ncbi.nlm.nih.gov/pubmed/21799620"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 98, "text": "Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620"}, {"offsetInBeginSection": 493, "offsetInEndSection": 618, "text": "Those include cardiac arrest, meningitis, intracranial subdural hematoma, spinal epidural hematoma and cauda equina syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 0, "offsetInEndSection": 311, "text": "We present a case of a 42-year-old male, an old case of deep vein thrombosis on warfarin and other drugs like quetiapine, aspirin, diclofenac sodium, fenofibrate, atorvastatin, propanolol and citalopram for concurrent illnesses, who presented with widespread mucocutaneous bleeding and epidural spinal hematoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "Spontaneous spinal epidural hematoma is an uncommon cause of spinal cord compression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "PURPOSE: Although intracranial hemorrhage remains a leading cause of death in hemophilia, spinal epidural hematoma is seen rarely.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8447556"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Spinal epidural hematoma following epidural catheter removal during antiplatelet therapy with cilostazol.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18685937"}, {"offsetInBeginSection": 274, "offsetInEndSection": 367, "text": "Spontaneous spinal epidural hematoma is an uncommon phenomenon and may be of uncertain cause.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724"}, {"offsetInBeginSection": 97, "offsetInEndSection": 230, "text": "Even though spinal epidural hematoma after caudal epidural injection is rare but it can cause serious neurologic complication.PATIENT", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614233"}, {"offsetInBeginSection": 133, "offsetInEndSection": 436, "text": "We assume that the pathogenic cause of this rare disease was an overlap between three main factors: the surgical aggression of the internal anterior epidural venous plexus; a possible increase of intra-thoracic pressure due to chronic obstructive pulmonary disease; and double antiplatelet drug therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23351908"}, {"offsetInBeginSection": 116, "offsetInEndSection": 275, "text": "After an epidural catheter (used for intraoperative/postoperative management) was removed, a spinal epidural hematoma involving the Th12 to L3 areas developed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18685937"}]}, {"id": "5ac28c0c95d006272400000a", "body": "What is the basis of the Sp3 procedure used in proteomics?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25358341", "http://www.ncbi.nlm.nih.gov/pubmed/28948796", "http://www.ncbi.nlm.nih.gov/pubmed/27668303"], "snippets": [{"offsetInBeginSection": 197, "offsetInEndSection": 511, "text": "In this study, we examined the effect of TFF2 on gastric cancer cell lines in\u00a0vitro and characterized the interaction between TFF2 and Sp3, including the mechanisms that mediate this interaction, using genomics and proteomics approaches, as well as genetics techniques, such as RNA interference and gene knockdown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303"}, {"offsetInBeginSection": 137, "offsetInEndSection": 347, "text": "Here, we performed an independent comparison between single-pot solid-phase-enhanced sample preparation (SP3), filter-aided sample preparation (FASP), and a commercial kit based on the in-StageTip (iST) method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796"}, {"offsetInBeginSection": 1125, "offsetInEndSection": 1330, "text": "Together, the findings of this work position SP3 as a superior protocol that facilitates exciting new directions in multiple areas of proteomics ranging from developmental biology to clinical applications.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341"}, {"offsetInBeginSection": 699, "offsetInEndSection": 927, "text": "To illustrate these benefits, characterization of 1,000 HeLa cells and single Drosophila embryos is used to establish that SP3 provides an enhanced platform for profiling proteomes derived from sub-microgram amounts of material.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341"}, {"offsetInBeginSection": 305, "offsetInEndSection": 459, "text": "To address these challenges, here we introduce a novel protocol using paramagnetic beads, termed Single-Pot Solid-Phase-enhanced Sample Preparation (SP3).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "Efficient and reproducible sample preparation is a prerequisite for any robust and sensitive quantitative bottom-up proteomics workflow.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796"}, {"offsetInBeginSection": 770, "offsetInEndSection": 852, "text": "In contrast, SP3 and iST provided high proteome coverage even in the low \u03bcg range.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796"}, {"offsetInBeginSection": 1243, "offsetInEndSection": 1390, "text": "The data from our study demonstrate that the antitumor activity of TFF2 is mediated by an interaction with the Sp3 protein in gastric cancer cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303"}, {"offsetInBeginSection": 512, "offsetInEndSection": 623, "text": "Assays were performed to examine the role of TFF2 and Sp3 in cancer cell proliferation, invasion and migration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303"}]}, {"id": "5a896c26fcd1d6a10c000007", "body": "In which syndrome is the RPS19 gene most frequently mutated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24675553", "http://www.ncbi.nlm.nih.gov/pubmed/23990987", "http://www.ncbi.nlm.nih.gov/pubmed/21223253", "http://www.ncbi.nlm.nih.gov/pubmed/12351378", "http://www.ncbi.nlm.nih.gov/pubmed/18515656", "http://www.ncbi.nlm.nih.gov/pubmed/17053056", "http://www.ncbi.nlm.nih.gov/pubmed/21989989", "http://www.ncbi.nlm.nih.gov/pubmed/21435505", "http://www.ncbi.nlm.nih.gov/pubmed/15075082"], "snippets": [{"offsetInBeginSection": 142, "offsetInEndSection": 231, "text": "The ribosomal protein S19 gene (RPS19) is the most frequently mutated gene in DBA (~25%).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21223253"}, {"offsetInBeginSection": 203, "offsetInEndSection": 310, "text": "Recent reports show that the ribosomal protein S19 (RPS19) gene is mutated in 25% of all patients with DBA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12351378"}, {"offsetInBeginSection": 1217, "offsetInEndSection": 1356, "text": "In conclusion, heterozygous mutations in the known DBA genes RPS19, RPS26 and RPS17 were detected in seven out of nine Korean DBA patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 151, "offsetInEndSection": 227, "text": "Among these genes, ribosomal protein S19 (RPS19) is mutated most frequently.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21989989"}, {"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "The gene encoding the ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a congenital erythroblastopenia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17053056"}, {"offsetInBeginSection": 481, "offsetInEndSection": 649, "text": "Extensive study of the most frequently mutated gene, RPS19, has shown that mutations prevent the assembly of the ribosomal protein into forming pre-ribosomal particles.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21435505"}, {"offsetInBeginSection": 163, "offsetInEndSection": 309, "text": "It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987"}, {"offsetInBeginSection": 541, "offsetInEndSection": 634, "text": "Mutations in RPS19, RPS26 and RPS17 were detected in four, two and one patient, respectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 424, "offsetInEndSection": 563, "text": "These vectors were used to introduce the RPS19 gene into CD34(+) bone marrow (BM) cells from 4 patients with DBA with RPS19 gene mutations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12351378"}, {"offsetInBeginSection": 352, "offsetInEndSection": 540, "text": "In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}]}, {"id": "5ab908d4fcf456587200001a", "body": "What is the alternative lengthening of telomeres?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26428317", "http://www.ncbi.nlm.nih.gov/pubmed/26022452", "http://www.ncbi.nlm.nih.gov/pubmed/20403221", "http://www.ncbi.nlm.nih.gov/pubmed/19154407", "http://www.ncbi.nlm.nih.gov/pubmed/27726944", "http://www.ncbi.nlm.nih.gov/pubmed/26769142", "http://www.ncbi.nlm.nih.gov/pubmed/24531712", "http://www.ncbi.nlm.nih.gov/pubmed/22575867", "http://www.ncbi.nlm.nih.gov/pubmed/18215414", "http://www.ncbi.nlm.nih.gov/pubmed/21574432"], "snippets": [{"offsetInBeginSection": 942, "offsetInEndSection": 1296, "text": "Conversely, the number of the alternative lengthening of telomeres-associated promyelocytic leukemia bodies (APBs) detected by combined promyelocytic leukemia immunofluorescence and telomere-fluorescent in situ hybridization was statistically higher (57%) in the MSI-H gastric carcinomas compared to that in non-MSI-H gastric carcinomas (19%, P = 0.026).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19154407"}, {"offsetInBeginSection": 1365, "offsetInEndSection": 1575, "text": "Remarkably, all cases with loss of either ATRX or DAXX expression had alternative lengthening of telomeres, and 83% (19/23) of tumors that had alternative lengthening of telomeres showed loss of either protein.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452"}, {"offsetInBeginSection": 767, "offsetInEndSection": 981, "text": "Undifferentiated pleomorphic sarcomas were frequently alternative lengthening of telomeres positive (65%) and loss of ATRX was seen in approximately half of the alternative lengthening of telomeres-positive tumors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 748, "offsetInEndSection": 1069, "text": "In this study, we characterized the status of alternative telomere lengthening and expression of ATRX and DAXX in 111 liposarcomas (28 well-differentiated, 52 dedifferentiated, 20 myxoid or round cell, and 11 pleomorphic liposarcomas) by telomere fluorescence in situ hybridization and immunohistochemistry, respectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452"}, {"offsetInBeginSection": 1132, "offsetInEndSection": 1371, "text": "The presence of tumor-associated macrophages conferred a worse prognosis with reduced patient survival times (alternative lengthening of telomeres with and without macrophages P=0.0004, and telomerase with and without macrophages P=0.013).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26769142"}, {"offsetInBeginSection": 1905, "offsetInEndSection": 1984, "text": "Loss of ATRX was highly associated with alternative lengthening of telomeres (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 0, "offsetInEndSection": 199, "text": "Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22575867"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 234, "offsetInEndSection": 365, "text": "However, some cancer cells maintain telomere length through an alternative mechanism termed 'alternative lengthening of telomeres'.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20403221"}, {"offsetInBeginSection": 371, "offsetInEndSection": 567, "text": "We previously reported that alternative lengthening of telomeres and loss of ATRX expression were common in leiomyosarcoma, angiosarcoma, pleomorphic liposarcoma, and dedifferentiated liposarcoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}]}, {"id": "5abcf010fcf4565872000023", "body": "What nerve is involved in carpal tunnel syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27894853", "http://www.ncbi.nlm.nih.gov/pubmed/7235907", "http://www.ncbi.nlm.nih.gov/pubmed/19336461", "http://www.ncbi.nlm.nih.gov/pubmed/25206437", "http://www.ncbi.nlm.nih.gov/pubmed/25630774", "http://www.ncbi.nlm.nih.gov/pubmed/26014322", "http://www.ncbi.nlm.nih.gov/pubmed/7594983", "http://www.ncbi.nlm.nih.gov/pubmed/6231697", "http://www.ncbi.nlm.nih.gov/pubmed/23590784", "http://www.ncbi.nlm.nih.gov/pubmed/28718333"], "snippets": [{"offsetInBeginSection": 349, "offsetInEndSection": 535, "text": "If paresthesia involved the thenar eminence and proximal forearm pain was noted in cases of carpal tunnel syndrome, carpal tunnel syndrome combined with pronator syndrome was considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 1182, "offsetInEndSection": 1363, "text": "These findings indicate that in patients with minimal to moderate carpal tunnel syndrome, there is some electrophysiological evidence of traction on the adjacent ulnar nerve fibers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25206437"}, {"offsetInBeginSection": 1423, "offsetInEndSection": 1591, "text": "Of the 344 cases, 322 involved carpal tunnel syndrome alone, 1 involved pronator syndrome alone, and 21 involved carpal tunnel syndrome combined with pronator syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 614, "offsetInEndSection": 716, "text": "Therefore, if nocturnal symptoms occurred in pronator syndrome, carpal tunnel syndrome was considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 542, "offsetInEndSection": 696, "text": "The bifid median nerve is one cause of carpal tunnel syndrome because of its relatively higher cross-sectional area compared with a nonbifid median nerve.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23590784"}, {"offsetInBeginSection": 0, "offsetInEndSection": 155, "text": "The distribution of sensory symptoms in carpal tunnel syndrome is strongly dependent on the degree of electrophysiological dysfunction of the median nerve.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25206437"}, {"offsetInBeginSection": 2270, "offsetInEndSection": 2479, "text": "CONCLUSION: It is important to consider the diagnosis of double crush syndrome of the median nerve, as carpal tunnel syndrome combined with pronator syndrome may impede treatment of the carpal tunnel syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 144, "offsetInEndSection": 312, "text": "Carpal tunnel syndrome is usually caused by compression of the median nerve due to synovial swelling, tumor, or anomalous anatomical structure within the carpal tunnel.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28718333"}, {"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "BACKGROUND: Compression of the median nerve at the wrist, or carpal tunnel syndrome, is the most commonly recognized nerve entrapment syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28718333"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774"}]}, {"id": "5ad240f70340b9f058000015", "body": "Is human lysyl oxidase-like 2 a glycoprotein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20306300", "http://www.ncbi.nlm.nih.gov/pubmed/28112368", "http://www.ncbi.nlm.nih.gov/pubmed/25146937", "http://www.ncbi.nlm.nih.gov/pubmed/28350101", "http://www.ncbi.nlm.nih.gov/pubmed/21954900", "http://www.ncbi.nlm.nih.gov/pubmed/17018530", "http://www.ncbi.nlm.nih.gov/pubmed/27063404", "http://www.ncbi.nlm.nih.gov/pubmed/7706256", "http://www.ncbi.nlm.nih.gov/pubmed/23319596", "http://www.ncbi.nlm.nih.gov/pubmed/11334717"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 153, "text": "The human lysyl oxidase-like 3 (LOXL3) encodes a member of the emerging family of lysyl oxidase (LOX) that functions as a copper-dependent amine oxidase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018530"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28350101"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Human lysyl oxidase-like 3\u00a0(LOXL3) functions as a copper-dependent amine oxidase toward collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Human lysyl oxidase-like 3\u00a0(LOXL3) functions as a copper-dependent amine oxidase toward collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28350101"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256"}, {"offsetInBeginSection": 0, "offsetInEndSection": 119, "text": "Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23319596"}, {"offsetInBeginSection": 0, "offsetInEndSection": 167, "text": "Lysyl oxidase-like 2 (LOXL2) is a member of the lysyl oxidase family, which plays an important role in extracellular matrix protein biosynthesis and tumor progression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27063404"}, {"offsetInBeginSection": 0, "offsetInEndSection": 233, "text": "A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900"}, {"offsetInBeginSection": 0, "offsetInEndSection": 153, "text": "Lysyl oxidase like-2 (LOXL2) belongs to the lysyl oxidase (LOX) family, which comprises Cu(2+)- and lysine tyrosylquinone (LTQ)-dependent amine oxidases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25146937"}]}, {"id": "5a86e6fafaa1ab7d2e000036", "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25602132", "http://www.ncbi.nlm.nih.gov/pubmed/26359231", "http://www.ncbi.nlm.nih.gov/pubmed/25559185", "http://www.ncbi.nlm.nih.gov/pubmed/24717229", "http://www.ncbi.nlm.nih.gov/pubmed/23934658", "http://www.ncbi.nlm.nih.gov/pubmed/25784758"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231"}, {"offsetInBeginSection": 1007, "offsetInEndSection": 1159, "text": "Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231"}, {"offsetInBeginSection": 856, "offsetInEndSection": 1006, "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231"}, {"offsetInBeginSection": 203, "offsetInEndSection": 312, "text": "However, little is known about how these lamina-associated domains (LADs) are directed to the nuclear lamina.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559185"}, {"offsetInBeginSection": 104, "offsetInEndSection": 265, "text": "LADs have been identified by DamID, a proximity labeling assay, and more recently by chromatin immunoprecipitation-sequencing (ChIP-seq) of A- and B-type lamins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": "The nuclear lamina (NL) is thought to aid in the spatial organization of interphase chromosomes by providing an anchoring platform for hundreds of large genomic regions named lamina associated domains (LADs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24717229"}, {"offsetInBeginSection": 143, "offsetInEndSection": 378, "text": "Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "The nuclear lamina has been shown to interact with the genome through lamina-associated domains (LADs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 602, "offsetInEndSection": 855, "text": "Mesas form at lamin B1-associated domains (LADs) in replicative senescence and oncogene-induced senescence and overlap DNA hypomethylation regions in cancer, suggesting that pre-malignant senescent chromatin changes foreshadow epigenetic cancer changes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23934658"}]}, {"id": "5ac716810340b9f058000003", "body": "Name an lncRNA associated with dilated cardiomyopathy.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26951817"], "snippets": [{"offsetInBeginSection": 123, "offsetInEndSection": 258, "text": "Dysregulation of the lncRNA known as myocardial infarction-associated transcript (MIAT) has been associated with myocardial infarction.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 382, "offsetInEndSection": 624, "text": "A whole-transcriptome analysis of heart biopsy specimens and formalin-fixed, paraffin-embedded samples revealed that MIAT was overexpressed in patients with CCC, compared with subjects with noninflammatory dilated cardiomyopathy and controls.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Myocardial Infarction-Associated Transcript, a Long Noncoding RNA, Is Overexpressed During Dilated Cardiomyopathy Due to Chronic Chagas Disease.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 259, "offsetInEndSection": 340, "text": "Chagas disease causes a severe inflammatory dilated chronic cardiomyopathy (CCC).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Long noncoding RNAs (lncRNAs) modulate gene expression at the epigenetic, transcriptional, and posttranscriptional levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 672, "offsetInEndSection": 729, "text": "Results suggest that MIAT is a specific biomarker of CCC.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 341, "offsetInEndSection": 381, "text": "We investigated the role of MIAT in CCC.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 625, "offsetInEndSection": 671, "text": "These results were confirmed in a mouse model.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}]}, {"id": "5abcf108fcf4565872000025", "body": "What is myelin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28377211", "http://www.ncbi.nlm.nih.gov/pubmed/7650750", "http://www.ncbi.nlm.nih.gov/pubmed/24684721", "http://www.ncbi.nlm.nih.gov/pubmed/20186338", "http://www.ncbi.nlm.nih.gov/pubmed/25682762", "http://www.ncbi.nlm.nih.gov/pubmed/21401967", "http://www.ncbi.nlm.nih.gov/pubmed/2752082", "http://www.ncbi.nlm.nih.gov/pubmed/22102008", "http://www.ncbi.nlm.nih.gov/pubmed/2470784", "http://www.ncbi.nlm.nih.gov/pubmed/6191815"], "snippets": [{"offsetInBeginSection": 1617, "offsetInEndSection": 1855, "text": "Further, phagocytosis in serum-free medium of CD47+/+ myelin is augmented after knocking down SIRP\u03b1 levels (SIRP\u03b1-KD) in phagocytes by lentiviral infection with SIRP\u03b1-shRNA, whereas phagocytosis of myelin that lacks CD47 (CD47-/-) is not.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21401967"}, {"offsetInBeginSection": 1362, "offsetInEndSection": 1616, "text": "We then demonstrate that phagocytosis of CD47+/+ myelin is augmented when binding between myelin CD47 and SIRP\u03b1 on phagocytes is blocked by mAbs against CD47 and SIRP\u03b1, indicating that down-regulation of phagocytosis indeed depends on CD47-SIRP\u03b1 binding.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21401967"}, {"offsetInBeginSection": 154, "offsetInEndSection": 254, "text": "The present study was designed to determine whether myelin is opsonizable by anti-myelin antibodies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2470784"}, {"offsetInBeginSection": 1221, "offsetInEndSection": 1447, "text": "The myelin induced inflammatory response is myelin specific as sphingomyelin (the major lipid of myelin) and myelin basic protein (MBP, one of the major proteins of myelin) are not able to activate NF-kappaB signaling pathway.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20186338"}, {"offsetInBeginSection": 256, "offsetInEndSection": 745, "text": "Although it is well documented that degenerated myelin triggers undesirable inflammatory responses in autoimmune diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), there has been very little study of the direct inflammatory consequences of damaged myelin in spinal cord injury (SCI), i.e., there is no direct evidence to show that myelin debris from injured spinal cord can trigger undesirable inflammation in vitro and in vivo.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20186338"}, {"offsetInBeginSection": 1048, "offsetInEndSection": 1227, "text": "The MWF also correlated strongly with the TEM-derived myelin fraction, suggesting that MWF measures the amount of compact appearing myelin in both intact myelin and myelin debris.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 943, "offsetInEndSection": 1300, "text": "RESULTS: MS-derived myelin was phagocytosed more efficiently by THP-1 macrophages after 6-hour incubation (P\u2009=\u20090.001 for the percentage of myelin-phagocytosing cells and P\u2009=\u20090.0005 for total myelin uptake) and after 24-hour incubation (P\u2009=\u20090.0006 and P\u2009=\u20090.0001, respectively), and by microglia after 24-hour incubation (P\u2009=\u20090.0106 for total myelin uptake).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24684721"}, {"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "Myelin content is an important marker for neuropathology and MRI generated myelin water fraction (MWF) has been shown to correlate well with myelin content.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 157, "offsetInEndSection": 344, "text": "However, because MWF is based on the amount of signal from myelin water, that is, the water trapped between the myelin lipid bilayers, the reading may depend heavily on myelin morphology.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 831, "offsetInEndSection": 1047, "text": "The myelin period between normal and 3 or 8 weeks post-injury cords did not differ significantly, suggesting that as long as the bilayer structure is intact, myelin debris has the same water content as intact myelin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}]}, {"id": "5ad3013d0340b9f058000019", "body": "Can GDF15 be a biomarker for metformin treatment?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27974345"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 68, "text": "Growth Differentiation Factor 15 as a Novel Biomarker for Metformin.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 847, "offsetInEndSection": 995, "text": "CONCLUSIONS: GDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 374, "offsetInEndSection": 443, "text": "Regression models were used to identify biomarkers for metformin use.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 180, "offsetInEndSection": 373, "text": "METHODS: A total of 237 biomarkers were assayed in baseline serum from 8,401 participants (2,317 receiving metformin) in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 0, "offsetInEndSection": 62, "text": "OBJECTIVE: Metformin is a commonly used glucose-lowering drug.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 443, "offsetInEndSection": 695, "text": "RESULTS: Growth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 771, "offsetInEndSection": 846, "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 63, "offsetInEndSection": 179, "text": "However, apart from glycemic measures, no biomarker for its presence or dose has been identified.RESEARCH DESIGN AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 696, "offsetInEndSection": 770, "text": "For the remaining 25 linked biomarkers, the odds ranged from 0.71 to 1.24.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}]}, {"id": "5a8d8f39fcd1d6a10c000024", "body": "What is the TALE-iD method used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27940490", "http://www.ncbi.nlm.nih.gov/pubmed/23840477", "http://www.ncbi.nlm.nih.gov/pubmed/26854857", "http://www.ncbi.nlm.nih.gov/pubmed/24976123", "http://www.ncbi.nlm.nih.gov/pubmed/27811079", "http://www.ncbi.nlm.nih.gov/pubmed/26876161", "http://www.ncbi.nlm.nih.gov/pubmed/28074901", "http://www.ncbi.nlm.nih.gov/pubmed/23316790", "http://www.ncbi.nlm.nih.gov/pubmed/23869221", "http://www.ncbi.nlm.nih.gov/pubmed/23821439"], "snippets": [{"offsetInBeginSection": 778, "offsetInEndSection": 1139, "text": "Using different cell types and loci, computational modeling, and a methylation-based orthogonal validation method, \"TALE-iD\", we show that native interactions resemble cross-linked ones, but display improved signal-to-noise ratios and are more focal on regulatory elements and CTCF sites, while strictly abiding to topologically associating domain restrictions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490"}, {"offsetInBeginSection": 771, "offsetInEndSection": 1062, "text": "Here we describe FusX, a streamlined Golden Gate TALE assembly system that (1) is backward compatible with popular TALE backbones, (2) is functionalized as a single-tube 3-day TALE assembly process, (3) requires only commonly used basic molecular biology reagents, and (4) is cost-effective.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26854857"}, {"offsetInBeginSection": 1061, "offsetInEndSection": 1307, "text": "12 TALE constructs including 4 TALEN pairs targeted to mouse Gt(ROSA)26Sor gene and mouse Mstn gene sequences as well as 4 TALE-TF constructs targeted to mouse Oct4, c-Myc, Klf4 and Sox2 gene promoter sequences were generated by using our method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 166, "offsetInEndSection": 366, "text": "TALE nucleases (TALENs), composed of an engineered array of TALE repeats fused to the FokI nuclease domain, have been used successfully for directed genome editing in various organisms and cell types.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821439"}, {"offsetInBeginSection": 711, "offsetInEndSection": 852, "text": "We used our TALE-FP method to investigate the nuclei of several multicellular plant tissues including roots, hypocotyls, leaves, and flowers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27811079"}, {"offsetInBeginSection": 830, "offsetInEndSection": 1061, "text": "Third, we increased the versatility for diverse downstream applications by providing series of vector sets to generate both TALENs (TALE nucleases) and TALE-TFs (TALE-transcription factors) under the control of different promoters.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23316790"}, {"offsetInBeginSection": 367, "offsetInEndSection": 592, "text": "TALE transcription factors (TALE-TFs), consisting of engineered TALE repeat arrays linked to a transcriptional regulatory domain, have been used to up- or downregulate expression of endogenous genes in human cells and plants.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821439"}, {"offsetInBeginSection": 1259, "offsetInEndSection": 1481, "text": "This unit also describes improvements to the Zinc Finger and TALE Targeter (ZiFiT Targeter) web server (http://ZiFiT.partners.org) that facilitate the design and construction of FLASH TALE repeat arrays in high throughput.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821439"}, {"offsetInBeginSection": 451, "offsetInEndSection": 550, "text": "Here, we describe an improved method for characterizing TALE genes by the use of PacBio sequencing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26876161"}, {"offsetInBeginSection": 1080, "offsetInEndSection": 1300, "text": "Integrating predictions and available expression data in a TALE-gene network revealed multiple candidate transcriptional targets for many TALEs as well as several possible instances of functional convergence among TALEs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23869221"}]}, {"id": "5aa395fcd6d6b54f79000007", "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22007328", "http://www.ncbi.nlm.nih.gov/pubmed/28243993", "http://www.ncbi.nlm.nih.gov/pubmed/28984295", "http://www.ncbi.nlm.nih.gov/pubmed/28164324", "http://www.ncbi.nlm.nih.gov/pubmed/21247220", "http://www.ncbi.nlm.nih.gov/pubmed/10589082", "http://www.ncbi.nlm.nih.gov/pubmed/28782884", "http://www.ncbi.nlm.nih.gov/pubmed/28235209", "http://www.ncbi.nlm.nih.gov/pubmed/28877546", "http://www.ncbi.nlm.nih.gov/pubmed/28856423"], "snippets": [{"offsetInBeginSection": 253, "offsetInEndSection": 395, "text": "Recently, however, tumor lysis syndrome (TLS) resulting from rituximab has been reported in a patient with chronic lymphocytic leukemia (CLL).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082"}, {"offsetInBeginSection": 561, "offsetInEndSection": 772, "text": "Participants cited a range of etiologies and overlapping conditions including asthma, Reactive Airway Dysfunction Syndrome (RADS), Sick Building Syndrome (SBS), Chronic Fatigues Syndrome (CFS), and Fibromyalgia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328"}, {"offsetInBeginSection": 1147, "offsetInEndSection": 1282, "text": "For physically fit patients, chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab remains the current standard therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28782884"}, {"offsetInBeginSection": 1774, "offsetInEndSection": 1857, "text": "For the high-risk patients, treatment with rituximab and lenalidomide is an option.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 888, "offsetInEndSection": 1092, "text": "CONCLUSION: As with adults, JMG has high morbidity, particularly among children with generalized symptoms, and rituximab should be considered early in the course of the disease as a second-line treatment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28877546"}, {"offsetInBeginSection": 753, "offsetInEndSection": 1086, "text": "METHODS: From 1 to 30 November 2009, we retrospectively reviewed medical charts from Partners Multiple Sclerosis Centre, Brookline, MA, USA, of patients being treated with rituximab for MS between 20 November 2007 and 24 November 2009 for evidence of infusion-associated reactions and further classified reactions on a grading scale.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247220"}, {"offsetInBeginSection": 731, "offsetInEndSection": 859, "text": "Improvements in fragile X phenotypes have been observed following chronic treatment with R-baclofen, a selective agonist of GABA", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28984295"}, {"offsetInBeginSection": 1668, "offsetInEndSection": 1773, "text": "For the low-risk patients, bendamustine and rituximab or obinutuzumab and chlorambucil can be considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 772, "offsetInEndSection": 1061, "text": "Healthy, young patients with low-risk disease (mutated IgVH, del (13q)) should be offered fludarabine, chlorambucil, and rituximab (FCR), while similar patients with high-risk disease (unmutated IgVH, del (17p), del (11q), and complex karyotype) should be considered for ibrutinib therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1283, "offsetInEndSection": 1509, "text": "For unfit patients, currently available evidence supports two options for a first-line therapy: chlorambucil combined with an anti-CD20 antibody (obinutuzumab or rituximab or ofatumumab) or a continuous therapy with ibrutinib.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28782884"}]}, {"id": "5aa67b4fd6d6b54f7900000f", "body": "What disease is tinea ?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21169831", "http://www.ncbi.nlm.nih.gov/pubmed/15050029", "http://www.ncbi.nlm.nih.gov/pubmed/12040364", "http://www.ncbi.nlm.nih.gov/pubmed/24739076", "http://www.ncbi.nlm.nih.gov/pubmed/8021081", "http://www.ncbi.nlm.nih.gov/pubmed/7742235", "http://www.ncbi.nlm.nih.gov/pubmed/19231646", "http://www.ncbi.nlm.nih.gov/pubmed/8821157", "http://www.ncbi.nlm.nih.gov/pubmed/134458", "http://www.ncbi.nlm.nih.gov/pubmed/19942789"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 50, "text": "Tinea capitis: new perspectives on an old disease.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7742235"}, {"offsetInBeginSection": 1391, "offsetInEndSection": 1516, "text": "In some cases of refractory asthma, treatment of the associated tinea pedis infection may induce remission in airway disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}, {"offsetInBeginSection": 195, "offsetInEndSection": 262, "text": "Iatrogenic disease (tinea incognito) is a new and more subtle form.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "Occult tinea pedis in an Israeli population and predisposing factors for the acquisition of the disease.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24739076"}, {"offsetInBeginSection": 355, "offsetInEndSection": 689, "text": "FINDINGS: This review covers the most interesting aspects of the infrequent disease tinea imbricata, including the historical background, the epidemiologic aspects, highlighting the genetic and racial patterns of susceptibility to the acquisition of the disease, and the immunologic aspects that help to explain its clinical behavior.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Tinea pedis responds well to topical antifungal therapy, however, relapse of the disease is not uncommon.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12040364"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Tinea pedis is a chronic fungal infection of the feet, very often observed in patients who are immuno-suppressed or have diabetes mellitus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}, {"offsetInBeginSection": 274, "offsetInEndSection": 443, "text": "In Japan, any dermatophytosis other than favus or tinea imbricata is considered to be tinea, while outside Japan, favus and tinea imbricata are also classified as tinea.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789"}, {"offsetInBeginSection": 869, "offsetInEndSection": 924, "text": "Tinea unguium is regarded as one type of onychomycosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789"}, {"offsetInBeginSection": 142, "offsetInEndSection": 284, "text": "Tinea versicolor is a normal commensal of the skin which can become pathogenic particularly in patients with depressed cell-mediated immunity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8021081"}]}, {"id": "5ad4dd93133db5eb78000008", "body": "What is the clathrin triskelia structure?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19925798", "http://www.ncbi.nlm.nih.gov/pubmed/22563470", "http://www.ncbi.nlm.nih.gov/pubmed/18502808", "http://www.ncbi.nlm.nih.gov/pubmed/7738035", "http://www.ncbi.nlm.nih.gov/pubmed/1587861", "http://www.ncbi.nlm.nih.gov/pubmed/7674375", "http://www.ncbi.nlm.nih.gov/pubmed/2571614", "http://www.ncbi.nlm.nih.gov/pubmed/23270814", "http://www.ncbi.nlm.nih.gov/pubmed/11943181", "http://www.ncbi.nlm.nih.gov/pubmed/10926122"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 253, "text": "Atomic force microscopy (AFM), single molecule force spectroscopy (SMFS), and single particle force spectroscopy (SPFS) are used to characterize intermolecular interactions and domain structures of clathrin triskelia and clathrin-coated vesicles (CCVs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23270814"}, {"offsetInBeginSection": 899, "offsetInEndSection": 1066, "text": "SPFS of clathrin assemblies exposes weaker clathrin-clathrin interactions that are indicative of inter-leg association essential for RME and intracellular trafficking.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23270814"}, {"offsetInBeginSection": 420, "offsetInEndSection": 572, "text": "The 42-kDa central region of AP-3 can bind to both clathrin triskelia and to clathrin cages, but cannot assemble clathrin triskelia into clathrin cages.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7738035"}, {"offsetInBeginSection": 1378, "offsetInEndSection": 1574, "text": "The finding that the 33 kD NH2-terminus of F1-20/AP-3 binds to clathrin triskelia but fails to assemble clathrin triskelia into clathrin cages is consistent with the published proteolysis studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7674375"}, {"offsetInBeginSection": 880, "offsetInEndSection": 1082, "text": "We also express the 33 kD NH2-terminus of F1-20/AP-3 in E. coli, and measure its ability to bind to clathrin triskelia, to bind to clathrin cages, and to assemble clathrin triskelia into clathrin cages.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7674375"}, {"offsetInBeginSection": 349, "offsetInEndSection": 580, "text": "Here, we subject individual triskelia, bovine-brain CCVs, and reconstituted clathrin-AP180 coats to AFM-SMFS and AFM-SPFS pulling experiments and apply novel analytics to extract force-extension relations from very large data sets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23270814"}, {"offsetInBeginSection": 573, "offsetInEndSection": 727, "text": "The 16-kDa C-terminal region of AP-3 can bind to clathrin cages, but cannot bind to clathrin triskelia or assemble clathrin triskelia into clathrin cages.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7738035"}, {"offsetInBeginSection": 515, "offsetInEndSection": 628, "text": "The CALM protein could promote clathrin triskelia into clathrin cages and could bind the preformed clathrin cage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10926122"}, {"offsetInBeginSection": 629, "offsetInEndSection": 767, "text": "However, 33 kD N-terminal domain of CALM could not bind pre-assembled clathrin cages, but assemble clathrin triskelia into clathrin cages.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10926122"}, {"offsetInBeginSection": 297, "offsetInEndSection": 460, "text": "Likewise, incubation of soluble clathrin triskelia with purified uncoating ATPase also led to trimeric binding of the ATPase to the vertices of clathrin triskelia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2571614"}]}, {"id": "5ace37d50340b9f058000011", "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/16034947", "http://www.ncbi.nlm.nih.gov/pubmed/19009138", "http://www.ncbi.nlm.nih.gov/pubmed/19127040", "http://www.ncbi.nlm.nih.gov/pubmed/21982529", "http://www.ncbi.nlm.nih.gov/pubmed/17290547", "http://www.ncbi.nlm.nih.gov/pubmed/16011530", "http://www.ncbi.nlm.nih.gov/pubmed/14716388", "http://www.ncbi.nlm.nih.gov/pubmed/14617302", "http://www.ncbi.nlm.nih.gov/pubmed/19245939", "http://www.ncbi.nlm.nih.gov/pubmed/28483415"], "snippets": [{"offsetInBeginSection": 169, "offsetInEndSection": 445, "text": "The increasing incidence of cryptococcal infection as a result of the AIDS epidemic, the recent emergence of a hypervirulent cryptococcal strain in Canada and the fact that mortality from cryptococcal disease remains high have stimulated intensive research into this organism.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19245939"}, {"offsetInBeginSection": 2211, "offsetInEndSection": 2394, "text": "CONCLUSIONS: Antifungal primary prophylaxis with either itraconazole or fluconazole is effective in reducing the incidence of cryptococcal disease in adults with advanced HIV disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Despite advances in the treatment of HIV disease, the incidence and mortality of invasive cryptococcal disease remain significant.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16011530"}, {"offsetInBeginSection": 131, "offsetInEndSection": 250, "text": "Primary prophylaxis with antifungal interventions may decrease cryptococcal disease incidence and associated mortality.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 113, "offsetInEndSection": 317, "text": "Global burden estimates are crucial to guide prevention strategies and to determine treatment needs, and we aimed to provide an updated estimate of global incidence of HIV-associated cryptococcal disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28483415"}, {"offsetInBeginSection": 131, "offsetInEndSection": 334, "text": "A matched, case-control study was performed to examine the impact of highly active antiretroviral therapy (HAART) and azole use on the incidence of invasive cryptococcal disease in HIV-infected patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16011530"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "BACKGROUND: Cryptococcal disease is an opportunistic infection that causes significant morbidity and mortality in adults with HIV.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 0, "offsetInEndSection": 189, "text": "BACKGROUND: Cryptococcal disease remains an important cause of morbidity and mortality in HIV-infected individuals in sub-Saharan Africa, despite the introduction of antiretroviral therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21982529"}, {"offsetInBeginSection": 95, "offsetInEndSection": 189, "text": "The incidence of cryptococcal meningitis has increased in parallel with that of HIV infection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388"}, {"offsetInBeginSection": 396, "offsetInEndSection": 512, "text": "RESULTS: The incidence of cryptococcal meningitis in Scandinavia seems to be lower than in other parts of the world.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388"}]}, {"id": "5ab8fb5bfcf4565872000017", "body": "How is the nuclear localization of lncRNA mediated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24732794", "http://www.ncbi.nlm.nih.gov/pubmed/27198227", "http://www.ncbi.nlm.nih.gov/pubmed/26578588"], "snippets": [{"offsetInBeginSection": 150, "offsetInEndSection": 427, "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 601, "offsetInEndSection": 863, "text": "Mutational analyses indicated that nuclear localization of BORG was mediated through a novel RNA motif consisting of the pentamer sequence AGCCC with sequence restrictions at positions -8 (T or A) and -3 (G or C) relative to the first nucleotide of the pentamer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 788, "offsetInEndSection": 1067, "text": "To address whether localization of the lncRNA influences susceptibility to degradation by either ASOs or RNAi, nuclear lncRNAs (MALAT1 and NEAT1), cytoplasmic lncRNAs (DANCR and OIP5-AS1) and dual-localized lncRNAs (TUG1, CasC7 and HOTAIR) were compared for knockdown efficiency.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588"}, {"offsetInBeginSection": 850, "offsetInEndSection": 1040, "text": "Our findings indicate that RBPs HuR and GRSF1 govern the cytoplasmic and mitochondrial localization of the lncRNA RMRP, which is encoded by nuclear DNA but has key functions in mitochondria.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 1068, "offsetInEndSection": 1269, "text": "We found that nuclear lncRNAs were more effectively suppressed using ASOs, cytoplasmic lncRNAs were more effectively suppressed using RNAi and dual-localized lncRNAs were suppressed using both methods.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588"}, {"offsetInBeginSection": 0, "offsetInEndSection": 166, "text": "Some mitochondrial long noncoding RNAs (lncRNAs) are encoded by nuclear DNA, but the mechanisms that mediate their transport to mitochondria are poorly characterized.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 1270, "offsetInEndSection": 1448, "text": "A mixed-modality approach combining ASOs and RNAi reagents improved knockdown efficacy, particularly for those lncRNAs that localize to both nuclear and cytoplasmic compartments.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588"}, {"offsetInBeginSection": 167, "offsetInEndSection": 440, "text": "Using affinity RNA pull-down followed by mass spectrometry analysis, we found two RNA-binding proteins (RBPs), HuR (human antigen R) and GRSF1 (G-rich RNA sequence-binding factor 1), that associated with the nuclear DNA-encoded lncRNA RMRP and mobilized it to mitochondria.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 864, "offsetInEndSection": 1092, "text": "Mutation of the motif to a scrambled sequence resulted in complete loss of nuclear localization, while addition of even a single copy of the motif to a cytoplasmically localized RNA was sufficient to impart nuclear localization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}]}, {"id": "5aa67b6ad6d6b54f79000010", "body": "What is Paget's Disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/7695525", "http://www.ncbi.nlm.nih.gov/pubmed/24160789", "http://www.ncbi.nlm.nih.gov/pubmed/17447970", "http://www.ncbi.nlm.nih.gov/pubmed/15389972", "http://www.ncbi.nlm.nih.gov/pubmed/6290548", "http://www.ncbi.nlm.nih.gov/pubmed/25025000", "http://www.ncbi.nlm.nih.gov/pubmed/3026195", "http://www.ncbi.nlm.nih.gov/pubmed/16429324", "http://www.ncbi.nlm.nih.gov/pubmed/8009241", "http://www.ncbi.nlm.nih.gov/pubmed/19032921"], "snippets": [{"offsetInBeginSection": 400, "offsetInEndSection": 620, "text": "Indeed, mammary Paget's disease is as a rule associated with an underlying breast carcinoma whereas association of extramammary Paget's disease with underlying (skin or visceral) malignancies occurs much less frequently.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17447970"}, {"offsetInBeginSection": 972, "offsetInEndSection": 1098, "text": "Among the environmental factors suggested to induce Paget's disease, chronic measles (MV) infection has been the most studied.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25025000"}, {"offsetInBeginSection": 59, "offsetInEndSection": 222, "text": "The classic late-onset Paget's disease is often caused by a P392L mutation in the gene SQSTM1, which disturbs signaling pathways in osteoclasts on cell activation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19032921"}, {"offsetInBeginSection": 143, "offsetInEndSection": 408, "text": "Based on the epidermal changes alone, Paget cells in 90% of specimens from lesions of extramammary Paget's disease had abundant mucin that stained well, whereas Paget cells in only 40% of specimens from mammary Paget's disease stained for mucin and faintly at that.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195"}, {"offsetInBeginSection": 621, "offsetInEndSection": 860, "text": "The Paget cells in these two conditions seem to have different origins, i.e., those of mammary Paget's disease ascend to the epidermis from lactiferous ducts, whereas those of extramammary Paget's disease originate in the epidermis itself.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Ten cases of mammary Paget's disease and 10 cases of extramammary Paget's disease were studied for differences of histologic features in them.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195"}, {"offsetInBeginSection": 309, "offsetInEndSection": 662, "text": "Its identification, along with the elucidation of other mutations underlying early-onset Paget's and Paget's disease seen in association with inclusion body myopathy and frontotemporal dementia, have redefined our understanding of genetic disorders of bone remodeling by emphasizing the importance of environmental determinants in their pathophysiology.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19032921"}, {"offsetInBeginSection": 443, "offsetInEndSection": 620, "text": "The conclusion derived from these observations is that the mucin in Paget cells of extramammary Paget's disease is different from that found in cells of mammary Paget's disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195"}, {"offsetInBeginSection": 129, "offsetInEndSection": 186, "text": "Paget's disease is primarily a disease of the osteoclast.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "Paget's disease is an intra-epidermal adenocarcinoma seen over the nipple/areola (mammary Paget's disease) or in extramammary body zones, such as the anogenital and perineal skin and the axilla.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17447970"}]}, {"id": "5a8980d2fcd1d6a10c00000d", "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24809334", "http://www.ncbi.nlm.nih.gov/pubmed/27339605", "http://www.ncbi.nlm.nih.gov/pubmed/19906816", "http://www.ncbi.nlm.nih.gov/pubmed/1763812", "http://www.ncbi.nlm.nih.gov/pubmed/22535970", "http://www.ncbi.nlm.nih.gov/pubmed/18407130", "http://www.ncbi.nlm.nih.gov/pubmed/21373720", "http://www.ncbi.nlm.nih.gov/pubmed/16464973", "http://www.ncbi.nlm.nih.gov/pubmed/27498420", "http://www.ncbi.nlm.nih.gov/pubmed/27641099"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 123, "text": "Cold-induced adaptive (or nonshivering) thermogenesis in small mammals is produced primarily in brown adipose tissue (BAT).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19906816"}, {"offsetInBeginSection": 365, "offsetInEndSection": 512, "text": "Heat production during hibernation is provided, in part, by nonshivering thermogenesis that occurs in large deposits of brown adipose tissue (BAT).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16464973"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "Brown adipose tissue (BAT) is the main effector of nonshivering thermogenesis and diet-induced thermogenesis in mammals.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1763812"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "BACKGROUND: Brown adipose tissue (BAT) thermogenesis is an adaptive process, essential for energy expenditure and involved in the control of obesity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339605"}, {"offsetInBeginSection": 0, "offsetInEndSection": 238, "text": "Promoting brown adipose tissue (BAT) development is an attractive strategy for the treatment of obesity, as activated BAT dissipates energy through thermogenesis; however, the mechanisms controlling BAT formation are not fully understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27641099"}, {"offsetInBeginSection": 0, "offsetInEndSection": 155, "text": "Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19906816"}, {"offsetInBeginSection": 217, "offsetInEndSection": 397, "text": "The finding of type II-thyroxine (T(4)) 5'-deiodinase in brown adipose tissue (BAT) has opened a way to uncover a more important role for thyroid hormone in adaptive thermogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18407130"}, {"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "CONTEXT: Stimulation of thermogenesis in brown adipose tissue (BAT) is a potential target to treat obesity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22535970"}, {"offsetInBeginSection": 0, "offsetInEndSection": 73, "text": "Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 0, "offsetInEndSection": 67, "text": "Thermogenic activation represses autophagy in brown adipose tissue.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339605"}]}, {"id": "5a99566e1d1251d03b00000f", "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12566936", "http://www.ncbi.nlm.nih.gov/pubmed/16436187", "http://www.ncbi.nlm.nih.gov/pubmed/16110245", "http://www.ncbi.nlm.nih.gov/pubmed/29075213", "http://www.ncbi.nlm.nih.gov/pubmed/16360899", "http://www.ncbi.nlm.nih.gov/pubmed/19657584", "http://www.ncbi.nlm.nih.gov/pubmed/18845200", "http://www.ncbi.nlm.nih.gov/pubmed/19194374", "http://www.ncbi.nlm.nih.gov/pubmed/25794322", "http://www.ncbi.nlm.nih.gov/pubmed/12554604"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 377, "text": "By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187"}, {"offsetInBeginSection": 357, "offsetInEndSection": 682, "text": "Subjects who were homozygous for the 4-repeat allele of the MAOA-uVNTR gene tended to have a higher total score on the Harm Avoidance (HA) dimension of the Tridimensional Personality Questionnaire (TPQ) (p = 0.056), and had a significantly higher score on subdimension 4 of HA (p = 0.020) compared with the 3-repeat carriers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": "Association studies suggest that the low activity variant of the monoamine oxidase A (MAOA)-uVNTR polymorphism confers risk for emotional disturbances associated with antisocial traits, particularly in males.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19194374"}, {"offsetInBeginSection": 0, "offsetInEndSection": 101, "text": "[Association between the MAOA-uVNTR polymorphism and antisocial personality traits in alcoholic men].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794322"}, {"offsetInBeginSection": 0, "offsetInEndSection": 111, "text": "Association study of a functional MAOA-uVNTR gene polymorphism and personality traits in Chinese young females.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "AIMS: We have analysed the MAOA-uVNTR polymorphism in the promoter region of the X-chromosomal monoamine oxidase A (MAOA) gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794322"}, {"offsetInBeginSection": 1129, "offsetInEndSection": 1313, "text": "CONCLUSIONS: Taken together, these findings suggest that the three-repeat allele of the MAOAuVNTR 30-bp polymorphism is not associated with impulsive and aggressive personality traits.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12554604"}, {"offsetInBeginSection": 1414, "offsetInEndSection": 1585, "text": "CONCLUSION: Taken together, these findings suggest that the MAOA-L genotype is to some extent associated with impulsive and antisocial personality traits in alcoholic men.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794322"}, {"offsetInBeginSection": 0, "offsetInEndSection": 222, "text": "Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584"}, {"offsetInBeginSection": 133, "offsetInEndSection": 274, "text": "We hypothesised that a functional polymorphism in the 5' untranslated region of the MAOA gene is associated with specific personality traits.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}]}, {"id": "5ab9032afcf4565872000018", "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20177397", "http://www.ncbi.nlm.nih.gov/pubmed/27725641", "http://www.ncbi.nlm.nih.gov/pubmed/25959793", "http://www.ncbi.nlm.nih.gov/pubmed/21311564", "http://www.ncbi.nlm.nih.gov/pubmed/26292731", "http://www.ncbi.nlm.nih.gov/pubmed/23204322", "http://www.ncbi.nlm.nih.gov/pubmed/21641882", "http://www.ncbi.nlm.nih.gov/pubmed/24845676", "http://www.ncbi.nlm.nih.gov/pubmed/27160911", "http://www.ncbi.nlm.nih.gov/pubmed/20098673"], "snippets": [{"offsetInBeginSection": 489, "offsetInEndSection": 846, "text": "Instead, the mutation patterns of the tumour suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397"}, {"offsetInBeginSection": 307, "offsetInEndSection": 482, "text": "We have previously shown that expression of oncogenes leads to DNA replication stress and genomic instability, explaining the high frequency of p53 mutations in human cancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311564"}, {"offsetInBeginSection": 1078, "offsetInEndSection": 1196, "text": "Thus, our results reveal a process of genomic instability generation triggered by precancerous DNA replication stress.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20098673"}, {"offsetInBeginSection": 389, "offsetInEndSection": 492, "text": "Aberrant oncogene expression induces replication stress, leading to DNA breaks and genomic instability.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793"}, {"offsetInBeginSection": 461, "offsetInEndSection": 677, "text": "Although oncogene acceleration primarily induces DNA replication stress and the resulting lesions in the S phase, these lesions are carried over into the M phase and cause cytokinesis failure and genomic instability.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20098673"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "Oncogene-induced DNA replication stress is thought to drive genomic instability in cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322"}, {"offsetInBeginSection": 639, "offsetInEndSection": 908, "text": "Here, we review our current understanding of replication initiation and its regulation, describe mechanisms by which activated oncogenes might interfere with these processes and discuss how replicative stress might contribute to the genomic instability seen in cancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24845676"}, {"offsetInBeginSection": 1007, "offsetInEndSection": 1228, "text": "Comparative genomic hybridization analysis of stem cells derived by these protocols revealed the presence of genomic deletions and amplifications, whose signature was suggestive of oncogene-induced DNA replication stress.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311564"}, {"offsetInBeginSection": 778, "offsetInEndSection": 957, "text": "Our data reveal that lowering replication stress during reprogramming, genetically or chemically, provides a simple strategy to reduce genomic instability on mouse and human iPSC.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26292731"}, {"offsetInBeginSection": 0, "offsetInEndSection": 56, "text": "DNA replication and oncogene-induced replicative stress.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24845676"}]}, {"id": "5aa6800ad6d6b54f79000011", "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25566611", "http://www.ncbi.nlm.nih.gov/pubmed/17296251", "http://www.ncbi.nlm.nih.gov/pubmed/23942901", "http://www.ncbi.nlm.nih.gov/pubmed/16739129", "http://www.ncbi.nlm.nih.gov/pubmed/23837364", "http://www.ncbi.nlm.nih.gov/pubmed/4295848", "http://www.ncbi.nlm.nih.gov/pubmed/10941733", "http://www.ncbi.nlm.nih.gov/pubmed/25480485", "http://www.ncbi.nlm.nih.gov/pubmed/20117540", "http://www.ncbi.nlm.nih.gov/pubmed/4882024"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 125, "text": "Brucella abortus is the etiologic agent of bovine brucellosis and causes a chronic disease in humans known as undulant fever.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16739129"}, {"offsetInBeginSection": 154, "offsetInEndSection": 290, "text": "Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611"}, {"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "Association of Histophilus somni with spontaneous abortions in dairy cattle herds from Brazil.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25480485"}, {"offsetInBeginSection": 349, "offsetInEndSection": 592, "text": "PCR/RT-PCR assays targeted specific genes of abortifacient agents of cattle: bovine viral diarrhea virus (BVDV), bovine herpesvirus 1 (BoHV-1), Listeria monocytogenes, Neospora caninum, Leptospira spp., Brucella abortus, and Histophilus somni.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25480485"}, {"offsetInBeginSection": 178, "offsetInEndSection": 295, "text": "It is also known to cause persistent undulant fever, endocarditis, arthritis, osteomyelitis and meningitis in humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251"}, {"offsetInBeginSection": 0, "offsetInEndSection": 126, "text": "Brucella abortus RB51 is the vaccine strain currently licensed for immunizing cattle against brucellosis in the United States.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23942901"}, {"offsetInBeginSection": 186, "offsetInEndSection": 305, "text": "Brucella abortus strain RB51 vaccine is being considered as a means to control B. abortus induced abortions in cow elk.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10941733"}, {"offsetInBeginSection": 259, "offsetInEndSection": 352, "text": "Therefore, the organism causing canine abortion appears to be a member of the genus Brucella.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/4882024"}, {"offsetInBeginSection": 291, "offsetInEndSection": 449, "text": "This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611"}, {"offsetInBeginSection": 1038, "offsetInEndSection": 1201, "text": "The elucidation of the immunome of B. abortus CE identified a number of candidate proteins for developing vaccines against Brucella infection in bovine and humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16739129"}]}, {"id": "5abd3707fcf456587200002d", "body": "Is the petrous bone used in ancient DNA sampling?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28129388", "http://www.ncbi.nlm.nih.gov/pubmed/28625158", "http://www.ncbi.nlm.nih.gov/pubmed/26086078"], "snippets": [{"offsetInBeginSection": 517, "offsetInEndSection": 890, "text": "In this study we investigate whether (a) different parts of the petrous bone of archaeological human specimens give different percentages of endogenous DNA yields, (b) there are significant differences in average DNA read lengths, damage patterns and total DNA concentration, and (c) it is possible to obtain endogenous ancient DNA from petrous bones from hot environments.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}, {"offsetInBeginSection": 1715, "offsetInEndSection": 2076, "text": "Our results also show that while endogenous yields from part C were lower than 1% for samples from hot (both arid and humid) parts, the DNA damage patterns indicate that at least some of the reads originate from ancient DNA molecules, potentially enabling ancient DNA analyses of samples from hot regions that are otherwise not amenable to ancient DNA analyses.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}, {"offsetInBeginSection": 731, "offsetInEndSection": 943, "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 0, "offsetInEndSection": 77, "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}, {"offsetInBeginSection": 341, "offsetInEndSection": 516, "text": "The only skeletal element for which a systematically higher endogenous DNA content compared to other skeletal elements has been shown is the petrous part of the temporal bone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}, {"offsetInBeginSection": 1092, "offsetInEndSection": 1359, "text": "We obtained shotgun DNA sequences from three distinct areas within the petrous: a spongy part of trabecular bone (part A), the dense part of cortical bone encircling the osseous inner ear, or otic capsule (part B), and the dense part within the otic capsule (part C).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": "Ancient DNA (aDNA) research involves invasive and destructive sampling procedures that are often incompatible with anthropological, anatomical, and bioarcheological analyses requiring intact skeletal remains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 1360, "offsetInEndSection": 1714, "text": "Our results confirm that dense bone parts of the petrous bone can provide high endogenous aDNA yields and indicate that endogenous DNA fractions for part C can exceed those obtained for part B by up to 65-fold and those from part A by up to 177-fold, while total endogenous DNA concentrations are up to 126-fold and 109-fold higher for these comparisons.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 944, "offsetInEndSection": 1160, "text": "We show a decrease in endogenous DNA and molecular copy numbers when the drilling method is used; however, we also show that this method produces more endogenous DNA and higher copy numbers than any postcranial bone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}]}, {"id": "5abc9157fcf456587200001e", "body": "What is \"enhancer hijacking\"?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27869826", "http://www.ncbi.nlm.nih.gov/pubmed/25043047", "http://www.ncbi.nlm.nih.gov/pubmed/29059320", "http://www.ncbi.nlm.nih.gov/pubmed/26229090"], "snippets": [{"offsetInBeginSection": 1312, "offsetInEndSection": 1503, "text": "We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an \"enhancer hijacking\" translocation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090"}, {"offsetInBeginSection": 235, "offsetInEndSection": 476, "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826"}, {"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047"}, {"offsetInBeginSection": 347, "offsetInEndSection": 589, "text": "To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29059320"}, {"offsetInBeginSection": 390, "offsetInEndSection": 596, "text": "This method detects rearrangements involving known cancer genes, including CCND1, BCL2, MYC, PDCD1LG2, NOTCH1, CIITA, and SGK1, as well as novel enhancer duplication events of likely oncogenic significance.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090"}, {"offsetInBeginSection": 751, "offsetInEndSection": 880, "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826"}, {"offsetInBeginSection": 1060, "offsetInEndSection": 1264, "text": "DiseaseEnhancer provides a promising avenue for researchers to facilitate the understanding of enhancer deregulation in disease pathogenesis, and identify new biomarkers for disease diagnosis and therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29059320"}, {"offsetInBeginSection": 154, "offsetInEndSection": 346, "text": "Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29059320"}, {"offsetInBeginSection": 801, "offsetInEndSection": 1080, "text": "We show that BCL6-locus enhancers are acetylated by the BCL6-activating transcription factor MEF2B, and can undergo genomic duplication, or target the MYC promoter for activation in the context of a \"pseudo-double-hit\" t(3;8)(q27;q24) rearrangement linking the BCL6 and MYC loci.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826"}]}, {"id": "5ab9050bfcf4565872000019", "body": "What is break induced replication?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28427283", "http://www.ncbi.nlm.nih.gov/pubmed/25329304", "http://www.ncbi.nlm.nih.gov/pubmed/11030337", "http://www.ncbi.nlm.nih.gov/pubmed/12660252", "http://www.ncbi.nlm.nih.gov/pubmed/17671506", "http://www.ncbi.nlm.nih.gov/pubmed/21183718", "http://www.ncbi.nlm.nih.gov/pubmed/26055704", "http://www.ncbi.nlm.nih.gov/pubmed/28732309", "http://www.ncbi.nlm.nih.gov/pubmed/20479284", "http://www.ncbi.nlm.nih.gov/pubmed/6275090"], "snippets": [{"offsetInBeginSection": 298, "offsetInEndSection": 467, "text": "When DNA double-strand breaks are induced at specific sites in the chromosome, Tn7 transposition is stimulated and insertions are directed proximal to the induced break.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "Break-induced replication (BIR) is an efficient homologous recombination process to initiate DNA replication when only one end of a chromosome double-strand break shares homology with a template.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17671506"}, {"offsetInBeginSection": 102, "offsetInEndSection": 314, "text": "We propose that a critical function of transcription termination factors is to prevent TEC from blocking DNA replication and inducing replication fork arrest, one consequence of which is DNA double-strand breaks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21183718"}, {"offsetInBeginSection": 878, "offsetInEndSection": 1034, "text": "Collectively, our data point to the existence of a functional interplay between hMSH5 and FANCJ in double-strand break repair induced by replication stress.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26055704"}, {"offsetInBeginSection": 340, "offsetInEndSection": 453, "text": "In some cases, a single-strand break seems to occur at the level of the dimer inhibiting the fork of replication.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6275090"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Broken replication forks result in DNA breaks that are normally repaired via homologous recombination or break induced replication (BIR).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304"}, {"offsetInBeginSection": 0, "offsetInEndSection": 124, "text": "Break-induced replication (BIR) is an important pathway specializing in repair of one-ended double-strand DNA breaks (DSBs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283"}, {"offsetInBeginSection": 468, "offsetInEndSection": 599, "text": "The targeting preference for the terminus of replication and DNA double-strand breaks is dependent on the Tn7-encoded protein TnsE.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337"}, {"offsetInBeginSection": 754, "offsetInEndSection": 1154, "text": "This gammaH2AX formation is suppressed in ATR (ataxia telangiectasia and Rad3-related) deficient cells and markedly decreased in DNA-dependent protein kinase-deficient cells but is not abrogated in ataxia telangiectasia cells, indicating that ATR and DNA-dependent protein kinase are the kinases primarily involved in gammaH2AX formation at the sites of replication-mediated DNA double-strand breaks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12660252"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "hMSH5 Facilitates the Repair of Camptothecin-induced Double-strand Breaks through an Interaction with FANCJ.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26055704"}]}, {"id": "5aac543bfcf4565872000004", "body": "What biologic process in the body is associated with Mast cells?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22706316", "http://www.ncbi.nlm.nih.gov/pubmed/17386403", "http://www.ncbi.nlm.nih.gov/pubmed/22906983", "http://www.ncbi.nlm.nih.gov/pubmed/9354811", "http://www.ncbi.nlm.nih.gov/pubmed/6184614", "http://www.ncbi.nlm.nih.gov/pubmed/10359893", "http://www.ncbi.nlm.nih.gov/pubmed/16141514", "http://www.ncbi.nlm.nih.gov/pubmed/17468237", "http://www.ncbi.nlm.nih.gov/pubmed/17062134", "http://www.ncbi.nlm.nih.gov/pubmed/6178551"], "snippets": [{"offsetInBeginSection": 333, "offsetInEndSection": 500, "text": "OBJECTIVE: We sought to determine the ability of HgCl2 to degranulate murine mast cells and promote cytokine secretion and whether this was an active biologic process.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359893"}, {"offsetInBeginSection": 1076, "offsetInEndSection": 1299, "text": "Lipid body accumulation in mast cells is mechanistically distinct from the process in adipocytes; for example, it is independent of PPAR\u03b3 up-regulation and does not involve significant accumulation of conjugated glycerides.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 513, "offsetInEndSection": 887, "text": "The functional roles of mast cell in vivo have been principally characterized by comparing the biological responses in mast cell-deficient mice (WBB6F(1)-W/W(v)), their normal wild-type littermates (WBB6F(1)-+/+) and mast cell deficient mice reconstituted locally or systemically with mast cells cultured from the bone marrow cells of WBB6F(1)-+/+ mice (WBB6F(1)-W/W(v)+MC).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403"}, {"offsetInBeginSection": 330, "offsetInEndSection": 512, "text": "Since mast cells clearly play both physiological and pathophysiological functions in the body, it is important to learn about the components of mast cells that drive these responses.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403"}, {"offsetInBeginSection": 141, "offsetInEndSection": 321, "text": "However, it is not clear to what extent cromolyn can either limit the function of mouse mast cells or influence biological processes in mice independently of effects on mast cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22906983"}, {"offsetInBeginSection": 328, "offsetInEndSection": 454, "text": "Lipid body accumulation in mast cells is associated with enhanced levels of leukotriene-synthesizing enzymes (LTC4S and 5-LO).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 670, "offsetInEndSection": 870, "text": "RESULTS: HgCl2 was found to directly activate murine mast cells to release the granule-associated enzyme N-acetyl-beta-D-hexosaminidase and to secrete the proinflammatory cytokines IL-4 and TNF-alpha.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359893"}, {"offsetInBeginSection": 888, "offsetInEndSection": 1137, "text": "Recently investigators have demonstrated that mast cell-deficient mice (WBB6F(1)-W/W(v)) can be reconstituted with mast cells derived in vitro from the bone marrow cells of certain gene knock-out mice or genetically-manipulated embryonic stem cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403"}, {"offsetInBeginSection": 466, "offsetInEndSection": 632, "text": "Mast cells are associated with hypersensitivity reactions, not only in the classical immunoglobulin E (IgE)-dependent mechanism but also in an IgE-independent manner.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16141514"}, {"offsetInBeginSection": 0, "offsetInEndSection": 189, "text": "Mast cells have long been known to play a detrimental role in the pathogenesis of IgE-associated allergic disorders by their ability to release a wide variety of pro-inflammatory mediators.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403"}]}, {"id": "5abd44b1fcf4565872000030", "body": "List proteins with HEAT repeats", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19777061", "http://www.ncbi.nlm.nih.gov/pubmed/11042144", "http://www.ncbi.nlm.nih.gov/pubmed/11491282", "http://www.ncbi.nlm.nih.gov/pubmed/23895768", "http://www.ncbi.nlm.nih.gov/pubmed/25435324", "http://www.ncbi.nlm.nih.gov/pubmed/14970380", "http://www.ncbi.nlm.nih.gov/pubmed/24053231", "http://www.ncbi.nlm.nih.gov/pubmed/27802131", "http://www.ncbi.nlm.nih.gov/pubmed/15099583", "http://www.ncbi.nlm.nih.gov/pubmed/20060908"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 384, "text": "Karyopherin \u03b2 family proteins mediate the nuclear/cytoplasmic transport of various proteins through the nuclear pore complex (NPC), although they are substantially larger than the size limit of the NPC.To elucidate the molecular mechanism underlying this paradoxical function, we focused on the unique structures called HEAT repeats, which consist of repetitive amphiphilic \u03b1 helices.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25435324"}, {"offsetInBeginSection": 304, "offsetInEndSection": 525, "text": "The HEAT motif consists of two alpha-helices and two turns: molecular modeling suggests that in the PA200 and Ecm29 repeats, the alpha-helices may be slightly turned relative to their orientations in typical HEAT repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15099583"}, {"offsetInBeginSection": 422, "offsetInEndSection": 625, "text": "All the proteins identified in the database searches could be clustered by sequence similarity into four groups: canonical ARM-repeat proteins and three groups of the more divergent HEAT-repeat proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11491282"}, {"offsetInBeginSection": 984, "offsetInEndSection": 1172, "text": "These observations lead us to speculate that the archaeal HEAT-like repeats of TON1937 have evolved to engage in protein-protein interactions in the same manner as eukaryotic HEAT repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23895768"}, {"offsetInBeginSection": 385, "offsetInEndSection": 632, "text": "An in vitro transport assay and FRAP analyses demonstrated that not only karyopherin \u03b2 family proteins but also other proteins with HEAT repeats could pass through the NPC by themselves, and serve as transport mediators for their binding partners.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25435324"}, {"offsetInBeginSection": 268, "offsetInEndSection": 437, "text": "Because other HEAT-repeat proteins play key roles in transport processes, this finding provides a plausible mechanistic explanation for the function of the Noc proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380"}, {"offsetInBeginSection": 230, "offsetInEndSection": 462, "text": "In order to investigate the origin of the stability of these proteins, we dissect the subdomain architecture of the giant repeat protein PR65/A, which comprises 15 \u03b1-helical HEAT repeats, using a series of truncations and deletions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231"}, {"offsetInBeginSection": 575, "offsetInEndSection": 745, "text": "The HHpred strategy predicts that TOR contains 32 tandem HEAT repeats extending from the N-terminus to the FAT domain, which is itself comprised of 16 tandem TPR repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20060908"}, {"offsetInBeginSection": 155, "offsetInEndSection": 438, "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144"}, {"offsetInBeginSection": 1266, "offsetInEndSection": 1498, "text": "HEAT repeats also were found in dis1-TOG family and cofactor D family microtubule-associated proteins, which, owing to their roles in microtubule dynamics, perform functions related to mitotic progression and chromosome segregation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144"}]}, {"id": "5abc974bfcf456587200001f", "body": "Is recursive splicing more common in short introns?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27965595", "http://www.ncbi.nlm.nih.gov/pubmed/15802507", "http://www.ncbi.nlm.nih.gov/pubmed/25970244", "http://www.ncbi.nlm.nih.gov/pubmed/25970246"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244"}, {"offsetInBeginSection": 1038, "offsetInEndSection": 1226, "text": "Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244"}, {"offsetInBeginSection": 562, "offsetInEndSection": 709, "text": "The sequential nature of recursive splicing was confirmed by identification of lariat introns generated by splicing to and from the ratchet points.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244"}, {"offsetInBeginSection": 113, "offsetInEndSection": 310, "text": "However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970246"}, {"offsetInBeginSection": 167, "offsetInEndSection": 364, "text": "We present bioinformatic, phylogenetic, and experimental evidence in Drosophila for a mechanism that subdivides many large introns by recursive splicing at nonexonic elements and alternative exons.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}, {"offsetInBeginSection": 161, "offsetInEndSection": 354, "text": "Recursive splicing was first identified in the Drosophila Ultrabithorax (Ubx) gene and only three additional Drosophila genes have since been experimentally shown to undergo recursive splicing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244"}, {"offsetInBeginSection": 710, "offsetInEndSection": 922, "text": "We also show that recursive splicing is a constitutive process, that depletion of U2AF inhibits recursive splicing, and that the sequence and function of ratchet points are evolutionarily conserved in Drosophila.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244"}, {"offsetInBeginSection": 844, "offsetInEndSection": 1029, "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 365, "offsetInEndSection": 638, "text": "Recursive splice sites predicted with highly stringent criteria are found at much higher frequency than expected in the sense strands of introns >20 kb, but they are found only at the expected frequency on the antisense strands, and they are underrepresented within introns", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}]}, {"id": "5ac0a82d19833b0d7b000003", "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28373570", "http://www.ncbi.nlm.nih.gov/pubmed/24942628", "http://www.ncbi.nlm.nih.gov/pubmed/20924363", "http://www.ncbi.nlm.nih.gov/pubmed/19796077", "http://www.ncbi.nlm.nih.gov/pubmed/8213828", "http://www.ncbi.nlm.nih.gov/pubmed/19277018", "http://www.ncbi.nlm.nih.gov/pubmed/21851223"], "snippets": [{"offsetInBeginSection": 407, "offsetInEndSection": 701, "text": "In this study, we examined the effect of peptide-conjugated PMO (PPMO)-mediated exon skipping on disease progression of utrophin-dystrophin-deficient mice (dko) of four age groups (21-29, 30-39, 40-49 and 50+ days), representing diseases from early stage to advanced stage with severe kyphosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 730, "offsetInEndSection": 848, "text": "administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 0, "offsetInEndSection": 191, "text": "Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21851223"}, {"offsetInBeginSection": 1055, "offsetInEndSection": 1178, "text": "Dystrophin protein was restored to approximately 50 and 10% of normal levels in skeletal and cardiac muscles, respectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19277018"}, {"offsetInBeginSection": 925, "offsetInEndSection": 1092, "text": "The results provide further evidence of exon skipping in the dystrophin gene and indicate that this may be involved in the synthesis of dystrophin by revertant fibers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8213828"}, {"offsetInBeginSection": 686, "offsetInEndSection": 884, "text": "Single intravenous (IV) injections of 6 mg/kg Vivo-MorpholinoE23 (Vivo-ME23) generated dystrophin expression in skeletal muscles at the levels higher than the injection of 300 mg/kg unmodified ME23.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19277018"}, {"offsetInBeginSection": 203, "offsetInEndSection": 395, "text": "Exon skipping via synthetic phosphorodiamidate morpholino oligomers (PMOs) represents one of the most promising therapeutic options, yet PMOs have shown very little efficacy in cardiac muscle.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570"}, {"offsetInBeginSection": 248, "offsetInEndSection": 438, "text": "However, simple, unmodified AONs exhibit inefficient delivery systemically, leading to dystrophin induction with high variability in skeletal muscles and barely detectable in cardiac muscle.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19277018"}, {"offsetInBeginSection": 112, "offsetInEndSection": 247, "text": "Reading frame restoration of the dystrophin transcript can be achieved by AON-mediated exon skipping in the dystrophic mdx mouse model.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19277018"}, {"offsetInBeginSection": 0, "offsetInEndSection": 231, "text": "Although many Duchenne muscular dystrophy patients have a deletion in the dystrophin gene which disrupts the translational reading frame, they express dystrophin in a small proportion of skeletal muscle fibers (\"revertant fibers\").", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8213828"}]}, {"id": "5aac5469fcf4565872000005", "body": "What are 7 symptoms of yellow fever?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12410495", "http://www.ncbi.nlm.nih.gov/pubmed/8599063", "http://www.ncbi.nlm.nih.gov/pubmed/19869938", "http://www.ncbi.nlm.nih.gov/pubmed/19868337", "http://www.ncbi.nlm.nih.gov/pubmed/16498293", "http://www.ncbi.nlm.nih.gov/pubmed/559399", "http://www.ncbi.nlm.nih.gov/pubmed/9402373", "http://www.ncbi.nlm.nih.gov/pubmed/20300380", "http://www.ncbi.nlm.nih.gov/pubmed/28358796", "http://www.ncbi.nlm.nih.gov/pubmed/11000957"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 219, "text": "By injecting into guinea pigs the blood of yellow fever cases occurring in Guayaquil a group of symptoms and lesions closely resembling those observed in human yellow fever were induced in a limited number of instances.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337"}, {"offsetInBeginSection": 900, "offsetInEndSection": 1076, "text": "Although not well-documented for this outbreak, malaria, viral hepatitis, and typhoid fever are common differential diagnoses among suspected yellow fever cases in this region.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28358796"}, {"offsetInBeginSection": 220, "offsetInEndSection": 730, "text": "Of 74 guinea pigs inoculated with specimens of blood from 27 cases of yellow fever, 8, representing 6 cases, came down with the symptoms; namely, a marked rise of temperature after a period of incubation averaging 3 to 6 days, with simultaneous suffusion of the capillaries, particularly of the conjunctivaes and soles, then preliminary hyperleucocytosis followed by progressive leucopenia, the early appearance of albumin and casts in the urine, which gradually diminishes in volume as the disease progresses.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337"}, {"offsetInBeginSection": 895, "offsetInEndSection": 1083, "text": "If the brain was mildly injured at the time of the intraperitoneal injection, the symptoms of yellow fever encephalitis appeared 6 days later, but the virus was then absent from the blood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19869938"}, {"offsetInBeginSection": 226, "offsetInEndSection": 307, "text": "Clinical symptoms and signs observed among yellow fever cases are also described.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20300380"}, {"offsetInBeginSection": 714, "offsetInEndSection": 899, "text": "Thirty seven of the 393 specimens tested in the laboratory were confirmed as positive for yellow fever virus (local outbreak threshold is one laboratory-confirmed case of yellow fever).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28358796"}, {"offsetInBeginSection": 1964, "offsetInEndSection": 2124, "text": "The leptospira transmitted from yellow fever cases to guinea pigs was found to induce similar symptoms and lesions upon further passage into normal guinea pigs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337"}, {"offsetInBeginSection": 2125, "offsetInEndSection": 2238, "text": "The leptospira obtained from cases of yellow fever has been givern the provisional name of Leptospira icteroides.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337"}, {"offsetInBeginSection": 142, "offsetInEndSection": 254, "text": "The pathophysiology of severe yellow fever in humans and in monkeys susceptible to the virus is largely unknown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957"}, {"offsetInBeginSection": 335, "offsetInEndSection": 467, "text": "The degree of severity in yellow fever disease is linked to different factors related to virus virulence and to host susceptibility.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957"}]}, {"id": "5ac07b67dd95b2cd42000001", "body": "Is Lysyl oxidase crosslinking collagen?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12918034", "http://www.ncbi.nlm.nih.gov/pubmed/8116", "http://www.ncbi.nlm.nih.gov/pubmed/2870873", "http://www.ncbi.nlm.nih.gov/pubmed/906929", "http://www.ncbi.nlm.nih.gov/pubmed/8096378", "http://www.ncbi.nlm.nih.gov/pubmed/4531019", "http://www.ncbi.nlm.nih.gov/pubmed/2890532", "http://www.ncbi.nlm.nih.gov/pubmed/26918", "http://www.ncbi.nlm.nih.gov/pubmed/22633114", "http://www.ncbi.nlm.nih.gov/pubmed/9524359"], "snippets": [{"offsetInBeginSection": 979, "offsetInEndSection": 1290, "text": "The results suggest that lysyl oxidase and collagen crosslinking play a vital role in primary mesenchyme migration, gastrulation, and morphogenesis during sea urchin development and indicate that BAPN may be very useful in studying the extracellular matrix-cell interactions at the cellular and molecular level.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2890532"}, {"offsetInBeginSection": 185, "offsetInEndSection": 348, "text": "A decrease in the functional activity of lysyl oxidase, a cuproenzyme, is thought in part to be responsible for the decreased crosslinking of collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8096378"}, {"offsetInBeginSection": 0, "offsetInEndSection": 174, "text": "Nutritional copper deficiency effects marked changes in the crosslinking of collagen and elastin, presumably in relationship to copper's role as a cofactor for lysyl oxidase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/906929"}, {"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "The role of lysyl oxidase and collagen crosslinking during sea urchin development.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2890532"}, {"offsetInBeginSection": 0, "offsetInEndSection": 202, "text": "Lysyl oxidase (LO) is a copper-dependent amine oxidase that plays a critical role in the biogenesis of connective tissue matrices by crosslinking the extracellular matrix proteins, collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9524359"}, {"offsetInBeginSection": 312, "offsetInEndSection": 480, "text": "The enzyme lysyl oxidase which catalyses the aldehyde formation in certain lysyl residues of collagen and elastin was extracted from the skin of hypophysectomized rats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8116"}, {"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "Lysyl oxidase catalyzes the crosslinking of collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26918"}, {"offsetInBeginSection": 663, "offsetInEndSection": 793, "text": "Indirect immunofluorescence studies showed that lysyl oxidase was present in association with collagen in the extracellular space.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26918"}, {"offsetInBeginSection": 596, "offsetInEndSection": 928, "text": "METHODS: Protein and mRNA expression of major elastic fiber components (elastin, fibrillin-1, fibulin-4), collagens (types I, III, and IV), and lysyl oxidase crosslinking enzymes (LOX, LOXL1, LOXL2) were assessed in situ by quantitative real-time polymerase chain reaction, (immuno)histochemistry, and light and electron microscopy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22633114"}, {"offsetInBeginSection": 556, "offsetInEndSection": 777, "text": "These data indicate that although skin lysyl oxidase activity is decreased by glucocorticoid treatment, the crosslinking of acid extracted collagen as measured by the alpha/beta ratio and collagen solubility is increased.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873"}]}, {"id": "5abc9c1efcf4565872000020", "body": "How are deletion breakpoints defined?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/1684331", "http://www.ncbi.nlm.nih.gov/pubmed/1741389", "http://www.ncbi.nlm.nih.gov/pubmed/16293123", "http://www.ncbi.nlm.nih.gov/pubmed/11001932", "http://www.ncbi.nlm.nih.gov/pubmed/11336982", "http://www.ncbi.nlm.nih.gov/pubmed/9326327", "http://www.ncbi.nlm.nih.gov/pubmed/10631140", "http://www.ncbi.nlm.nih.gov/pubmed/19484265", "http://www.ncbi.nlm.nih.gov/pubmed/17351135", "http://www.ncbi.nlm.nih.gov/pubmed/12297986"], "snippets": [{"offsetInBeginSection": 231, "offsetInEndSection": 372, "text": "By sequence-tagged site (STS) content mapping, we roughly defined deletion breakpoints in two unrelated, azoospermic men with AZFa deletions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932"}, {"offsetInBeginSection": 282, "offsetInEndSection": 499, "text": "Subsequently, the deletion of exon 2 of the copper metabolism domain containing 1 (COMMD1) gene (formerly MURR1) was shown to be the major cause of copper toxicosis, although the deletion breakpoints were not defined.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123"}, {"offsetInBeginSection": 1225, "offsetInEndSection": 1465, "text": "Therefore, the Fah gene maps within or proximal to the hsdr-1 locus, as defined by deletion breakpoints, and disruption of this gene may be partially or completely responsible for the phenotypes associated with the hsdr-1 deletion syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389"}, {"offsetInBeginSection": 694, "offsetInEndSection": 879, "text": "Here we report the use of a probe derived from a deletion breakpoint fusion fragment cloned from c24R75M/c24R75M DNA to clone a breakpoint fusion fragment caused by the c14CoS deletion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389"}, {"offsetInBeginSection": 783, "offsetInEndSection": 1099, "text": "By mapping the cloned breakpoints relative to the remaining three deletions, the c11DSD distal breakpoint was found to define the distal limit of the region containing eed, whereas the c2YPSj and c6H distal breakpoints were found to define the proximal and distal limits, respectively, of the region containing exed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331"}, {"offsetInBeginSection": 837, "offsetInEndSection": 965, "text": "The two breakpoints share sequence homology suggesting that homologous recombination may have been responsible for the deletion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123"}, {"offsetInBeginSection": 1254, "offsetInEndSection": 1423, "text": "An apparently common centromeric deletion breakpoint was shared by all of the patients, whereas a different telomeric breakpoint defined a deletion interval of 0.8-3 Mb.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10631140"}, {"offsetInBeginSection": 788, "offsetInEndSection": 939, "text": "The deletion breakpoints were defined by a combination of long polymerase chain reaction (PCR) amplifications, and conventional PCR and DNA sequencing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336982"}, {"offsetInBeginSection": 391, "offsetInEndSection": 615, "text": "To understand the molecular basis for chromosomal deletions, we defined the extent of the deletion, by genotyping 151 VCFS patients and performing haplotype analysis on 105, using 15 consecutive polymorphic markers in 22q11.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9326327"}, {"offsetInBeginSection": 508, "offsetInEndSection": 786, "text": "In subsequent FISH experiments, performed with locus-specific probes generated from the same YACs by means of a novel procedure, we identified the smallest region of overlapping (SRO), mapped the deletion breakpoints, and identified the genes that map to each deletion interval.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10631140"}]}, {"id": "5ac7185f0340b9f058000004", "body": "Which cellular functions are affected by lncRNA H19 in the heart?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27317124", "http://www.ncbi.nlm.nih.gov/pubmed/29036538", "http://www.ncbi.nlm.nih.gov/pubmed/27895893", "http://www.ncbi.nlm.nih.gov/pubmed/26853553", "http://www.ncbi.nlm.nih.gov/pubmed/28790415", "http://www.ncbi.nlm.nih.gov/pubmed/27796346", "http://www.ncbi.nlm.nih.gov/pubmed/27307343", "http://www.ncbi.nlm.nih.gov/pubmed/27040767", "http://www.ncbi.nlm.nih.gov/pubmed/28063931", "http://www.ncbi.nlm.nih.gov/pubmed/28881833"], "snippets": [{"offsetInBeginSection": 189, "offsetInEndSection": 345, "text": "We reported that the long noncoding RNA H19 (LncRNA H19) and LncRNA H19-derived microRNA (miR-675) are overexpressed in neointima of balloon-injured artery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28063931"}, {"offsetInBeginSection": 1178, "offsetInEndSection": 1333, "text": "Nine of these lncRNAs (CDKN2B-AS1/ANRIL, EGOT, H19, HOTAIR, LOC285194/TUSC7, RMRP, RNY5, SOX2-OT and SRA1) were also confirmed in end-stage failing hearts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 1334, "offsetInEndSection": 1454, "text": "Intriguingly, among the conserved lncRNAs, h19, rmrp and hotair were also induced in a mouse model of heart hypertrophy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 1785, "offsetInEndSection": 1980, "text": "Gene ontology analysis of the mRNAs displaying a significant correlation in expression with heart failure lncRNAs identified numerous pathways and functions involved in heart failure progression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 937, "offsetInEndSection": 1085, "text": "Interestingly, either constitutive H19 expression or silencing H19 expression in MSCs significantly impaired BMP9-induced osteogenic differentiation", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28881833"}, {"offsetInBeginSection": 0, "offsetInEndSection": 74, "text": "LncRNA H19-mediated mouse cleft palate induced by all-trans retinoic acid.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27307343"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27796346"}, {"offsetInBeginSection": 1269, "offsetInEndSection": 1444, "text": "Taken together, our results suggest that increased plasma levels of H19 and LIPCAR are associated with increased risk of CAD and may be considered as novel biomarkers for CAD.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28790415"}, {"offsetInBeginSection": 1102, "offsetInEndSection": 1268, "text": "Further studies identified that plasma levels of H19 and LIPCAR were also increased in CAD patients with heart failure compared to those with normal cardiac function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28790415"}, {"offsetInBeginSection": 213, "offsetInEndSection": 334, "text": "The aim of this study is to identify and characterize lncRNAs deregulated in patients affected by ischemic heart failure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}]}, {"id": "5aae651ffcf456587200000d", "body": "What is the function of penicillinase, also known as beta lactamase?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/806305", "http://www.ncbi.nlm.nih.gov/pubmed/3541135", "http://www.ncbi.nlm.nih.gov/pubmed/3877980", "http://www.ncbi.nlm.nih.gov/pubmed/2406875", "http://www.ncbi.nlm.nih.gov/pubmed/9624479", "http://www.ncbi.nlm.nih.gov/pubmed/6448580", "http://www.ncbi.nlm.nih.gov/pubmed/11399858", "http://www.ncbi.nlm.nih.gov/pubmed/6803835", "http://www.ncbi.nlm.nih.gov/pubmed/9158769", "http://www.ncbi.nlm.nih.gov/pubmed/4985545"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 331, "text": "The function of the hydroxyl group of the tyrosine residue readily nitrated by tetranitromethane (tyrosine-105) in the RTEM plasmid-derived beta-lactamase (penicillinase; penicillin amido beta-lactam-hydrolase, EC 3.5.1.6) from E. coli and in Bacillus cereus beta-lactamase I has been investigated by chemical modification methods.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6803835"}, {"offsetInBeginSection": 332, "offsetInEndSection": 657, "text": "In the case of B. cereus beta-lactamase I the nitrated tyrosine can be acetylated by acetic anhydride without effect on beta-lactamase activity The nitrated tyrosine of the E. coli enzyme can also be acetylated but in this case beta-lactamase activity is lost in a manner which directly correlates with extent of acetylation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6803835"}, {"offsetInBeginSection": 0, "offsetInEndSection": 232, "text": "BACKGROUND: Mechanisms of borderline resistance of Staphylococcus aureus to penicillinase-resistant penicillins (PRPs) may include hyperproduction of classical penicillinase and/or production of beta-lactamase hydrolyzing also PRPs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11399858"}, {"offsetInBeginSection": 970, "offsetInEndSection": 1302, "text": "The more recent discovery of a PRP-hydrolyzing beta-lactamase (methicillinase) produced, in addition to the conventional penicillinase, by borderline S. aureus strains suggests that this second, more specific beta-lactamase is more likely to be responsible for the borderline phenotype than an increased amount of the penicillinase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9158769"}, {"offsetInBeginSection": 0, "offsetInEndSection": 362, "text": "Staphylococcus aureus strains with borderline levels of susceptibility or resistance to antistaphylococcal penicillinase-resistant penicillins (PRPs) were initially reported as neither heteroresistant nor multiply resistant organisms, producing large amounts of beta-lactamase, and becoming fully susceptible to PRPs in the presence of beta-lactamase inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9158769"}, {"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "Derepression of beta-lactamase (penicillinase in Bacillus cereus by peptidoglycans.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/4985545"}, {"offsetInBeginSection": 1169, "offsetInEndSection": 1406, "text": "Such derepression also occurs in a strain of B. cereus very sensitive to penicillin and in which both uninduced as well as \"spore-peptide\"-induced beta-lactamase is a small fraction of that produced by the typical penicillinase producer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/4985545"}, {"offsetInBeginSection": 228, "offsetInEndSection": 316, "text": "The most important factor in beta-lactam resistance is the production of beta-lactamase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135"}, {"offsetInBeginSection": 212, "offsetInEndSection": 501, "text": "In both cases, we have shown the simultaneous biosynthesis of two enzymes: an inducible and chromosome cephalosporinase frequently found in this germ, and a constitutive beta lactamase, with a penicillinase activity which has been identified with the extrachromosomic beta lactamase R-TEM.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305"}, {"offsetInBeginSection": 1595, "offsetInEndSection": 1724, "text": "We conclude that the major beta-lactamase of M. tuberculosis is a class A beta-lactamase with predominant penicillinase activity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9624479"}]}, {"id": "5ac0817cd0c506ce46000001", "body": "Is p53 a transcription factor?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/7651386", "http://www.ncbi.nlm.nih.gov/pubmed/9690516", "http://www.ncbi.nlm.nih.gov/pubmed/1944276", "http://www.ncbi.nlm.nih.gov/pubmed/29125602", "http://www.ncbi.nlm.nih.gov/pubmed/9215863", "http://www.ncbi.nlm.nih.gov/pubmed/7478550", "http://www.ncbi.nlm.nih.gov/pubmed/8862400", "http://www.ncbi.nlm.nih.gov/pubmed/21042708", "http://www.ncbi.nlm.nih.gov/pubmed/9572492", "http://www.ncbi.nlm.nih.gov/pubmed/17762884"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Tumor suppressor p53 is a transcription factor that induces growth arrest and/or apoptosis in response to cellular stress.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21042708"}, {"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "The p53 protein is a transcription factor involved in processes of cell growth and differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9690516"}, {"offsetInBeginSection": 283, "offsetInEndSection": 446, "text": "Using microarray analysis, we have identified the transcription factor early growth response 2 (EGR2) as a target of the p53 family, specifically p53, p63 and p73.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21042708"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}, {"offsetInBeginSection": 332, "offsetInEndSection": 419, "text": "p53 is a transcription factor which is involved in cell cycle regulation and apoptosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9215863"}, {"offsetInBeginSection": 515, "offsetInEndSection": 1188, "text": "In this review, we focus on recent advances in our understanding of mechanisms of p53-dependent transcriptional control as they relate to five key areas: (1) the functionally distinct N-terminal transactivation domains, (2) the diverse regulatory roles of its C-terminal domain, (3) evidence that p53 is solely a direct transcriptional activator, not a direct repressor, (4) the ability of p53 to recognize many of its enhancers across diverse chromatin environments, and (5) mechanisms that modify the p53-dependent transcriptional program in a context-dependent manner.Cell Death and Differentiation advance online publication, 10 November 2017; doi:10.1038/cdd.2017.174.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29125602"}, {"offsetInBeginSection": 139, "offsetInEndSection": 388, "text": "The activity of this master transcription factor is inactivated in nearly all tumors, either by mutations in the TP53 locus or by oncogenic events that decrease the activity of the wild-type protein, such as overexpression of the p53 repressor MDM2.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29125602"}, {"offsetInBeginSection": 0, "offsetInEndSection": 138, "text": "p53 is a transcription factor that suppresses tumor growth through regulation of dozens of target genes with diverse biological functions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29125602"}, {"offsetInBeginSection": 127, "offsetInEndSection": 315, "text": "To examine the role of p53 as a transcription factor, we made fusion proteins containing human or mouse p53 sequences fused to the DNA binding domain of a known transcription factor, GAL4.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1944276"}, {"offsetInBeginSection": 135, "offsetInEndSection": 241, "text": "p53, a transcription factor, controls the expression of genes, leading to cell cycle arrest and apoptosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}]}, {"id": "5abc9ecffcf4565872000021", "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25124333", "http://www.ncbi.nlm.nih.gov/pubmed/25193669", "http://www.ncbi.nlm.nih.gov/pubmed/22661583", "http://www.ncbi.nlm.nih.gov/pubmed/9128755", "http://www.ncbi.nlm.nih.gov/pubmed/15313545", "http://www.ncbi.nlm.nih.gov/pubmed/22529999", "http://www.ncbi.nlm.nih.gov/pubmed/16432145", "http://www.ncbi.nlm.nih.gov/pubmed/12090301", "http://www.ncbi.nlm.nih.gov/pubmed/7605803", "http://www.ncbi.nlm.nih.gov/pubmed/9375854"], "snippets": [{"offsetInBeginSection": 1003, "offsetInEndSection": 1403, "text": "A biochemical analysis of purified recombinant human Twinkle protein (gene product of c10orf2) showed that the mitochondrial replicative helicase inefficiently unwinds well characterized intermolecular and intramolecular G-quadruplex DNA substrates, as well as a unimolecular G4 substrate derived from a mitochondrial sequence that nests a deletion breakpoint described in human renal cell carcinoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 1404, "offsetInEndSection": 1751, "text": "Although G4 has been implicated in the initiation of mitochondrial DNA replication, our current findings suggest that mitochondrial G-quadruplexes are also likely to be a source of instability for the mitochondrial genome by perturbing the normal progression of the mitochondrial replication machinery, including DNA unwinding by Twinkle helicase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 0, "offsetInEndSection": 125, "text": "Mitochondrial DNA (mtDNA) deletions are a common cause of human mitochondrial disease and also occur as part of normal aging.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15313545"}, {"offsetInBeginSection": 348, "offsetInEndSection": 635, "text": "In this work, we performed a computational analysis of the human mitochondrial genome using the \"Pattern Finder\" G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 907, "offsetInEndSection": 1319, "text": "However, the average distance between the reported age associated mtDNA breakpoints and their respective nearest DR motifs is significantly shorter than what is expected of random chance in human (p10 bp) tend to decrease with increasing lifespan among the four mammals studied here, further suggesting an evolutionary selection against stable mtDNA misalignments associated with long DRs in long-living animals.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22529999"}, {"offsetInBeginSection": 653, "offsetInEndSection": 848, "text": "Furthermore, we discover that the most frequent deletion breakpoints occur within or near predicted structures, a result that is supported by data from transgenic mice with mitochondrial disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661583"}, {"offsetInBeginSection": 0, "offsetInEndSection": 217, "text": "DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative Twinkle helicase.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "We characterized a mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7605803"}, {"offsetInBeginSection": 287, "offsetInEndSection": 398, "text": "In these muscle fiber segments, there is accumulation of mitochondria with mitochondrial DNA (mtDNA) deletions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9375854"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "Characterization of a 5025 base pair mitochondrial DNA deletion in Kearns-Sayre syndrome.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7605803"}]}, {"id": "5ac721230340b9f058000005", "body": "Name 4 circular RNA molecules associated with carcinogenesis.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28185365", "http://www.ncbi.nlm.nih.gov/pubmed/28342987", "http://www.ncbi.nlm.nih.gov/pubmed/9154796", "http://www.ncbi.nlm.nih.gov/pubmed/27429839", "http://www.ncbi.nlm.nih.gov/pubmed/29081691", "http://www.ncbi.nlm.nih.gov/pubmed/26874353", "http://www.ncbi.nlm.nih.gov/pubmed/19010924", "http://www.ncbi.nlm.nih.gov/pubmed/850304", "http://www.ncbi.nlm.nih.gov/pubmed/28253710", "http://www.ncbi.nlm.nih.gov/pubmed/8692851"], "snippets": [{"offsetInBeginSection": 813, "offsetInEndSection": 1100, "text": "In rat testis, a similar analysis allowed the detection of a circular RNA molecule composed of exons 6 and 7 of the androgen binding protein (ABP) gene, with the donor splice site of exon 7 joined to the acceptor splice site of exon 6, and of an ABP mRNA which had skipped exons 6 and 7.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796"}, {"offsetInBeginSection": 948, "offsetInEndSection": 1104, "text": "The circRNA-miRNA-mRNA axis is a known regulatory pattern of several cancer-associated pathways, with both agonist and antagonist effects on carcinogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26874353"}, {"offsetInBeginSection": 1463, "offsetInEndSection": 1628, "text": "It is therefore proposed that alternative pre-mRNA processing has the potential to generate not only mRNAs lacking one or more exons but also circular RNA molecules.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8692851"}, {"offsetInBeginSection": 846, "offsetInEndSection": 1091, "text": "These antisense RNA molecules originate in the early region of the SV40 circular chromosome and proceed in antisense orientation into the late gene region, leading to the formation of highly unstable double-strand RNA, which is rapidly degraded.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19010924"}, {"offsetInBeginSection": 388, "offsetInEndSection": 600, "text": "By serving as sponges of microRNAs, interacting with long non-coding RNAs, mRNA, or proteins, circRNAs regulate gene expression at transcriptional and post-transcriptional levels and contribute to carcinogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365"}, {"offsetInBeginSection": 1170, "offsetInEndSection": 1413, "text": "We conclude that the three size classes of RNA that comprise the Uukuniemi virus genome are circular molecules probably maintained in that form by base pairing between inverted complementary sequences at the 3' and 5' ends of linear molecules.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/850304"}, {"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "Circular RNAs (circRNAs) are a class of newly-identified non-coding RNA molecules.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28253710"}, {"offsetInBeginSection": 1101, "offsetInEndSection": 1342, "text": "These results apparently substantiate the hypothesis that alternative pre-mRNA splicing has the potential to generate not only mRNAs that lack one or more exons but also circular RNA molecules that are composed of the exons that are skipped.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796"}, {"offsetInBeginSection": 761, "offsetInEndSection": 845, "text": "Late gene suppression is achieved through the production of antisense RNA molecules.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19010924"}, {"offsetInBeginSection": 228, "offsetInEndSection": 347, "text": "After spreading under moderately denaturing conditions (50 or 60% formamide), 50 to 70% of the molecules were circular.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/850304"}]}, {"id": "5ab147edfcf4565872000013", "body": "The Mantoux test detects what latent infection/disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22527447", "http://www.ncbi.nlm.nih.gov/pubmed/17663901", "http://www.ncbi.nlm.nih.gov/pubmed/16307510", "http://www.ncbi.nlm.nih.gov/pubmed/17158278", "http://www.ncbi.nlm.nih.gov/pubmed/12238571", "http://www.ncbi.nlm.nih.gov/pubmed/1983096", "http://www.ncbi.nlm.nih.gov/pubmed/16956501", "http://www.ncbi.nlm.nih.gov/pubmed/19831558", "http://www.ncbi.nlm.nih.gov/pubmed/10524588", "http://www.ncbi.nlm.nih.gov/pubmed/18579028"], "snippets": [{"offsetInBeginSection": 1036, "offsetInEndSection": 1305, "text": "They are more sensitive than the tuberculin skin test in detecting people with active tuberculosis, and their results correlate more closely with M. tuberculosis exposure risk factors than the tuberculin skin test in people likely to have latent tuberculosis infection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510"}, {"offsetInBeginSection": 1544, "offsetInEndSection": 1826, "text": "According to the results obtained in this study and considering the prevalence of tuberculosis in our environment, we propose that the systematic application of the Mantoux test be discontinued except in children from countries with a high incidence of this disease or risk factors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16956501"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Prevalence of tuberculosis infection and comparison of multiple-puncture liquid tuberculin test and Mantoux test among drug users.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12238571"}, {"offsetInBeginSection": 0, "offsetInEndSection": 288, "text": "In order to determine the prevalence of latent infection due to Mycobacterium tuberculosis in drug users and to provide centres for drug users with a practical tool for tuberculosis screening, 237 drug users were subjected to the Monotest and, for reference purposes, to the Mantoux test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12238571"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17158278"}, {"offsetInBeginSection": 1131, "offsetInEndSection": 1324, "text": "Many aspects of the physical and social circumstances of homeless people predispose to reactivation and have the potential to enhance rapid spread should latent infection become active disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10524588"}, {"offsetInBeginSection": 1876, "offsetInEndSection": 2021, "text": "It was more sensitive than the Mantoux test and is not significantly affected by previous treatment with systemic steroids or immunosuppressives.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "Role of the mantoux test and treatment with antitubercular therapy in a South Indian patient population of presumed intraocular tuberculosis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19831558"}, {"offsetInBeginSection": 0, "offsetInEndSection": 101, "text": "Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510"}, {"offsetInBeginSection": 474, "offsetInEndSection": 657, "text": "Until recently, the 100-year-old tuberculin skin test (Mantoux) has been the only available diagnostic test for latent tuberculosis infection, despite its many well-known limitations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510"}]}, {"id": "5ac08478d0c506ce46000002", "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/29082276", "http://www.ncbi.nlm.nih.gov/pubmed/27167179", "http://www.ncbi.nlm.nih.gov/pubmed/19151744"], "snippets": [{"offsetInBeginSection": 729, "offsetInEndSection": 840, "text": "The mechanism by which BAG-1 affected the function of Bcl-2 was exploredby using the cycloheximide chase assay.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151744"}, {"offsetInBeginSection": 1646, "offsetInEndSection": 1799, "text": "Furthermore, the cycloheximide chase assay indicated that the degradation of Bcl-2 protein was extended in the BAG-1 p50 and p46 transfected MCF-7 cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151744"}, {"offsetInBeginSection": 328, "offsetInEndSection": 452, "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 0, "offsetInEndSection": 63, "text": "Analysis of Protein Stability by the Cycloheximide Chase Assay.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 1023, "offsetInEndSection": 1172, "text": "The cycloheximide chase procedure permits visualization of the degradation kinetics of the steady state population of a variety of cellular proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 444, "offsetInEndSection": 648, "text": "This article describes the use of cycloheximide chase followed by western blotting to specifically analyze protein degradation in the model unicellular eukaryote, Saccharomyces cerevisiae (budding yeast).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 649, "offsetInEndSection": 755, "text": "In this procedure, yeast cells are incubated in the presence of the translational inhibitor cycloheximide.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 0, "offsetInEndSection": 184, "text": "Comparison of protein stability in eukaryotic cells has been achieved by cycloheximide, which is an inhibitor of protein biosynthesis due to its prevention in translational elongation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 756, "offsetInEndSection": 870, "text": "Aliquots of cells are collected immediately after and at specific time points following addition of cycloheximide.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}]}, {"id": "5abcf6b9fcf4565872000027", "body": "What is caused by the ectopic expression of CTCF?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/11507042", "http://www.ncbi.nlm.nih.gov/pubmed/19369356", "http://www.ncbi.nlm.nih.gov/pubmed/21465478", "http://www.ncbi.nlm.nih.gov/pubmed/22724006", "http://www.ncbi.nlm.nih.gov/pubmed/15941718", "http://www.ncbi.nlm.nih.gov/pubmed/14980504", "http://www.ncbi.nlm.nih.gov/pubmed/28862757", "http://www.ncbi.nlm.nih.gov/pubmed/26929370", "http://www.ncbi.nlm.nih.gov/pubmed/26268681", "http://www.ncbi.nlm.nih.gov/pubmed/24725430"], "snippets": [{"offsetInBeginSection": 585, "offsetInEndSection": 1087, "text": "By using these model systems we demonstrated that: (i) ectopic expression of CTCF in K562 cells led to growth retardation and promotion of differentiation into the erythroid lineage; (ii) CTCF knock-down significantly inhibited differentiation of K562 cells into erythroid lineage; (iii) differentiation of K562 into the megakaryocytic lineage was not significantly affected; and (iv) down-regulation of MYC has been identified as one of the mechanisms by which CTCF promotes erythroid differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15941718"}, {"offsetInBeginSection": 1173, "offsetInEndSection": 1405, "text": "Ectopic expression of Rad21 repressed CTCF-regulated transcription of KSHV lytic genes, and a Rad21-CTCF chimeric protein converted CTCF into an efficient transcriptional repressor of KSHV genes normally activated in the G(2) phase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356"}, {"offsetInBeginSection": 506, "offsetInEndSection": 655, "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 213, "offsetInEndSection": 381, "text": "Ectopic expression of CTCF results in severe cell growth inhibition at multiple points within the cell cycle, indicating that CTCF levels must be stringently monitored.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14980504"}, {"offsetInBeginSection": 1014, "offsetInEndSection": 1228, "text": "Depletion of CTCF resulted in reduced motility and invasiveness in HCC cells that could be reversed by ectopic expression of FOXM1, suggesting that FOXM1 is one of the important downstream effectors of CTCF in HCC.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757"}, {"offsetInBeginSection": 0, "offsetInEndSection": 354, "text": "The 11-zinc finger protein CCTC-binding factor (CTCF) employs different sets of zinc fingers to form distinct complexes with varying CTCF- target sequences (CTSs) that mediate the repression or activation of gene expression and the creation of hormone-responsive gene silencers and of diverse vertebrate enhancer-blocking elements (chromatin insulators).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 898, "offsetInEndSection": 1094, "text": "CTCF is a zinc-finger protein that binds to an insulator region in genomic DNA and plays a fundamental role in controlling higher order chromatin structure and gene expression in vertebrate cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370"}, {"offsetInBeginSection": 1464, "offsetInEndSection": 1675, "text": "The presence of an ectopic CTCF-BS introduced by the retrovirus in tens of thousands of genomic locations has the potential to cause widespread abnormalities in host cell chromatin structure and gene expression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370"}, {"offsetInBeginSection": 120, "offsetInEndSection": 310, "text": "Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21465478"}, {"offsetInBeginSection": 833, "offsetInEndSection": 1065, "text": "Depletion of the BORIS gene leads to altered transcription of a large number of genes and the differentiation of K562 cells, while the ectopic expression of this CTCF paralog leads to specific changes in transcription in MCF7 cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26268681"}]}, {"id": "5ab2cdc5fcf4565872000016", "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23624983", "http://www.ncbi.nlm.nih.gov/pubmed/26290838", "http://www.ncbi.nlm.nih.gov/pubmed/29075945", "http://www.ncbi.nlm.nih.gov/pubmed/16967378", "http://www.ncbi.nlm.nih.gov/pubmed/20494064"], "snippets": [{"offsetInBeginSection": 452, "offsetInEndSection": 691, "text": "METHODS: Data were collected retrospectively on 1,354 patients who underwent sternal closure after major cardiac surgery, using either the multifilament cable wiring system or conventional steel wires between January 2009 and October 2010.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838"}, {"offsetInBeginSection": 561, "offsetInEndSection": 731, "text": "RESULTS: Conventional closure of primary sternotomy is done using many different methods, most often with surgical steel sutures (87 %) passed trans/peristernally (64 %).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16967378"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Multifilament Cable Wire versus Conventional Wire for Sternal Closure in Patients Undergoing Major Cardiac Surgery.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838"}, {"offsetInBeginSection": 0, "offsetInEndSection": 220, "text": "OBJECTIVES: To determine the difference in sternal infection and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "BACKGROUND: Sternal instability and mediastinitis are rare but serious complications following cardiac surgery with median sternotomy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16967378"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "PURPOSE: Midline sternotomy remains the preferred technique for access in cardiac surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20494064"}, {"offsetInBeginSection": 407, "offsetInEndSection": 675, "text": "DESCRIPTION: The Sternal Talon (KLS Martin Group, Jacksonville, FL), a lightweight titanium closure device is designed to encircle the sternum, thus yielding a stable closure by effectively distributing the strength of closure over the entire length of the sternotomy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20494064"}, {"offsetInBeginSection": 309, "offsetInEndSection": 452, "text": "We aimed to compare conventional steel wiring to multifilament cable fixation for sternal closure in patients undergoing major cardiac surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838"}, {"offsetInBeginSection": 1627, "offsetInEndSection": 1775, "text": "Therefore, the multifilament cable wiring system may be considered a viable option for sternal closure in patients undergoing major cardiac surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838"}, {"offsetInBeginSection": 1470, "offsetInEndSection": 1670, "text": "CONCLUSIONS: These initial cases prove the safety and efficacy of the Sternal Talon device for sternum closure in high-risk patients and may be regarded as an alternative to conventional wire closure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20494064"}]}, {"id": "5ac09a7b19833b0d7b000001", "body": "Where is the EpCam protein mainly located?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21115857", "http://www.ncbi.nlm.nih.gov/pubmed/23026194", "http://www.ncbi.nlm.nih.gov/pubmed/26054340", "http://www.ncbi.nlm.nih.gov/pubmed/16054130"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 260, "text": "We recently described that in the metastasizing rat pancreatic carcinoma line BSp73ASML the cell-cell adhesion molecule EpCAM, CD44 variant isoforms and the tetraspanins D6.1A and CD9 form a complex that is located in glycolipid-enriched membrane microdomains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16054130"}, {"offsetInBeginSection": 478, "offsetInEndSection": 563, "text": "EPCAM protein, expressed in epithelial tissues, is encoded by the EPCAM/TACSTD1 gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194"}, {"offsetInBeginSection": 324, "offsetInEndSection": 477, "text": "Of interest, 3' exons deletions of the EPCAM gene, which is located upstream of MSH2 in chromosome 2, are associated with MSH2 promoter hypermethylation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194"}, {"offsetInBeginSection": 1172, "offsetInEndSection": 1299, "text": "In contrast, EPCAM expression was positive in all cancers from patients with germline alterations affecting MSH2 but not EPCAM.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 157, "offsetInEndSection": 400, "text": "Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 879, "offsetInEndSection": 1074, "text": "Evidence for direct protein-protein interactions between EpCAM and claudin-7 was obtained by co-immunoprecipitation after treatment of tumor cells with a membrane-permeable chemical cross-linker.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16054130"}, {"offsetInBeginSection": 466, "offsetInEndSection": 597, "text": "This 20 kDa protein, which co-precipitated with EpCAM in BSp73ASML lysates, was identified as the tight junction protein claudin-7.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16054130"}, {"offsetInBeginSection": 113, "offsetInEndSection": 236, "text": "Basolaterally located cld7 is enriched in glycolipid-enriched membrane domains (GEM), where it associates with EpCAM (EpC).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340"}, {"offsetInBeginSection": 1375, "offsetInEndSection": 1514, "text": "CONCLUSION: These results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 1075, "offsetInEndSection": 1311, "text": "The complex, which is located in glycolipid-enriched membrane microdomains, is not disrupted by partial cholesterol depletion, but claudin-7 phosphorylation is restricted to the localization in glycolipid-enriched membrane microdomains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16054130"}]}, {"id": "5ac24f7595d0062724000003", "body": "Is transcription of eRNA bidirectional?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23728302", "http://www.ncbi.nlm.nih.gov/pubmed/25810254", "http://www.ncbi.nlm.nih.gov/pubmed/25348400", "http://www.ncbi.nlm.nih.gov/pubmed/24778216", "http://www.ncbi.nlm.nih.gov/pubmed/25561718", "http://www.ncbi.nlm.nih.gov/pubmed/25934506", "http://www.ncbi.nlm.nih.gov/pubmed/27932455"], "snippets": [{"offsetInBeginSection": 1131, "offsetInEndSection": 1362, "text": "Lastly, basal eRNA transcription at enhancers, but not E2-induced transcription, is maintained upon depletion of MLL1 and ER\u03b1, suggesting some degree of chromatin accessibility prior to signal-dependent activation of transcription.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455"}, {"offsetInBeginSection": 1363, "offsetInEndSection": 1497, "text": "Together, our findings suggest that eRNA accumulation at enhancer-promoter loops is not required to sustain target gene transcription.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455"}, {"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455"}, {"offsetInBeginSection": 285, "offsetInEndSection": 455, "text": "Using single-molecule fluorescence in situ hybridization (smFISH), we investigated the eRNA-mediated regulation of transcription during estrogen induction in MCF-7 cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455"}, {"offsetInBeginSection": 935, "offsetInEndSection": 1130, "text": "When co-expressed, sub-diffraction distance measurements between nascent mRNA and eRNA signals reveal that co-transcription of eRNAs and mRNAs rarely occurs within closed enhancer-promoter loops.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455"}, {"offsetInBeginSection": 405, "offsetInEndSection": 608, "text": "Here we report that in human breast cancer cells 17\u03b2-oestradiol (E2)-bound oestrogen receptor \u03b1 (ER-\u03b1) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}, {"offsetInBeginSection": 918, "offsetInEndSection": 1066, "text": "XR-seq maps capture transcription-coupled repair at sites of divergent gene promoters and bidirectional enhancer RNA (eRNA) production at enhancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25934506"}, {"offsetInBeginSection": 94, "offsetInEndSection": 289, "text": "In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}, {"offsetInBeginSection": 461, "offsetInEndSection": 596, "text": "Instead, communication between promoters and enhancers can be bidirectional with promoters required to activate enhancer transcription.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561718"}, {"offsetInBeginSection": 844, "offsetInEndSection": 1059, "text": "Cohesin, present on many ER-\u03b1-regulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-\u03b1/eRNA-induced enhancer-promoter looping.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}]}, {"id": "5abbe429fcf456587200001c", "body": "What is the drug target for Eliquis (Apixaban)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23649961", "http://www.ncbi.nlm.nih.gov/pubmed/24624626", "http://www.ncbi.nlm.nih.gov/pubmed/26298448", "http://www.ncbi.nlm.nih.gov/pubmed/23305476", "http://www.ncbi.nlm.nih.gov/pubmed/23821689", "http://www.ncbi.nlm.nih.gov/pubmed/28008269", "http://www.ncbi.nlm.nih.gov/pubmed/27984753", "http://www.ncbi.nlm.nih.gov/pubmed/25195485", "http://www.ncbi.nlm.nih.gov/pubmed/22533680", "http://www.ncbi.nlm.nih.gov/pubmed/26369819"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 201, "text": "The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689"}, {"offsetInBeginSection": 692, "offsetInEndSection": 814, "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269"}, {"offsetInBeginSection": 0, "offsetInEndSection": 332, "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626"}, {"offsetInBeginSection": 245, "offsetInEndSection": 458, "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961"}, {"offsetInBeginSection": 365, "offsetInEndSection": 691, "text": "These new oral anticoagulants fall into two different categories: a direct thrombin inhibitor dabigatran etexilate (Pradaxa Boehringer-Ingelheim, Bracknell, Berkshire) and activated Factor X inhibitors rivaroxaban (Xarelto Bayer HealthCare, Newbury, Berkshire) and apixaban (Eliquis Bristol-Myers Squibb, Uxbridge, Middlesex).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25195485"}, {"offsetInBeginSection": 788, "offsetInEndSection": 1186, "text": "RESULTS: The new oral agents demonstrate several advantages over traditional anticoagulants, including administration at fixed doses and no requirement for routine coagulation monitoring On the basis of phase III clinical trials, rivaroxaban, apixaban and dabigatran etexilate have been approved in many countries for the prevention of venous thromboembolism after hip and knee replacement surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23305476"}, {"offsetInBeginSection": 1763, "offsetInEndSection": 1941, "text": "Apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban (Savaysa) are the new Xa inhibitors that have been recently approved by the U.S. FDA and are in current clinical practice.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26369819"}, {"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689"}, {"offsetInBeginSection": 580, "offsetInEndSection": 748, "text": "Cases were initially identified by a search of the poison centers' databases for case mentions involving a human exposure to Xarelto, rivaroxaban, Eliquis, or apixaban.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448"}, {"offsetInBeginSection": 1034, "offsetInEndSection": 1237, "text": "The search was limited to phase III studies and performed up to 26 March 2012 with the terms 'rivaroxaban OR Xarelto', 'dabigatran OR Pradaxa', 'apixaban OR Eliquis' and 'edoxaban OR DU-176b OR Lixiana'.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22533680"}]}, {"id": "5ac0a36f19833b0d7b000002", "body": "What is an exosome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26725667", "http://www.ncbi.nlm.nih.gov/pubmed/24462375", "http://www.ncbi.nlm.nih.gov/pubmed/27599779", "http://www.ncbi.nlm.nih.gov/pubmed/23376832", "http://www.ncbi.nlm.nih.gov/pubmed/27348448", "http://www.ncbi.nlm.nih.gov/pubmed/21618876", "http://www.ncbi.nlm.nih.gov/pubmed/21713679", "http://www.ncbi.nlm.nih.gov/pubmed/26341056", "http://www.ncbi.nlm.nih.gov/pubmed/27756426", "http://www.ncbi.nlm.nih.gov/pubmed/16087368"], "snippets": [{"offsetInBeginSection": 545, "offsetInEndSection": 937, "text": "We hypothesized that 1) pathological changes in the environment, such as fever, change in pH, or ethanol consumption, would increase exosome permeability; 2) different exosome inducers would result in different exosomal protein content; 3) ethanol at \"physiological\" concentrations would cause exosome release; and 4) ROS production is an underlying mechanism of increased exosome production.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23376832"}, {"offsetInBeginSection": 151, "offsetInEndSection": 187, "text": "Exosome is an important part of TME.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27756426"}, {"offsetInBeginSection": 1256, "offsetInEndSection": 1459, "text": "Although there was no correlation between the tumor progression and the exosome levels, exosome number was the independent prognostic marker and low levels of exosome predicted a poor prognosis (P=0.03).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27599779"}, {"offsetInBeginSection": 0, "offsetInEndSection": 163, "text": "The exosome consists of a core often essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "The exosome consists of a core of ten essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27599779"}, {"offsetInBeginSection": 840, "offsetInEndSection": 1074, "text": "The Exosome Display technology is very versatile since soluble, membrane-bound, trans-membrane or multimeric antigens that are not naturally found on exosomes can now be efficiently expressed at their surface in a native conformation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "Exosome Display is a novel methodology enabling the manipulation of exosome protein content.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368"}, {"offsetInBeginSection": 182, "offsetInEndSection": 394, "text": "Alternatively, when exosome source cells are unavailable for customized exosome production, exosomes derived from a variety of biological origins can be modified post isolation which is the focus of this article.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27348448"}, {"offsetInBeginSection": 705, "offsetInEndSection": 855, "text": "Here, we review cofactors and functions of the cytoplasmic exosome and provide unanswered questions on the mechanisms of cytoplasmic exosome function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876"}]}, {"id": "5ac3699f0340b9f058000001", "body": "Are human enhancers or promoters evolving faster?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21282711", "http://www.ncbi.nlm.nih.gov/pubmed/8931987", "http://www.ncbi.nlm.nih.gov/pubmed/12610136", "http://www.ncbi.nlm.nih.gov/pubmed/8417365", "http://www.ncbi.nlm.nih.gov/pubmed/1668145", "http://www.ncbi.nlm.nih.gov/pubmed/28116828", "http://www.ncbi.nlm.nih.gov/pubmed/18367463", "http://www.ncbi.nlm.nih.gov/pubmed/8508026", "http://www.ncbi.nlm.nih.gov/pubmed/21326370", "http://www.ncbi.nlm.nih.gov/pubmed/21457775"], "snippets": [{"offsetInBeginSection": 1215, "offsetInEndSection": 1328, "text": "Promoters were primarily evolving under purifying selection but with certain categories of genes evolving faster.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711"}, {"offsetInBeginSection": 1266, "offsetInEndSection": 1433, "text": "Proximal and distal chimeras of the human and murine enhancers also replicated less efficiently at a low MOI and expressed lower levels of GFP from the UL127 promoter.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12610136"}, {"offsetInBeginSection": 0, "offsetInEndSection": 186, "text": "The promoters and enhancers of cell type-specific genes are often conserved in evolution, and hence one might expect that a given enhancer has evolved to work best with its own promoter.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145"}, {"offsetInBeginSection": 461, "offsetInEndSection": 603, "text": "Promoters and enhancers are functionally similar; both can regulate the transcription of distal promoters and both direct local transcription.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116828"}, {"offsetInBeginSection": 265, "offsetInEndSection": 460, "text": "The main hypothesis of this manuscript is that, developmental enhancers evolved from unicellular inducible promoters that diversified the expression of regulatory genes during metazoan evolution.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116828"}, {"offsetInBeginSection": 276, "offsetInEndSection": 388, "text": "A total of 27 combinations of different promoters and enhancers were tested by transfection into cultured cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145"}, {"offsetInBeginSection": 0, "offsetInEndSection": 150, "text": "Despite much interest in regulatory evolution, how promoters have evolved remains poorly studied, mainly owing to paucity of data on promoter regions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463"}, {"offsetInBeginSection": 1329, "offsetInEndSection": 1435, "text": "Many of these fast-evolving categories were the same as those associated with rapid evolution in proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711"}, {"offsetInBeginSection": 985, "offsetInEndSection": 1146, "text": "We also used population genetic approaches to examine the evolution of core promoters in human populations and found evidence of positive selection at some loci.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463"}, {"offsetInBeginSection": 599, "offsetInEndSection": 732, "text": "Moreover, a strong TATA \"motif\" was evident in the core region within the functional CArG elements in both human and mouse promoters.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21326370"}]}, {"id": "5abbfd97fcf456587200001d", "body": "What is the Formalin test used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17166125", "http://www.ncbi.nlm.nih.gov/pubmed/19762763", "http://www.ncbi.nlm.nih.gov/pubmed/2247320", "http://www.ncbi.nlm.nih.gov/pubmed/16492837", "http://www.ncbi.nlm.nih.gov/pubmed/19168051", "http://www.ncbi.nlm.nih.gov/pubmed/15105218", "http://www.ncbi.nlm.nih.gov/pubmed/18799335", "http://www.ncbi.nlm.nih.gov/pubmed/15172765", "http://www.ncbi.nlm.nih.gov/pubmed/11226110", "http://www.ncbi.nlm.nih.gov/pubmed/9431444"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "The formalin test for nociception, predominantly used with rodents, is characterized by continuous pain due to tissue injury induced by formalin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444"}, {"offsetInBeginSection": 1284, "offsetInEndSection": 1479, "text": "Tramadol and CP-96345 tend to have more activity in the second phase of the formalin test, whereas morphine, SR-48968, SR-142801 and R116301 demonstrates to be more active in the cold plate test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 806, "offsetInEndSection": 947, "text": "In the late phase indomethacin induced antinociception when 1% formalin was used, while no significant effect was observed using 5% formalin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320"}, {"offsetInBeginSection": 0, "offsetInEndSection": 135, "text": "The formalin test is used as a primary behavioural screen for assaying the antinociceptive activity of compounds in laboratory rodents.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051"}, {"offsetInBeginSection": 301, "offsetInEndSection": 442, "text": "METHODS: Twenty-four adult male rats were divided into four groups: control, formalin test, restricted control, and restricted formalin test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762763"}, {"offsetInBeginSection": 0, "offsetInEndSection": 219, "text": "Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: influence of low and high formalin concentrations.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051"}, {"offsetInBeginSection": 491, "offsetInEndSection": 742, "text": "Experiment 2 was intended to verify the effect of morphine 1, 2.5, or 5 mg/kg on USV during the 12.5% formalin test, whereas other groups of rats received naloxone 2 mg/kg with each one of the morphine doses to verify the specificity of opioid action.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16492837"}, {"offsetInBeginSection": 116, "offsetInEndSection": 330, "text": "We performed two experiments to establish the formalin concentration to induce USV and the relationship of USV emission with motor behaviors and the effects of morphine and naloxone on USV during the formalin test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16492837"}, {"offsetInBeginSection": 358, "offsetInEndSection": 578, "text": "The applied chemical stimulus (formalin) can be qualified as noxious since it produces tissue injury, activates Adelta and C nociceptors as well as trigeminal and spinal nociceptive neurons and is felt as painful in man.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15172765"}, {"offsetInBeginSection": 1480, "offsetInEndSection": 1725, "text": "In the present acute test conditions, there is a correlation in the pharmacological activity in rats and gerbils for the tested compounds a correlation between the second phase of the formalin test and the cold allodynia in CCI animals is found.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}]}, {"id": "5ac2776195d0062724000006", "body": "List diseases caused by protein glutamine expanded repeats", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/9932422", "http://www.ncbi.nlm.nih.gov/pubmed/9536080", "http://www.ncbi.nlm.nih.gov/pubmed/21933837", "http://www.ncbi.nlm.nih.gov/pubmed/11200958", "http://www.ncbi.nlm.nih.gov/pubmed/8980137", "http://www.ncbi.nlm.nih.gov/pubmed/8202492", "http://www.ncbi.nlm.nih.gov/pubmed/19692580", "http://www.ncbi.nlm.nih.gov/pubmed/9536081", "http://www.ncbi.nlm.nih.gov/pubmed/10434299", "http://www.ncbi.nlm.nih.gov/pubmed/7604023"], "snippets": [{"offsetInBeginSection": 1479, "offsetInEndSection": 1656, "text": "Pathological effects may arise when expanded glutamine repeats cause proteins to acquire excessively high affinities for each other or for other proteins with glutamine repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7604023"}, {"offsetInBeginSection": 1141, "offsetInEndSection": 1368, "text": "In both models, diffuse neuronal nuclear staining and nuclear inclusion bodies are observed in animals expressing the expanded glutamine repeat protein, further implicating the nucleus as a primary site of neuronal dysfunction.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10434299"}, {"offsetInBeginSection": 1346, "offsetInEndSection": 1530, "text": "These data indicate that N-terminal truncated fragments of huntingtin with expanded glutamine repeats can aggregate in cells in culture and that this aggregation can be toxic to cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536081"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422"}, {"offsetInBeginSection": 579, "offsetInEndSection": 759, "text": "We have now developed a cell culture model demonstrating that N-terminal fragments of huntingtin with expanded glutamine repeats aggregate both in the cytoplasm and in the nucleus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536081"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536081"}, {"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Five neurodegenerative diseases are caused by proteins with expanded polyglutamine domains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8980137"}, {"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7604023"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Four inherited neurodegenerative diseases are linked to abnormally expanded repeats of glutamine residues in the affected proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492"}, {"offsetInBeginSection": 319, "offsetInEndSection": 448, "text": "Aggregation of expanded polyglutamine is thought to be a common pathological mechanism in HD and other glutamine repeat diseases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}]}, {"id": "5ac37afc0340b9f058000002", "body": "What type of sequences do enhancers evolve from?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25956793", "http://www.ncbi.nlm.nih.gov/pubmed/21593416", "http://www.ncbi.nlm.nih.gov/pubmed/28760812", "http://www.ncbi.nlm.nih.gov/pubmed/21798176", "http://www.ncbi.nlm.nih.gov/pubmed/2134678", "http://www.ncbi.nlm.nih.gov/pubmed/1668145", "http://www.ncbi.nlm.nih.gov/pubmed/21151964", "http://www.ncbi.nlm.nih.gov/pubmed/24218638", "http://www.ncbi.nlm.nih.gov/pubmed/15014138", "http://www.ncbi.nlm.nih.gov/pubmed/29035697"], "snippets": [{"offsetInBeginSection": 1282, "offsetInEndSection": 1378, "text": "To our knowledge, this is the first estimate of waiting times for realistic enhancers to evolve.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 1283, "offsetInEndSection": 1474, "text": "We suggest that the novel optic lobe enhancer evolved by exploiting the cryptic activity of extant regulatory sequences, and this may reflect a general mechanism whereby new enhancers evolve.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416"}, {"offsetInBeginSection": 0, "offsetInEndSection": 186, "text": "The promoters and enhancers of cell type-specific genes are often conserved in evolution, and hence one might expect that a given enhancer has evolved to work best with its own promoter.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145"}, {"offsetInBeginSection": 0, "offsetInEndSection": 40, "text": "What does it take to evolve an enhancer?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 260, "offsetInEndSection": 400, "text": "One way in which changes in gene expression can evolve is through the acquisition of new transcription factor targets in enhancer sequences.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138"}, {"offsetInBeginSection": 93, "offsetInEndSection": 339, "text": "Although many studies have elucidated how individual enhancers can evolve, most of this work has focused on what are called 'minimal' enhancers, the smallest DNA regions that drive expression that approximates an aspect of native gene expression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760812"}, {"offsetInBeginSection": 586, "offsetInEndSection": 847, "text": "We report on our investigation of enhancer evolution through the use of PEBCRES, a framework for evolutionary simulation of enhancers that employs a mechanistic and well-supported sequence-to-expression model to assign fitness to the evolving enhancer genotype.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 811, "offsetInEndSection": 923, "text": "These findings suggest that new and more efficient enhancers evolve by a combination of basic enhancer elements.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2134678"}, {"offsetInBeginSection": 109, "offsetInEndSection": 259, "text": "Transcriptional control is brought about by the interactions of transcription factors with short target motifs in the DNAs of promoters and enhancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145"}]}, {"id": "5abcf66afcf4565872000026", "body": "What is Dupuytren's contracture?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22872850", "http://www.ncbi.nlm.nih.gov/pubmed/21992150", "http://www.ncbi.nlm.nih.gov/pubmed/21935843", "http://www.ncbi.nlm.nih.gov/pubmed/10409813", "http://www.ncbi.nlm.nih.gov/pubmed/20676061", "http://www.ncbi.nlm.nih.gov/pubmed/6130030", "http://www.ncbi.nlm.nih.gov/pubmed/18080603", "http://www.ncbi.nlm.nih.gov/pubmed/1769989", "http://www.ncbi.nlm.nih.gov/pubmed/26152183", "http://www.ncbi.nlm.nih.gov/pubmed/1616255"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "Dupuytren's contracture is a deforming, fibrotic condition of the palmar fascia which has confounded clinicians and scientists since the early descriptions by Guillaume Dupuytren in 1831.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1616255"}, {"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "Dupuytren's contracture is a fibroproliferate disease of the palmar aponeurosis with a formation of nodules and cords.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21935843"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Dupuytren's contracture is a condition commonly encountered by hand surgeons, although it is rare in the Asian population.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "BACKGROUND: Dupuytren's contracture is a condition of the palmar fascia involving contractures of the fascia and skin in the hand.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150"}, {"offsetInBeginSection": 892, "offsetInEndSection": 1039, "text": "Although the etiology of Dupuytren's contracture is unknown, an increase in tumor necrosis factor has been demonstrated to be a possible mechanism.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26152183"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "It is well known that Dupuytren's contracture is often associated with diabetes mellitus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10409813"}, {"offsetInBeginSection": 657, "offsetInEndSection": 978, "text": "Stress relaxation experiments revealed that the viscous fraction was slightly reduced in diabetes mellitus (6.5%) vs. controls (8.3%), whereas in Dupuytren's contracture, irrespective of additional diabetes mellitus, a pronounced increase of this parameter was seen (36.5% vs. 24.5%) in the presence of diabetes mellitus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10409813"}, {"offsetInBeginSection": 1090, "offsetInEndSection": 1175, "text": "CONCLUSION: Dupuytren's contracture is a rare presentation of diabetic hand syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18080603"}, {"offsetInBeginSection": 131, "offsetInEndSection": 206, "text": "Current treatment for Dupuytren's contracture is mainly limited to surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150"}, {"offsetInBeginSection": 0, "offsetInEndSection": 244, "text": "Ultrastructural, immunohistochemical, and biochemical studies to date show that the fibroblast in Dupuytren's contracture is identical to palmar fascia fibroblasts in patients unaffected by Dupuytren's contracture, and to all other fibroblasts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1769989"}]}, {"id": "5ad243e30340b9f058000016", "body": "What is the function of LOX proteins in the ECM?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17931358", "http://www.ncbi.nlm.nih.gov/pubmed/26024311", "http://www.ncbi.nlm.nih.gov/pubmed/24348049", "http://www.ncbi.nlm.nih.gov/pubmed/19592613", "http://www.ncbi.nlm.nih.gov/pubmed/16085123"], "snippets": [{"offsetInBeginSection": 897, "offsetInEndSection": 1268, "text": "Considering the current knowledge on the function of mammalian LOX isoforms in ECM remodeling, we propose that LOXL2/L3/L4 members might have preferentially been involved in making cross-linked collagen IV-based basement membrane, whereas the diversification of LOX/L1/L5 forms contributed to chordate/vertebrate-specific ECM innovations, such as elastin and fibronectin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311"}, {"offsetInBeginSection": 111, "offsetInEndSection": 311, "text": "The best-studied role of LOX enzymes is the remodeling of the extracellular matrix (ECM) in animals by cross-linking collagens and elastin, although intracellular functions have been reported as well.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311"}, {"offsetInBeginSection": 404, "offsetInEndSection": 645, "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 207, "offsetInEndSection": 352, "text": "The family of lysyl oxidase (LOX) enzymes cross-links collagens and elastin and, therefore, is a central player in ECM deposition and maturation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24348049"}, {"offsetInBeginSection": 0, "offsetInEndSection": 228, "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123"}, {"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "The extracellular matrix (ECM) is the physical scaffold where cells are organized into tissues and organs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24348049"}, {"offsetInBeginSection": 244, "offsetInEndSection": 403, "text": "We have recently reported the ECM enzyme, lysyl oxidase (LOX), in the central nervous system and observed up-regulation of LOX in anaplastic astrocytoma cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 1559, "offsetInEndSection": 1750, "text": "Our data signify that diet-induced MetS alters the remodeling enzymes, mainly LOX, thereby altering ECM structure by increasing the amount of cross-linking and inducing diastolic dysfunction.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19592613"}, {"offsetInBeginSection": 293, "offsetInEndSection": 411, "text": "Lysyl oxidase (LOX) is one of the cardiac ECM-modifying enzymes that catalyze the formation of collagen cross-linking.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19592613"}, {"offsetInBeginSection": 951, "offsetInEndSection": 1190, "text": "Immunohistochemistry detected increased LOX within tumour cells and ECM in grade I-IV astrocytic neoplasm compared with normal brain and coincidence of increased LOX with the loss of glial fibrillary acidic protein in higher-grade tumours.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}]}, {"id": "5ace12be0340b9f058000007", "body": "Which gene is responsible for proper speech development?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20571508", "http://www.ncbi.nlm.nih.gov/pubmed/26980647", "http://www.ncbi.nlm.nih.gov/pubmed/15884233", "http://www.ncbi.nlm.nih.gov/pubmed/17574010", "http://www.ncbi.nlm.nih.gov/pubmed/18554997", "http://www.ncbi.nlm.nih.gov/pubmed/22644823", "http://www.ncbi.nlm.nih.gov/pubmed/27771768", "http://www.ncbi.nlm.nih.gov/pubmed/25269856", "http://www.ncbi.nlm.nih.gov/pubmed/17565757"], "snippets": [{"offsetInBeginSection": 655, "offsetInEndSection": 1046, "text": "The following research problems have been assumed: 1) how does the speech competences' development with children of six and seven proceed, 2) in which level do the following factors of family environment (parents' age, parents' education, family's financial conditions) influence the child's speech development, 3) does the family's structure influence the proper child's speech development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}, {"offsetInBeginSection": 1065, "offsetInEndSection": 1244, "text": "The spectrum and frequency of genomic rearrangements at 7q11.23 presents an exceptional opportunity to identify gene(s) directly involved in human speech and language development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17565757"}, {"offsetInBeginSection": 743, "offsetInEndSection": 972, "text": "This article offers a theoretical overview and proposes future research to investigate which factors are indeed responsible for the speech problems encountered by patients with the 22q11.2 deletion and identify responsible genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997"}, {"offsetInBeginSection": 0, "offsetInEndSection": 123, "text": "Rearrangements of the Williams-Beuren syndrome locus: molecular basis and implications for speech and language development.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17565757"}, {"offsetInBeginSection": 351, "offsetInEndSection": 470, "text": "Therefore early diagnosis and treatment with rehabilitation of hearing loss is important for proper speech development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22644823"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "The FOXP2 gene is important for the development of proper speech motor control in humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647"}, {"offsetInBeginSection": 1266, "offsetInEndSection": 1393, "text": "The presented work is a trial of analysis how the selected family environment factors influence the child's speech development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}, {"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "BACKGROUND: Mutations in the human FOXP2 gene cause speech and language impairments.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856"}, {"offsetInBeginSection": 260, "offsetInEndSection": 415, "text": "An adequate amount of functional FOXP2 protein is thought to be critical for the proper development of the neural circuitry underlying speech and language.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856"}, {"offsetInBeginSection": 504, "offsetInEndSection": 654, "text": "The study was conducted with children of six and seven year old, where speech should be mastered with fixed pronunciation and proper speech technique.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}]}, {"id": "5abcf755fcf4565872000028", "body": "Please list 3 diseases treated with Valtrex(valacyclovir)", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28089147", "http://www.ncbi.nlm.nih.gov/pubmed/15043175", "http://www.ncbi.nlm.nih.gov/pubmed/28961065", "http://www.ncbi.nlm.nih.gov/pubmed/24736271", "http://www.ncbi.nlm.nih.gov/pubmed/21404597", "http://www.ncbi.nlm.nih.gov/pubmed/9589847", "http://www.ncbi.nlm.nih.gov/pubmed/24284060", "http://www.ncbi.nlm.nih.gov/pubmed/9514622", "http://www.ncbi.nlm.nih.gov/pubmed/19841603"], "snippets": [{"offsetInBeginSection": 818, "offsetInEndSection": 1093, "text": "As such, new findings linking mitochondrial function to the progression or outcome of this ever-increasing list of diseases has stimulated the discovery and development of the first true mitochondrial drugs, which are now entering the clinic and are discussed in this review.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961065"}, {"offsetInBeginSection": 461, "offsetInEndSection": 583, "text": "METHODS: 571 patients were treated with DCB angioplasty at the Heinrich-Heine University D\u00fcsseldorf between 2009 and 2012.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 296, "offsetInEndSection": 544, "text": "Diseases defined by mitochondrial dysfunction have also expanded from rare monogenic disorders in a strict sense to now also include many common polygenic diseases, including metabolic, cardiovascular, neurodegenerative, and neuromuscular diseases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961065"}, {"offsetInBeginSection": 284, "offsetInEndSection": 473, "text": "As patients with asthma get older, their medication regimen can become even more complex with the development of numerous other age-related diseases requiring their own list of medications.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9589847"}, {"offsetInBeginSection": 1216, "offsetInEndSection": 1300, "text": "Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961065"}, {"offsetInBeginSection": 0, "offsetInEndSection": 249, "text": "Christoph Steininger and colleagues explore how multiple infectious, autoimmune, metabolic, and neoplastic diseases have been associated with changes in the intestinal microbiome, although a cause-effect relationship is often difficult to establish.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24736271"}, {"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the D\u00fcsseldorf DCB registry.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 1424, "offsetInEndSection": 1549, "text": "CONCLUSION: MACE free survival was longer in Pantera Lux DCB treated patients as compared to SeQuent Please treated patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 723, "offsetInEndSection": 997, "text": "Many of these diseases require the use of nonsteroidal anti-inflammatory agents, well known to provoke wheezing in patients with intrinsic asthma, and diseases of the eye and cardiovascular system frequently require use of beta-blockers which can cause or exacerbate asthma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9589847"}, {"offsetInBeginSection": 234, "offsetInEndSection": 501, "text": "PATIENTS: Two hundred members of the Finnish M\u00e9ni\u00e8re's Association reporting a diagnosis compatible with the condition.INTERVENTION(S): Postal questionnaire, including the question \"Please make a list of the main effects that your M\u00e9ni\u00e8re's disorder has on your life.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19841603"}]}, {"id": "5ad35933133db5eb78000001", "body": "Is the protein pelota a ribosomal rescue factor?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27493551", "http://www.ncbi.nlm.nih.gov/pubmed/25061210", "http://www.ncbi.nlm.nih.gov/pubmed/9584085"], "snippets": [{"offsetInBeginSection": 308, "offsetInEndSection": 571, "text": "Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210"}, {"offsetInBeginSection": 572, "offsetInEndSection": 716, "text": "Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210"}, {"offsetInBeginSection": 271, "offsetInEndSection": 398, "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 318, "offsetInEndSection": 448, "text": "RPS30A, which encodes ribosomal protein S30, was identified in a screen for high-copy suppressors of the dom34delta growth defect.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085"}, {"offsetInBeginSection": 627, "offsetInEndSection": 771, "text": "In this review, we focus on the functional roles of Dom34/aPelota and Hbs1/aEF1\u03b1 in ribosome rescue, based on recent structural studies of them.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "Recent structural studies on Dom34/aPelota and Hbs1/aEF1\u03b1: important factors for solving general problems of ribosomal stall in translation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 677, "offsetInEndSection": 788, "text": "A Drosophila homolog of Dom34p, pelota, is required for the proper coordination of meiosis and spermatogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085"}, {"offsetInBeginSection": 449, "offsetInEndSection": 548, "text": "dom34delta mutants display an altered polyribosome profile that is rescued by expression of RPS30A.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085"}, {"offsetInBeginSection": 399, "offsetInEndSection": 521, "text": "In archaea, aPelota and aEF1\u03b1, homologous to Pelota and Hbs1, respectively, are considered to be involved in that process.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 789, "offsetInEndSection": 979, "text": "Heterologous expression of pelota in dom34delata mutants restores wild-type growth and differentiation, suggesting conservation of function between the eukaryotic members of the gene family.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085"}]}, {"id": "5ace17c30340b9f058000009", "body": "Which olfactory gene senses androsterone?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26140380", "http://www.ncbi.nlm.nih.gov/pubmed/23321429", "http://www.ncbi.nlm.nih.gov/pubmed/23230501", "http://www.ncbi.nlm.nih.gov/pubmed/8043710", "http://www.ncbi.nlm.nih.gov/pubmed/18808328", "http://www.ncbi.nlm.nih.gov/pubmed/20221768", "http://www.ncbi.nlm.nih.gov/pubmed/25091523", "http://www.ncbi.nlm.nih.gov/pubmed/1737068", "http://www.ncbi.nlm.nih.gov/pubmed/23721465", "http://www.ncbi.nlm.nih.gov/pubmed/9566734"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "The mammalian olfactory system senses an almost unlimited number of chemical stimuli and initiates a process of neural recognition that influences nearly every aspect of life.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18808328"}, {"offsetInBeginSection": 0, "offsetInEndSection": 185, "text": "BACKGROUND: Chemical senses are one of the foremost means by which organisms make sense of their environment, among them the olfactory and gustatory sense of vertebrates and arthropods.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25091523"}, {"offsetInBeginSection": 1580, "offsetInEndSection": 1658, "text": "CONCLUSION: Denture wearing does not influence gustatory and olfactory senses.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 799, "offsetInEndSection": 1046, "text": "However, the nonsynonymous-to-synonymous substitution rate ratio was relatively higher between orthologous OR genes of L. frontalis and L. colubrina, indicating that L. frontalis and L. colubrina have evolved to possess different olfactory senses.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23721465"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "Evaluation of the effect of upper complete denture on gustatory and olfactory senses.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 439, "offsetInEndSection": 683, "text": "METHODS: In this study, gustatory and olfactory senses in 30 patients (15 men and 15 women with a mean age of 52.93 \u00b1 12.97 years) were evaluated three times: before complete denture insertion, three days after insertion and 1 month after that.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 293, "offsetInEndSection": 438, "text": "The purpose of this study was to evaluate the effect of upper complete denture on gustatory and olfactory senses in denture wearers.MATERIALS AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 135, "offsetInEndSection": 319, "text": "In health and disease, it has been shown that in two of these senses, the trigeminal and olfactory senses, modification of one sense leads to changes in the other sense and vice versa.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20221768"}, {"offsetInBeginSection": 288, "offsetInEndSection": 445, "text": "High evolutionary dynamics of some olfactory and gustatory receptor gene families result in considerable variance of chemosensory perception between species.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25091523"}, {"offsetInBeginSection": 892, "offsetInEndSection": 1128, "text": "Based on these lines of evidence, it is concluded that the large portion of androsterone UDPGT gene is deleted in LA Wistar rats, which results in the absence of androsterone UDPGT mRNA and consequently the corresponding enzyme protein.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068"}]}, {"id": "5abd13e1fcf4565872000029", "body": "Where in the body would the navicular bone be found?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20525052", "http://www.ncbi.nlm.nih.gov/pubmed/2681808", "http://www.ncbi.nlm.nih.gov/pubmed/28099198", "http://www.ncbi.nlm.nih.gov/pubmed/9622323", "http://www.ncbi.nlm.nih.gov/pubmed/10029187", "http://www.ncbi.nlm.nih.gov/pubmed/27588043", "http://www.ncbi.nlm.nih.gov/pubmed/27298914", "http://www.ncbi.nlm.nih.gov/pubmed/24788547", "http://www.ncbi.nlm.nih.gov/pubmed/24719271", "http://www.ncbi.nlm.nih.gov/pubmed/9776073"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 391, "text": "OBJECTIVE: To test the anecdotal observation that isolated navicular collapse is associated with diabetes mellitus, we quantified the size of the tarsal navicular bone in subjects with and without diabetes and tested for association of size with age, height, weight, body mass index (BMI), gender, smoking, bone mineral density (BMD), duration, and level of control of diabetes.MATERIALS AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24788547"}, {"offsetInBeginSection": 1274, "offsetInEndSection": 1873, "text": "There were significant associations between a cystic structure in the distal third of the navicular bone and the presence of either a distal border fragment or entheseous new bone at the insertion of the DSIL, swelling of the DSIL and increased signal intensity in the DSIL in fat suppressed images; between distal elongation of the flexor border of the navicular bone and the presence of one or more distal border fragments and between swelling of the body of the DSIL and irregularity of its palmar border or increased signal intensity in fat suppressed images in the DSIL.CONCLUSIONS AND CLINICAL", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 458, "offsetInEndSection": 737, "text": "Gross changes seen only in ND horses included: full thickness defects in the palmar surface fibrocartilage, palmar cortex erosion, medullary lysis, flexor digitorum profundus tendon (FDPT) surface fibrillation, FDPT core lesions and adhesions between the FDPT and navicular bone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9622323"}, {"offsetInBeginSection": 2558, "offsetInEndSection": 2762, "text": "The histological and histomorphometric changes in the navicular bone and palmar fibrocartilage were considered similar of those found in articular hyaline cartilage and subchondral bone in osteoarthritis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9622323"}, {"offsetInBeginSection": 1375, "offsetInEndSection": 1740, "text": "Although assessment of total navicular displacement by combining concomitant vertical and medial navicular bone movements would appear advantageous compared to monoplanar measurement the combined measure did not seem to predict dynamic changes of the medial foot arch during walking, which are among several possible factors depending on different walking patterns.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27588043"}, {"offsetInBeginSection": 956, "offsetInEndSection": 1273, "text": "RESULTS: There were significant correlations between the presence of a cystic structure in the distal third of the navicular bone, or a distal border fragment, or increased signal intensity in fat suppressed images at the insertion of the DSIL on the distal phalanx and the histological grade of the body of the DSIL.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 437, "offsetInEndSection": 584, "text": "We also measured orientation of the navicular, morphological parameters of the talus and navicular, and angular position of the talar head to body.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24719271"}, {"offsetInBeginSection": 569, "offsetInEndSection": 657, "text": "In highly comminuted fractures, talo-navicular-cuneiform arthrodesis can be carried out.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808"}, {"offsetInBeginSection": 1203, "offsetInEndSection": 1374, "text": "CONCLUSIONS: Total navicular bone displacements determined by pMRI showed concurrent validity with stretch sensor measurements but only so under static loading conditions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27588043"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Fractures of the body of the tarsal navicular bone: case reports and literature review.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808"}]}, {"id": "5a9d9ab94e03427e73000003", "body": "Is Cystatin D a biomarker?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27861242", "http://www.ncbi.nlm.nih.gov/pubmed/26066476", "http://www.ncbi.nlm.nih.gov/pubmed/29087712", "http://www.ncbi.nlm.nih.gov/pubmed/21151566", "http://www.ncbi.nlm.nih.gov/pubmed/22350134", "http://www.ncbi.nlm.nih.gov/pubmed/19444952", "http://www.ncbi.nlm.nih.gov/pubmed/21918259", "http://www.ncbi.nlm.nih.gov/pubmed/24713815", "http://www.ncbi.nlm.nih.gov/pubmed/24266750", "http://www.ncbi.nlm.nih.gov/pubmed/22795897"], "snippets": [{"offsetInBeginSection": 1253, "offsetInEndSection": 1371, "text": "Cystatin C is more sensitive as an early biomarker of acute kidney injury in comparison with kidney injury molecule-1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24713815"}, {"offsetInBeginSection": 0, "offsetInEndSection": 60, "text": "Cystatin C is not a good candidate biomarker for HNF1A-MODY.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22350134"}, {"offsetInBeginSection": 0, "offsetInEndSection": 242, "text": "BACKGROUND: The aims of this study were to determine which of the two biomarkers of renal injury, kidney injury molecule-1 or cystatin C, is more sensitive and to evaluate whether erythropoietin protects kidneys injured by perinatal asphyxia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24713815"}, {"offsetInBeginSection": 402, "offsetInEndSection": 528, "text": "Since 1985 cystatin C has been studied mainly in serum/plasma as an alternative biomarker to serum creatinine to estimate GFR.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259"}, {"offsetInBeginSection": 382, "offsetInEndSection": 576, "text": "The cysteine protease inhibitor cystatin C has recently gained interest as a candidate diagnostic biomarker for ALS, but further studies are required to fully characterize its biomarker utility.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151566"}, {"offsetInBeginSection": 81, "offsetInEndSection": 602, "text": "In the present study, we examined the usefulness of urinary cystatin C for the detection of diabetic nephropathy in Zucker diabetic fatty (ZDF) rats compared to other biomarkers (\u03b22-microglobulin, calbindin, clusterin, epidermal growth factor (EGF), alpha-glutathione S-transferase (GST-\u03b1), mu-glutathione S-transferase (GST-\u03bc), kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), osteopontin, tissue inhibitor of metalloprotease-1 (TIMP-1), and vascular endothelial growth factor (VEGF).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897"}, {"offsetInBeginSection": 529, "offsetInEndSection": 652, "text": "In this review we present the recent discoveries concerning urinary cystatin C determination as a tubular injury biomarker.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897"}, {"offsetInBeginSection": 0, "offsetInEndSection": 165, "text": "Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259"}, {"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Cystatin C is a marker of glomerular filtration rate (GFR).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22350134"}]}, {"id": "5ace19420340b9f05800000a", "body": "Which gene is responsible for red hair?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12876664", "http://www.ncbi.nlm.nih.gov/pubmed/9302268", "http://www.ncbi.nlm.nih.gov/pubmed/28024137", "http://www.ncbi.nlm.nih.gov/pubmed/2363420"], "snippets": [{"offsetInBeginSection": 115, "offsetInEndSection": 190, "text": "A specific variant of MC1R gene (R allele) is responsible for the red hair.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137"}, {"offsetInBeginSection": 841, "offsetInEndSection": 1114, "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 335, "offsetInEndSection": 588, "text": "The previously reported Val92Met allele shows no association with hair colour, but the three alleles Arg151Cys, Arg160Trp and Asp294His were associated with red hair and one Val60Leu variant was most frequent in fair/blonde and light brown hair colours.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}, {"offsetInBeginSection": 598, "offsetInEndSection": 864, "text": "A possible explanation for the existence of these 2 different group of patients is that the locus of the gene responsible for the syndrome is closely linked to the locus for a gene responsible for hair color with linkage disequilibrium in Tunisian Jews (Sepharadim).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2363420"}, {"offsetInBeginSection": 238, "offsetInEndSection": 386, "text": "The majority of affected individuals develop some cutaneous melanin; this is predominantly seen as yellow/blond hair, whereas fewer have brown hair.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 589, "offsetInEndSection": 666, "text": "Variant MSHR genotypes are associated with lighter skin types and red hair (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}, {"offsetInBeginSection": 413, "offsetInEndSection": 507, "text": "Melanin has two types: eumelanin which is dark brown or even black and red/orange pheomelanin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137"}, {"offsetInBeginSection": 628, "offsetInEndSection": 775, "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 0, "offsetInEndSection": 218, "text": "The association between MSHR coding region variation and hair colour in humans has been examined by genotyping 25 red haired and 62 non-red Caucasians, all of whom were 12 years of age and members of a twin pair study.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}, {"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}]}, {"id": "5abd5a62fcf4565872000031", "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/10573394", "http://www.ncbi.nlm.nih.gov/pubmed/2695392", "http://www.ncbi.nlm.nih.gov/pubmed/6263856", "http://www.ncbi.nlm.nih.gov/pubmed/1979278", "http://www.ncbi.nlm.nih.gov/pubmed/403933", "http://www.ncbi.nlm.nih.gov/pubmed/6265073", "http://www.ncbi.nlm.nih.gov/pubmed/8246264", "http://www.ncbi.nlm.nih.gov/pubmed/18183461", "http://www.ncbi.nlm.nih.gov/pubmed/776705", "http://www.ncbi.nlm.nih.gov/pubmed/8760442"], "snippets": [{"offsetInBeginSection": 356, "offsetInEndSection": 476, "text": "Purified DNAs were digested with EcoRI restriction endonuclease, and restriction fragments separated by electrophoresis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1979278"}, {"offsetInBeginSection": 0, "offsetInEndSection": 138, "text": "The RsrI endonuclease, a type-II restriction endonuclease (ENase) found in Rhodobacter sphaeroides, is an isoschizomer of the EcoRI ENase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392"}, {"offsetInBeginSection": 0, "offsetInEndSection": 119, "text": "A restriction endonuclease analysis of the bacterial plasmid controlling the ecoRI restriction and modification of DNA.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/776705"}, {"offsetInBeginSection": 0, "offsetInEndSection": 242, "text": "The DNA's isolated from five mouse hyperplastic mammary gland outgrowth lines from BALB/cfC3H mice were digested with the restriction endonucleases PsTI, BamHI, or EcoRI; electrophoresed; and analyzed by Southern blotting and autoradiography.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6265073"}, {"offsetInBeginSection": 368, "offsetInEndSection": 547, "text": "Restriction endonucleases EcoRI and HindIII were used to analyze the structure of the plasmid genome responsible for the EcoRI restriction endonuclease and modification methylase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/776705"}, {"offsetInBeginSection": 259, "offsetInEndSection": 473, "text": "The isolates were initially classified according to their restriction endonuclease profiles using HindIII and EcoRI restriction endonucleases and further characterised by rRNA gene restriction patterns (ribotypes).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394"}, {"offsetInBeginSection": 530, "offsetInEndSection": 654, "text": "A fragment pattern of the products of EcoRI restriction endonuclease digestion of Euglena chloroplast DNA is also described.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/403933"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Comparison of the nucleotide and amino acid sequences of the RsrI and EcoRI restriction endonucleases.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392"}, {"offsetInBeginSection": 0, "offsetInEndSection": 407, "text": "High-level mupirocin resistance in coagulase-negative staphylococci isolated from patients undergoing peritoneal dialysis was investigated by transfer of the resistance determinants, usually in the form of a plasmid, to Staphylococcus aureus strains, cleavage of the plasmid by restriction endonuclease and hybridisation with a probe comprising a 4.05 kb EcoRI fragment of a plasmid from a S. aureus strain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8246264"}, {"offsetInBeginSection": 526, "offsetInEndSection": 899, "text": "Aliquots of this highly purified material were treated in the following ways: (i) sonicated and end-repaired to create short randomly sheared fragments for cloning into M13mp 18-Smal vector DNA; (ii) cut with EcoRI for cloning into EcoRI-cut lambda ZAPII or lambda DASHII vectors; (iii) cut with BamHI for cloning into BamHI-cut lambda ZAP-Express or lambda DASHII vectors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8760442"}]}, {"id": "5a9da37e4e03427e73000004", "body": "What is Mendelian randomization?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26291580", "http://www.ncbi.nlm.nih.gov/pubmed/26201704", "http://www.ncbi.nlm.nih.gov/pubmed/19432981", "http://www.ncbi.nlm.nih.gov/pubmed/23199790", "http://www.ncbi.nlm.nih.gov/pubmed/20978399", "http://www.ncbi.nlm.nih.gov/pubmed/19674341", "http://www.ncbi.nlm.nih.gov/pubmed/16410347", "http://www.ncbi.nlm.nih.gov/pubmed/20616999", "http://www.ncbi.nlm.nih.gov/pubmed/19174578", "http://www.ncbi.nlm.nih.gov/pubmed/27486138"], "snippets": [{"offsetInBeginSection": 336, "offsetInEndSection": 592, "text": "Akin to a randomized trial, Mendelian randomization is a genetic study design that takes advantage of the \"randomization\" of genetic information at birth to evaluate a potential causal relationship between a genetically determined biomarker and an outcome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199790"}, {"offsetInBeginSection": 117, "offsetInEndSection": 224, "text": "Mendelian randomization is a genetic epidemiologic approach used to disentangle causation from association.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20978399"}, {"offsetInBeginSection": 263, "offsetInEndSection": 705, "text": "In this review, we recall the principles of a \"Mendelian randomization\" approach in observational epidemiology, which is based on the technique of instrumental variables; we provide simulations and an example based on real data to demonstrate its implications; we present the results of a systematic search on original articles having used this approach; and we discuss some limitations of this approach in view of what has been found so far.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20616999"}, {"offsetInBeginSection": 1723, "offsetInEndSection": 2142, "text": "The possibility of epigenetic effects (non-Mendelian, heritable changes in gene expression not accompanied by alterations in DNA sequence) could alter the core instrumental variable assumptions of Mendelian randomization.This paper applies conceptual considerations, algebraic derivations and data simulations to question the appropriateness of Mendelian randomization methods when epigenetic modifications are present.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981"}, {"offsetInBeginSection": 770, "offsetInEndSection": 871, "text": "The authors conclude that Mendelian randomization is a powerful addition to etiologic research tools.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "OBJECTIVE: Mendelian randomization is a popular technique for assessing and estimating the causal effects of risk factors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 288, "offsetInEndSection": 522, "text": "Mendelian randomization is a recently developed methodology that combines genetic and classical epidemiological analysis to infer causality for environmental exposures, based on the principle of Mendel's law of independent assortment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19674341"}, {"offsetInBeginSection": 1621, "offsetInEndSection": 1814, "text": "We conclude that Mendelian randomization is not universally applicable, but, under the right conditions, can complement evidence for causal associations from conventional epidemiologic studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19174578"}, {"offsetInBeginSection": 1292, "offsetInEndSection": 1722, "text": "Although previous articles have addressed some of the limitations of Mendelian randomization (such as the lack of suitable genetic variants, unreliable associations, population stratification, linkage disequilibrium (LD), pleiotropy, developmental canalization, the need for large sample sizes and some potential problems with binary outcomes), none has directly characterized the impact of epigenetics on Mendelian randomization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981"}, {"offsetInBeginSection": 861, "offsetInEndSection": 1291, "text": "Unlike conventional randomized controlled trials (RCTs), Mendelian randomization studies can be conducted in a representative sample without imposing any exclusion criteria or requiring volunteers to be amenable to random treatment allocation.Within the last decade, epigenetics has gained recognition as an independent field of study, and appears to be the new direction for future research into the genetics of complex diseases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981"}]}, {"id": "5ace1a590340b9f05800000b", "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17146600", "http://www.ncbi.nlm.nih.gov/pubmed/17110569", "http://www.ncbi.nlm.nih.gov/pubmed/10788336", "http://www.ncbi.nlm.nih.gov/pubmed/27429943", "http://www.ncbi.nlm.nih.gov/pubmed/18768141", "http://www.ncbi.nlm.nih.gov/pubmed/21404232", "http://www.ncbi.nlm.nih.gov/pubmed/21078988"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 246, "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 330, "offsetInEndSection": 648, "text": "If the Neanderthal population was large compared to the Homo sapiens population at the beginning of the contact period, we show that genetic introgression should have been fast and complete meaning that most of the Neanderthal private alleles should be found in the modern human gene pool in case of ancient admixture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141"}, {"offsetInBeginSection": 146, "offsetInEndSection": 565, "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336"}, {"offsetInBeginSection": 0, "offsetInEndSection": 192, "text": "Mitochondrial Eve confirms the \"out of Africa\" theory, but the evidence also supports interbreeding between Homo sapiens and other hominins: Neanderthals, Denisovans, and Homo heidelbergensis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943"}, {"offsetInBeginSection": 1362, "offsetInEndSection": 1559, "text": "This initial analysis of the Neanderthal genome advances our understanding of the evolutionary relationship of Homo sapiens and Homo neanderthalensis and signifies the dawn of Neanderthal genomics.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "Are Homo sapiens nonsupranuchal fossa and Neanderthal suprainiac fossa convergent traits?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232"}, {"offsetInBeginSection": 806, "offsetInEndSection": 1144, "text": "Our analyses suggest that on average the Neanderthal genomic sequence we obtained and the reference human genome sequence share a most recent common ancestor approximately 706,000 years ago, and that the human and Neanderthal ancestral populations split approximately 370,000 years ago, before the emergence of anatomically modern humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569"}, {"offsetInBeginSection": 901, "offsetInEndSection": 1139, "text": "In the Sub-Saharan region, unaffected by Denisovan or Neanderthal interbreeding, H. sapiens interbred with H. heidelbergensis, because high humidity militated against fire-making and allowed the survival of these non-fire-making hominins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943"}, {"offsetInBeginSection": 566, "offsetInEndSection": 703, "text": "When labeled chimpanzee DNA was used as a probe, Neanderthal and human DNA, however, revealed hybridization signals of similar intensity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336"}, {"offsetInBeginSection": 998, "offsetInEndSection": 1164, "text": "We find that the power to reject ancient admixture might be particularly low if the population size of Homo sapiens was comparable to the Neanderthal population size.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141"}]}, {"id": "5ac0f7b919833b0d7b000006", "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26378211", "http://www.ncbi.nlm.nih.gov/pubmed/25485923", "http://www.ncbi.nlm.nih.gov/pubmed/27082776", "http://www.ncbi.nlm.nih.gov/pubmed/28314985", "http://www.ncbi.nlm.nih.gov/pubmed/12516682", "http://www.ncbi.nlm.nih.gov/pubmed/23953907", "http://www.ncbi.nlm.nih.gov/pubmed/19351313", "http://www.ncbi.nlm.nih.gov/pubmed/28471371", "http://www.ncbi.nlm.nih.gov/pubmed/27626268", "http://www.ncbi.nlm.nih.gov/pubmed/21254900"], "snippets": [{"offsetInBeginSection": 716, "offsetInEndSection": 949, "text": "This is followed by analysing the present-day results of clinical trials aimed at working out pharmaceutical agents (andexanet alpha, idarucizumab, aripazine) being antidotes to direct thrombin inhibitor and the factor Xa inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27626268"}, {"offsetInBeginSection": 267, "offsetInEndSection": 425, "text": "NOACs are classified into two groups: direct thrombin inhibitor (notably dabigatran) and factor Xa inhibitors (including rivaroxaban, apixaban, and edoxaban).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27626268"}, {"offsetInBeginSection": 0, "offsetInEndSection": 326, "text": "The direct thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban and apixaban are US Food and Drug Administration (FDA)-approved target-specific oral anticoagulants (TSOACs) that have emerged onto the market for use in some indications similar to those for warfarin; in addition, edoxaban is seeking FDA approval.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25485923"}, {"offsetInBeginSection": 0, "offsetInEndSection": 170, "text": "Several direct oral anticoagulants (DOACs), including direct thrombin and factor Xa inhibitors, have been approved as alternatives to vitamin K antagonist anticoagulants.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28471371"}, {"offsetInBeginSection": 1077, "offsetInEndSection": 1389, "text": "Andexanet alfa (PRT064445), a specific reversal agent against factor Xa inhibitors, showed a complete reversal of anticoagulant activity of apixaban and rivaroxaban within minutes after administration without adverse effects in two recently completed parallel phase III trials ANNEXA-A and ANNEXA-R respectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27082776"}, {"offsetInBeginSection": 1090, "offsetInEndSection": 1353, "text": "Specific laboratory tests have been developed for more accurate measurements of NOAC blood levels, including a dilute thrombin time test (Hemoclot test) and the ecarin clot test for dabigatran and chromogenic anti-factor Xa assays for direct factor Xa inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28314985"}, {"offsetInBeginSection": 1340, "offsetInEndSection": 1599, "text": "Further studies on the effect of factor Xa inhibitor on platelet aggregation; factor II, VII, and X functional levels; and fibrinopeptide A (FPA) generation were carried out at equivalent INR levels in comparison to oral anticoagulant and antithrombin agents.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12516682"}, {"offsetInBeginSection": 0, "offsetInEndSection": 235, "text": "Abstract The limits of traditional anticoagulants, such as heparin and warfarin, have prompted the search for new agents for prophylaxis and treatment of arterial and venous thromboembolism, including factor Xa and thrombin inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21254900"}, {"offsetInBeginSection": 744, "offsetInEndSection": 1159, "text": "To test the feasibility of using the prothrombin time (PT), International Normalized Ratio (INR), activated partial thromboplastin time (aPTT), Heptest, thrombin time, RVVT, ECT, and a modified anti-Xa amidolytic assay, to monitor a synthetic factor Xa inhibitor, normal human pool plasma samples were spiked with a synthetic factor Xa inhibitor in the concentration range of 0 to 1 microg/mL and 0 to 25 microg/mL.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12516682"}, {"offsetInBeginSection": 301, "offsetInEndSection": 576, "text": "Specific antidotes for the reversal of the anticoagulant effect of these drugs, such as monoclonal antibodies against the direct thrombin inhibitor dabigatran or recombinant Xa-analog in the case of factor Xa inhibitors, are still being investigated in early clinical trials.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907"}]}, {"id": "5a9da59c4e03427e73000005", "body": "What is PNPPP?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26551787", "http://www.ncbi.nlm.nih.gov/pubmed/25658120", "http://www.ncbi.nlm.nih.gov/pubmed/21747892", "http://www.ncbi.nlm.nih.gov/pubmed/24201366"], "snippets": [{"offsetInBeginSection": 919, "offsetInEndSection": 1050, "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 1827, "offsetInEndSection": 1913, "text": "PdeM, thus, is a novel representative of new subclass of class III phosphodiesterases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 1400, "offsetInEndSection": 1522, "text": "Although Mn2+ was required for the activity of PdeM, but addition of metals (Mn2+ or Fe3+) did not induce oligomerization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 654, "offsetInEndSection": 918, "text": "The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID(50) of 0.161\u2009mg/ml (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892"}, {"offsetInBeginSection": 428, "offsetInEndSection": 727, "text": "Bioinformatic analysis showed that PdeM sequence possessed the characteristic signature motifs of the class III phosphodiesterases and phylogenetic study of PdeM enabled us to identify three distinct subclasses (A, B, and C) within class III phosphodiesterases, PdeM clustering in new subclass IIIB.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 1523, "offsetInEndSection": 1646, "text": "Further increase in concentration of Mn2+ upto 3 mM, increased \u03b1-helical content as well as the phosphodiesterase activity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 0, "offsetInEndSection": 210, "text": "OBJECTIVE: To study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance.MATERIALS AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787"}, {"offsetInBeginSection": 1051, "offsetInEndSection": 1151, "text": "The recombinant PdeM possessed phosphodiesterase, phosphonate-ester hydrolase and nuclease activity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 514, "offsetInEndSection": 717, "text": "CONCLUSION: PNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787"}, {"offsetInBeginSection": 1225, "offsetInEndSection": 1399, "text": "Overexpression of PdeM in E.coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}]}, {"id": "5ace20fa0340b9f05800000c", "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25501874", "http://www.ncbi.nlm.nih.gov/pubmed/20961960", "http://www.ncbi.nlm.nih.gov/pubmed/28585439", "http://www.ncbi.nlm.nih.gov/pubmed/26053282", "http://www.ncbi.nlm.nih.gov/pubmed/22503288", "http://www.ncbi.nlm.nih.gov/pubmed/20838600", "http://www.ncbi.nlm.nih.gov/pubmed/28585440", "http://www.ncbi.nlm.nih.gov/pubmed/23874230", "http://www.ncbi.nlm.nih.gov/pubmed/27501156", "http://www.ncbi.nlm.nih.gov/pubmed/23666208"], "snippets": [{"offsetInBeginSection": 1858, "offsetInEndSection": 2100, "text": "These data suggest a genetic role in high-altitude adaption and provide a basis for future genotype/phenotype association studies necessary to confirm the role of selection-nominated candidate genes and gene regions in adaptation to altitude.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600"}, {"offsetInBeginSection": 785, "offsetInEndSection": 1129, "text": "Considering the demands imposed upon metabolism in meeting energy demands despite limitations on fuel oxidation, we hypothesized that other selected genes might alter metabolism to allow adaptation to altitude despite the desensitization of the upstream hypoxia sensing caused by the EGLN1 mutation that results in the failure to sense hypoxia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282"}, {"offsetInBeginSection": 1617, "offsetInEndSection": 1857, "text": "Our results indicate that several key HIF-regulatory and targeted genes are responsible for adaptation to high altitude in Andeans and Tibetans, and several different chromosomal regions are implicated in the putative response to selection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600"}, {"offsetInBeginSection": 87, "offsetInEndSection": 370, "text": "Genetic variants/haplotypes within regions containing three of these genes (EPAS1, EGLN1, and PPARA) are associated with relatively decreased hemoglobin levels observed in Tibetans at high altitude, providing corroborative evidence for genetic adaptation to this extreme environment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288"}, {"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874"}, {"offsetInBeginSection": 713, "offsetInEndSection": 1016, "text": "Several selection candidate genes identified in DU Mongolians are shared with other Asian groups (e.g., EDAR), neighboring Tibetan populations (including high-altitude candidates EPAS1, PKLR, and CYP2E1), as well as genes previously hypothesized to be associated with metabolic adaptation (e.g., PPARG).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23874230"}, {"offsetInBeginSection": 0, "offsetInEndSection": 197, "text": "Tibetans are well adapted to high-altitude hypoxic conditions, and in recent genome-wide scans, many candidate genes have been reported involved in the physiological response to hypoxic conditions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23666208"}, {"offsetInBeginSection": 1017, "offsetInEndSection": 1210, "text": "Hemoglobin concentration, a trait associated with high-altitude adaptation in Tibetans, is at an intermediate level in DU Mongolians compared to Tibetans and Han Chinese at comparable altitude.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23874230"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "The genetic adaptation of Tibetans to high altitude hypoxia likely involves a group of genes in the hypoxic pathway, as suggested by earlier studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440"}, {"offsetInBeginSection": 784, "offsetInEndSection": 1027, "text": "It is highly prevalent in Tibetans (70.9% on average) but extremely rare in Han Chinese, Japanese, Europeans, and Africans (0.56-2.27%), suggesting that it might be the causal mutation of EGLN1 contributing to high-altitude hypoxic adaptation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23666208"}]}, {"id": "5a74eaa50384be955100000b", "body": "What part of the body is affected by mesotheliomia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22879850", "http://www.ncbi.nlm.nih.gov/pubmed/16163658", "http://www.ncbi.nlm.nih.gov/pubmed/17509761", "http://www.ncbi.nlm.nih.gov/pubmed/26007284", "http://www.ncbi.nlm.nih.gov/pubmed/869834", "http://www.ncbi.nlm.nih.gov/pubmed/25274322", "http://www.ncbi.nlm.nih.gov/pubmed/24531623", "http://www.ncbi.nlm.nih.gov/pubmed/16051171", "http://www.ncbi.nlm.nih.gov/pubmed/23204474", "http://www.ncbi.nlm.nih.gov/pubmed/11058423"], "snippets": [{"offsetInBeginSection": 305, "offsetInEndSection": 487, "text": "This somatosensory motion aftereffect of opposite sign is temporarily abolished if one looks at the affected body area, but is again re-experienced when the gaze is shifted elswhere.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/869834"}, {"offsetInBeginSection": 421, "offsetInEndSection": 595, "text": "Twenty-seven participants who met the IASP CRPS classification were interviewed using qualitative methods to explore feelings and perceptions about their affected body parts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}, {"offsetInBeginSection": 628, "offsetInEndSection": 764, "text": "Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850"}, {"offsetInBeginSection": 1981, "offsetInEndSection": 2134, "text": "The reduced response to sensory threats approaching the body suggests a deep detachment of the affected body part from the patient's body representation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24531623"}, {"offsetInBeginSection": 612, "offsetInEndSection": 946, "text": "In the present study we investigated this issue by measuring the anticipatory skin conductance response to noxious stimuli approaching either the affected or the intact body side in a group of patients with somatoparaphrenia (n=5; three females, age range=66-84), and in a group of patients with anosognosia for sensory deficits, i.e.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24531623"}, {"offsetInBeginSection": 240, "offsetInEndSection": 410, "text": "Here, we demonstrate that an intrinsic primary quality of a tactile object, for example its size, is directly affected by the perceived size of the body part touching it.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16051171"}, {"offsetInBeginSection": 1369, "offsetInEndSection": 1616, "text": "These movements appear in the non-affected part of the body throughout cerebrovascular disease evolution, and which could be caused by maintained hypersolicitation of the unaffected part of the body and the neuroplastic process following a stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16163658"}, {"offsetInBeginSection": 247, "offsetInEndSection": 361, "text": "How this body image is affected by changes in sensory inputs from, and motor outputs to, the body remains unclear.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204474"}, {"offsetInBeginSection": 2135, "offsetInEndSection": 2380, "text": "Conversely, normal reactions to incoming threats are found in the presence of impaired sensory awareness but intact body ownership, supporting the notion that representation of the body may be affected at different levels following brain damage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24531623"}, {"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "In spite of pain in the CRPS limb, clinical observations show patients pay little attention to, and fail to care for, their affected limb as if it were not part of their body.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}]}, {"id": "5a9db99ffd02ddc336000001", "body": "Is CXCL7 a chemokine?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20652876", "http://www.ncbi.nlm.nih.gov/pubmed/28245630", "http://www.ncbi.nlm.nih.gov/pubmed/28368308", "http://www.ncbi.nlm.nih.gov/pubmed/26233476", "http://www.ncbi.nlm.nih.gov/pubmed/18707017", "http://www.ncbi.nlm.nih.gov/pubmed/23136963", "http://www.ncbi.nlm.nih.gov/pubmed/20022386", "http://www.ncbi.nlm.nih.gov/pubmed/12193731", "http://www.ncbi.nlm.nih.gov/pubmed/29038657", "http://www.ncbi.nlm.nih.gov/pubmed/20652010"], "snippets": [{"offsetInBeginSection": 461, "offsetInEndSection": 802, "text": "Solution nuclear magnetic resonance (NMR) and molecular dynamics characterization of platelet-derived chemokine CXCL7 heterodimerization with chemokines CXCL1, CXCL4, and CXCL8 indicated that packing interactions promote CXCL7-CXCL1 and CXCL7-CXCL4 heterodimers, and electrostatic repulsive interactions disfavor the CXCL7-CXCL8 heterodimer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 0, "offsetInEndSection": 147, "text": "Platelet-derived chemokine CXCL7 (also known as NAP-2) plays a crucial role in orchestrating neutrophil recruitment in response to vascular injury.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657"}, {"offsetInBeginSection": 243, "offsetInEndSection": 317, "text": "The chemokine CXCL7 binds heparin and the G-protein-linked receptor CXCR2.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652010"}, {"offsetInBeginSection": 0, "offsetInEndSection": 111, "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 522, "offsetInEndSection": 740, "text": "Induction of cell adhesion following exposure to CTAP-III, a molecule to date described to lack neutrophil-stimulating capacity, depended on proteolytical conversion of the inactive chemokine into CXCL7 by neutrophils.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12193731"}, {"offsetInBeginSection": 151, "offsetInEndSection": 303, "text": "The aim of our study was to analyse the effect of CXCL7, a chemokine that has the capacity to recruit MSCs, on the chondrogenic differentiation of MSCs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652876"}, {"offsetInBeginSection": 0, "offsetInEndSection": 218, "text": "CXCL7, a chemokine highly expressed in platelets, orchestrates neutrophil recruitment during thrombosis and related pathophysiological processes by interacting with CXCR2 receptor and sulfated glycosaminoglycans (GAG).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28245630"}, {"offsetInBeginSection": 189, "offsetInEndSection": 399, "text": "The aim of our study was to determine whether the chemokine CXCL7 stimulates migration of human bone marrow-derived MSC and to analyze the effect of CXCL7 on the recruitment of MSC on the broad molecular level.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017"}, {"offsetInBeginSection": 102, "offsetInEndSection": 248, "text": "Chemokine (C-X-C motif) ligand 7 (CXCL7) has been found associated with pro-inflammatory responses, but its role in cancer growth remains unclear.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23136963"}]}, {"id": "5ace2d600340b9f05800000e", "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25794181", "http://www.ncbi.nlm.nih.gov/pubmed/24045876", "http://www.ncbi.nlm.nih.gov/pubmed/15972726", "http://www.ncbi.nlm.nih.gov/pubmed/20876876", "http://www.ncbi.nlm.nih.gov/pubmed/26103569", "http://www.ncbi.nlm.nih.gov/pubmed/16567973", "http://www.ncbi.nlm.nih.gov/pubmed/17616515"], "snippets": [{"offsetInBeginSection": 684, "offsetInEndSection": 1010, "text": "Thus, at least in Spain, regions at opposite ends of the incident UV-B radiation distribution show significantly different frequencies for the melanoma-risk allele V60L (a mutation also associated to red hair and fair skin and even blonde hair), with higher frequency of V60L at those regions of lower incident UV-B radiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876"}, {"offsetInBeginSection": 1141, "offsetInEndSection": 1390, "text": "RESULTS: Carrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 \u00d7 10(-6) \u2264 P \u2264 .0007).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876"}, {"offsetInBeginSection": 222, "offsetInEndSection": 421, "text": "Here we used 11 computational tools based on different approaches to predict the damage-associated non-synonymous single nucleotide polymorphisms (nsSNPs) in the coding region of the human MC1R gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794181"}, {"offsetInBeginSection": 847, "offsetInEndSection": 989, "text": "A total of 26 MC1R variants, including a novel 123_124insT allele, was identified in our population, with the most frequent allele being V60L.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16567973"}, {"offsetInBeginSection": 1503, "offsetInEndSection": 1770, "text": "The risk of melanoma associated with at least two MC1R variants was 2.6-fold higher than the risk associated with only one variant (odds ratio = 5.83 [95% confidence interval = 3.60 to 9.46] vs 2.25 [95% confidence interval = 1.44 to 3.52]; P(trend) = 1.86 \u00d7 10(-8)).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876"}, {"offsetInBeginSection": 1310, "offsetInEndSection": 1465, "text": "CONCLUSIONS: Our pooled-analysis highlighted a role of MC1R variants in NMSC development and suggested an effect modification by red hair colour phenotype.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26103569"}, {"offsetInBeginSection": 1364, "offsetInEndSection": 1498, "text": "Amongst individual MC1R variants, the R151C allele was significantly associated with melanoma, with an OR of 2.94 (95% CI, 1.04-8.31).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16567973"}, {"offsetInBeginSection": 181, "offsetInEndSection": 304, "text": "Variant alleles are associated with red hair colour and fair skin, known as the RHC phenotype, as well as skin cancer risk.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}, {"offsetInBeginSection": 1408, "offsetInEndSection": 1659, "text": "These results indicate that reduced receptor coupling activity may not be the only contributing factor to the genetic association between the MC1R variants and the RHC phenotype, with MC1R polymorphisms now linked to a change in receptor localization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876"}]}, {"id": "5aae6499fcf456587200000c", "body": "What is BORSA?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28893360", "http://www.ncbi.nlm.nih.gov/pubmed/2261916", "http://www.ncbi.nlm.nih.gov/pubmed/20880412", "http://www.ncbi.nlm.nih.gov/pubmed/21337531", "http://www.ncbi.nlm.nih.gov/pubmed/15770100", "http://www.ncbi.nlm.nih.gov/pubmed/21875361", "http://www.ncbi.nlm.nih.gov/pubmed/17108271", "http://www.ncbi.nlm.nih.gov/pubmed/2069374", "http://www.ncbi.nlm.nih.gov/pubmed/26064878", "http://www.ncbi.nlm.nih.gov/pubmed/18630132"], "snippets": [{"offsetInBeginSection": 1066, "offsetInEndSection": 1175, "text": "This clearly shows that BORSA may be misidentified as MRSA while heteroresistant MRSA may appear to be BORSA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916"}, {"offsetInBeginSection": 162, "offsetInEndSection": 212, "text": "BORSA was isolated in 37 samples from 11 patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100"}, {"offsetInBeginSection": 436, "offsetInEndSection": 739, "text": "Genotyping revealed that BORSA ST1(MLST)-t2863(spa) isolates were responsible for most equine infections and were the main isolates found in colonized members of the personnel between 2005 and 2007, and that in 2007, MRSA ST398-t011-IVa(SCCmec) emerged in infection sites and personnel, replacing BORSA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875361"}, {"offsetInBeginSection": 671, "offsetInEndSection": 773, "text": "After the intervention, BORSA was isolated from another 3 patients before the outbreak was terminated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100"}, {"offsetInBeginSection": 607, "offsetInEndSection": 701, "text": "BORSA phenotype was found in 14% S. aureus isolates from pigs and 10% isolates from pork meat.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26064878"}, {"offsetInBeginSection": 0, "offsetInEndSection": 443, "text": "Eighty-eight Staphylococcus aureus clinical isolates meeting criteria for borderline oxacillin resistance (intermediate susceptibility or resistance to oxacillin but susceptibility to amoxicillin/clavulanic acid upon disk diffusion testing) were studied to determine optimal test techniques and conditions for differentiating borderline oxacillin-resistant Staphylococcus aureus (BORSA) from methicillin-resistant Staphylococcus aureus (MRSA).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916"}, {"offsetInBeginSection": 0, "offsetInEndSection": 301, "text": "Since it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/L, the in vitro bactericidal activity and pharmacodynamic effect of oxacillin against clinical BORSA isolates was evaluated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412"}, {"offsetInBeginSection": 338, "offsetInEndSection": 743, "text": "The study comprised of (1) identification of all children with at least one respiratory specimen positive for either BORSA or MRSA during the study period; (2) compilation of relevant clinical and epidemiological data from 12-month period leading up to first positive (index) culture; (3) microbiological and molecular characterization of index isolates and (4) measurement of subsequent clinical outcome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21337531"}, {"offsetInBeginSection": 1159, "offsetInEndSection": 1301, "text": "Further investigation into \u03b2-lactam dosing strategies against different BORSA strains is warranted in order to avoid possible therapy failure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412"}, {"offsetInBeginSection": 0, "offsetInEndSection": 193, "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1), but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108271"}]}, {"id": "5a9e202bde7cb99d40000002", "body": "Which method is Proseek based on?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25987887", "http://www.ncbi.nlm.nih.gov/pubmed/19040730", "http://www.ncbi.nlm.nih.gov/pubmed/28936257"], "snippets": [{"offsetInBeginSection": 738, "offsetInEndSection": 862, "text": "Liquid-based cytology samples showed a lower number of proteins above LOD than FTA cards with vaginal fluid samples applied.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 863, "offsetInEndSection": 1038, "text": "Our results demonstrate that samples applied to the indicating FTA elute micro card\u2122 are amendable to protein analyses, given that a sensitive protein detection assay is used.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 1279, "offsetInEndSection": 1488, "text": "RESULTS: Similar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 332, "offsetInEndSection": 494, "text": "Multiplex Ligation-dependent Probe Amplification (MLPA) is a targeted method to assess copy number differences for up to 40 genomic loci in one single experiment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730"}, {"offsetInBeginSection": 1545, "offsetInEndSection": 1673, "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730"}, {"offsetInBeginSection": 882, "offsetInEndSection": 1166, "text": "EDTA plasma samples (1\u00a0\u03bcL) obtained from 75 patients with Dukes' staged CRC or unaffected controls (age and sex matched with stringent inclusion/exclusion criteria) were assayed for expression of 92 human proteins employing the Proseek\u00ae Multiplex Oncology I proximity extension assay.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "The indicating FTA elute micro card\u2122 has been developed to collect and stabilize the nucleic acid in biological samples and is widely used in human and veterinary medicine and other disciplines.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 655, "offsetInEndSection": 737, "text": "Washing and protein elution protocols were compared to identify an optimal method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 0, "offsetInEndSection": 184, "text": "BACKGROUND: Current methods widely deployed for colorectal cancers (CRC) screening lack the necessary sensitivity and specificity required for population-based early disease detection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 0, "offsetInEndSection": 150, "text": "Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card\u2122.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}]}, {"id": "5ace34eb0340b9f058000010", "body": "Which genes are associated with Epidermolysis Bullosa Simplex?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/9406827", "http://www.ncbi.nlm.nih.gov/pubmed/12655565", "http://www.ncbi.nlm.nih.gov/pubmed/23894602", "http://www.ncbi.nlm.nih.gov/pubmed/19797037", "http://www.ncbi.nlm.nih.gov/pubmed/11851893", "http://www.ncbi.nlm.nih.gov/pubmed/10494094", "http://www.ncbi.nlm.nih.gov/pubmed/9036937", "http://www.ncbi.nlm.nih.gov/pubmed/20199538", "http://www.ncbi.nlm.nih.gov/pubmed/25354580", "http://www.ncbi.nlm.nih.gov/pubmed/7561171"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "BACKGROUND: Basal epidermolysis bullosa simplex (EBS) is a hereditary skin blistering disorder resulting in most cases from missense mutations in the keratin 5 (KRT5) or keratin 14 (KRT14) genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20199538"}, {"offsetInBeginSection": 461, "offsetInEndSection": 677, "text": "Based on the ultrastructural levels of tissue separation, EB is divided into the following three broad categories: epidermolysis bullosa simplex, junctional epidermolysis bullosa and dystrophic epidermolysis bullosa.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25354580"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Epidermolysis bullosa simplex Dowling-Meara (MIM# 1317600) is the most severe of the three common epidermolysis bullosa simplex subtypes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 159, "offsetInEndSection": 360, "text": "Dowling-Meara, the major subtype of epidermolysis bullosa simplex, is inherited in an autosomal dominant manner and can be caused by mutations in either the keratin-5 (K5) or the keratin-14 (K14) gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23894602"}, {"offsetInBeginSection": 361, "offsetInEndSection": 569, "text": "The keratin 5 and keratin 14 genes encode proteins that form the primary structural components of the basal epidermal keratinocytes, mutations in either of these genes can cause epidermolysis bullosa simplex.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 948, "offsetInEndSection": 1171, "text": "This glutamate to lysine substitution (E477K), located in the highly conserved KLLEGE motif at the end of the central rod domain, is the third recurrent mutation identified in dominant epidermolysis bullosa simplex disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9036937"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "A new pathogenic keratin 5 mutation in a Hindoestan family with localized epidermolysis bullosa simplex.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19797037"}, {"offsetInBeginSection": 159, "offsetInEndSection": 315, "text": "Here, we report a patient with mutations in the gene for BP180/collagen XVII, COL17A1, but predominant phenotypic features of epidermolysis bullosa simplex.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851893"}, {"offsetInBeginSection": 0, "offsetInEndSection": 138, "text": "Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851893"}, {"offsetInBeginSection": 201, "offsetInEndSection": 419, "text": "We describe a novel heterozygous pathogenic missense mutation (KRT5:c.596A>T, p.Lys199Met) in a Hindoestan male with early onset localized epidermolysis bullosa simplex that segregated with the phenotype in the family.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19797037"}]}, {"id": "5aafc37afcf4565872000010", "body": "What is the function of HDAC  proteins?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27345839", "http://www.ncbi.nlm.nih.gov/pubmed/26927903", "http://www.ncbi.nlm.nih.gov/pubmed/17786239", "http://www.ncbi.nlm.nih.gov/pubmed/10220385", "http://www.ncbi.nlm.nih.gov/pubmed/10869435", "http://www.ncbi.nlm.nih.gov/pubmed/26232305", "http://www.ncbi.nlm.nih.gov/pubmed/22621256", "http://www.ncbi.nlm.nih.gov/pubmed/15050820", "http://www.ncbi.nlm.nih.gov/pubmed/28337317", "http://www.ncbi.nlm.nih.gov/pubmed/17227860"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 146, "text": "Histone deacetylase (HDAC) proteins are epigenetic regulators that deacetylate protein substrates, leading to subsequent changes in cell function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28337317"}, {"offsetInBeginSection": 1117, "offsetInEndSection": 1426, "text": "These class II HDAC proteins have differential mRNA expression in human tissues and possess in vitro HDAC activity that is inhibited by trichostatin A. Coimmunoprecipitation experiments indicate that these HDAC proteins are not components of the previously identified HDAC1 and HDAC2 NRD and mSin3A complexes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10220385"}, {"offsetInBeginSection": 780, "offsetInEndSection": 896, "text": "Rpd3, the Drosophila HDAC1 homolog, is a class I lysine deacetylase and a member of a large family of HDAC proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903"}, {"offsetInBeginSection": 243, "offsetInEndSection": 406, "text": "Although the functions of HDAC proteins are becoming apparent both biochemically and clinically, how this class of proteins is regulated remains poorly understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 565, "offsetInEndSection": 741, "text": "The amino acid sequence of Hda1p was used to search the GenBank/expressed sequence tag databases to identify partial sequences from three putative class II human HDAC proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10220385"}, {"offsetInBeginSection": 166, "offsetInEndSection": 380, "text": "Previous analysis of the regulation of HDAC activity in transcription has focused primarily on the recruitment of HDAC proteins to specific promoters or chromosomal domains by association with DNA-binding proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10869435"}, {"offsetInBeginSection": 234, "offsetInEndSection": 434, "text": "Isoform-selective HDAC inhibitors would be useful tools to dissect the individual functions of HDAC proteins in cancer formation, in addition to potentially displaying effective anticancer properties.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26232305"}, {"offsetInBeginSection": 1288, "offsetInEndSection": 1465, "text": "Examination of HDAC characteristics in light of these evolutionary relationships leads to functional predictions, among them that self-association is common among HDAC proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050820"}, {"offsetInBeginSection": 847, "offsetInEndSection": 1016, "text": "Regulation of the cellular localization of HDAC4 and HDAC5 by 14-3-3 represents a mechanism for controlling the transcriptional activity of these class II HDAC proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10869435"}, {"offsetInBeginSection": 600, "offsetInEndSection": 734, "text": "The key feature of the ELISA-based HDAC activity assay is use of mammalian cell-derived HDAC isoforms instead of recombinant proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26232305"}]}, {"id": "5aacd487fcf4565872000007", "body": "Which human gene encode for DNA polymerase \u03b8?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28668117", "http://www.ncbi.nlm.nih.gov/pubmed/27264557", "http://www.ncbi.nlm.nih.gov/pubmed/27657134", "http://www.ncbi.nlm.nih.gov/pubmed/28695890", "http://www.ncbi.nlm.nih.gov/pubmed/28570559", "http://www.ncbi.nlm.nih.gov/pubmed/28687761", "http://www.ncbi.nlm.nih.gov/pubmed/25775267", "http://www.ncbi.nlm.nih.gov/pubmed/24375106"], "snippets": [{"offsetInBeginSection": 267, "offsetInEndSection": 633, "text": "Here we show that DNA polymerase \u03b8, despite its minor role in chromosomal DNA repair, substantially contributes to random integration, and that cells lacking both DNA polymerase \u03b8 and DNA ligase IV, which is essential for non-homologous end joining (NHEJ), exhibit 100% efficiency of spontaneous gene targeting by virtue of undetectable levels of random integration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28695890"}, {"offsetInBeginSection": 221, "offsetInEndSection": 567, "text": "Here, we show that the A-family DNA polymerase \u03b8 (Pol \u03b8) promotes random integration, while canonical non-homologous DNA end joining plays a secondary role; cells double deficient for polymerase \u03b8 and canonical non-homologous DNA end joining are devoid of any integration events, demonstrating that these two mechanisms define random integration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28687761"}, {"offsetInBeginSection": 0, "offsetInEndSection": 146, "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134"}, {"offsetInBeginSection": 864, "offsetInEndSection": 1005, "text": "Our findings provide new insights into the mechanics of foreign DNA integration and the role of DNA polymerase \u03b8 in human genome maintenance.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28695890"}, {"offsetInBeginSection": 0, "offsetInEndSection": 128, "text": "DNA polymerase \u03bd (pol \u03bd), encoded by the POLN gene, is an A-family DNA polymerase in vertebrates and some other animal lineages.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28570559"}, {"offsetInBeginSection": 831, "offsetInEndSection": 1001, "text": "Pol \u03bd-defective mice had no alteration in DNA end-joining during immunoglobulin class-switching, in contrast to animals defective in the related DNA polymerase \u03b8 (pol \u03b8).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28570559"}, {"offsetInBeginSection": 0, "offsetInEndSection": 63, "text": "DNA Polymerase \u03b8: A Unique Multifunctional End-Joining Machine.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134"}, {"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "DNA polymerase theta (pol \u03b8) is encoded in the genomes of many eukaryotes, though not in fungi.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "DNA polymerase \u03b8 protects against genomic instability via an alternative end-joining repair pathway for DNA double-strand breaks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25775267"}, {"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Analysis of DNA polymerase \u03bd function in meiotic recombination, immunoglobulin class-switching, and DNA damage tolerance.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28570559"}]}, {"id": "5ace3e3f0340b9f058000012", "body": "What is the biological role of Neddylation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25628956", "http://www.ncbi.nlm.nih.gov/pubmed/18247557", "http://www.ncbi.nlm.nih.gov/pubmed/25918018", "http://www.ncbi.nlm.nih.gov/pubmed/27956554", "http://www.ncbi.nlm.nih.gov/pubmed/18793140", "http://www.ncbi.nlm.nih.gov/pubmed/25531226", "http://www.ncbi.nlm.nih.gov/pubmed/25742093", "http://www.ncbi.nlm.nih.gov/pubmed/29074978", "http://www.ncbi.nlm.nih.gov/pubmed/23148618", "http://www.ncbi.nlm.nih.gov/pubmed/27591266"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "The neddylation conjugation pathway has a pivotal role in mediating ubiquitination of proteins and regulation of numerous biological processes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618"}, {"offsetInBeginSection": 908, "offsetInEndSection": 1045, "text": "We also summarize the recent progress in revealing the physiological and pathological role of neddylation and deneddylation in the heart.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29074978"}, {"offsetInBeginSection": 111, "offsetInEndSection": 227, "text": "Only a few neddylated substrates have been validated to date, and the role of neddylation remains poorly understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27956554"}, {"offsetInBeginSection": 120, "offsetInEndSection": 299, "text": "Although neddylation plays a critical regulatory role in cell proliferation and development, the spectrum of Nedd8 substrates and its interaction network remain poorly understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18247557"}, {"offsetInBeginSection": 826, "offsetInEndSection": 965, "text": "Understanding the biological significance of non-cullin neddylation is an exciting research prospect primed to reveal fundamental insights.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25531226"}, {"offsetInBeginSection": 0, "offsetInEndSection": 261, "text": "Protein neddylation, a newly characterized posttranslational modification that adds the ubiquitin-like molecule NEDD8 to substrates, modulates important biological processes, whereas dysfunction of neddylation may cause several serious diseases, such as cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742093"}, {"offsetInBeginSection": 165, "offsetInEndSection": 280, "text": "This post-translational modification, neddylation, plays important roles in tumor cell proliferation and viability.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018"}, {"offsetInBeginSection": 606, "offsetInEndSection": 832, "text": "Recently, accumulating evidences indicate that neddylation pathway also plays a pivotal role in the regulation of multiple processes of tumor microenvironment (TME), such as tumor angiogenesis and the function of immune cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742093"}, {"offsetInBeginSection": 1705, "offsetInEndSection": 1897, "text": "The vast amount of proteomic information obtained here can provide clues on the biological role of Nedd8 and lay the foundation for an in-depth analysis of the regulation of the Nedd8 pathway.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18247557"}]}, {"id": "5ab144fefcf4565872000012", "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24646197", "http://www.ncbi.nlm.nih.gov/pubmed/28970008", "http://www.ncbi.nlm.nih.gov/pubmed/24931166", "http://www.ncbi.nlm.nih.gov/pubmed/21140288", "http://www.ncbi.nlm.nih.gov/pubmed/18503142", "http://www.ncbi.nlm.nih.gov/pubmed/27919223", "http://www.ncbi.nlm.nih.gov/pubmed/16252251", "http://www.ncbi.nlm.nih.gov/pubmed/15708008", "http://www.ncbi.nlm.nih.gov/pubmed/8800739", "http://www.ncbi.nlm.nih.gov/pubmed/11380448"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 351, "text": "The G20210A mutation in the prothrombin gene is associated with an increased risk of a first venous thromboembolic episode; few data are available about the long-term risk for recurrent venous thromboembolism and it is not known whether or not carriers of the mutation should be recommended lifelong anticoagulant treatment after the first thrombosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448"}, {"offsetInBeginSection": 309, "offsetInEndSection": 599, "text": "We found that the 5.5-kb shorter transcript is transcribed from the intron 4 of the TRPM2 gene and encodes the striatum short form protein (SSF-TRPM2) with 1289 amino acid residues as compared to the long form protein (LF-TRPM2), in which the N-terminal 214 amino acid residues are removed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15708008"}, {"offsetInBeginSection": 212, "offsetInEndSection": 506, "text": "The temporal relationship between the conversion of atrial flutter to junctional bradycardia and two episodes of thromboembolism strongly suggest a role of the lack of atrial contraction during junctional rhythm for the development of spontaneous echocardiographic contrast and thromboembolism.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8800739"}, {"offsetInBeginSection": 1013, "offsetInEndSection": 1464, "text": "Moreover, targets of existing drugs and treatments were found to be consistently associated with high TRPM2-AS levels in both targeted cells and patients, ultimately suggesting that the measurement of the expression levels of TRPM2-AS allows not only for the early identification of aggressive PCa tumors, but also identifies a subset of at-risk patients who would benefit from currently available, but mostly differently purposed, therapeutic agents.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166"}, {"offsetInBeginSection": 352, "offsetInEndSection": 659, "text": "We investigated 624 patients, referred for previous objectively documented deep venous thrombosis of the legs or pulmonary embolism, to determine the risk of recurrent thromboembolism in heterozygous carriers of the G20210A mutation in the prothrombin gene after the first episode of venous thromboembolism.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448"}, {"offsetInBeginSection": 715, "offsetInEndSection": 1012, "text": "Mechanistically, TRPM2-AS knockdown led to PCa cell apoptosis, with a transcriptional profile that indicated an unbearable increase in cellular stress in the dying cells, which was coupled to cell cycle arrest, an increase in intracellular hydrogen peroxide and activation of the sense TRPM2 gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448"}, {"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 162, "offsetInEndSection": 265, "text": "Inherited thrombophilia, on the other hand, is associated with the occurrence of spontaneous abortions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 0, "offsetInEndSection": 161, "text": "Genetic polymorphisms in plasminogen activator inhibitor-1 gene-675 4G/5G (PAI-1 4G/5G) are claimed to contribute to an increased risk of venous thromboembolism.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}]}, {"id": "5abd2ce0fcf456587200002a", "body": "Which are the two main bacterial phyla in human gut?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19321416", "http://www.ncbi.nlm.nih.gov/pubmed/26061054", "http://www.ncbi.nlm.nih.gov/pubmed/19553672", "http://www.ncbi.nlm.nih.gov/pubmed/23982459", "http://www.ncbi.nlm.nih.gov/pubmed/24324923", "http://www.ncbi.nlm.nih.gov/pubmed/25516615", "http://www.ncbi.nlm.nih.gov/pubmed/24522631", "http://www.ncbi.nlm.nih.gov/pubmed/25873372", "http://www.ncbi.nlm.nih.gov/pubmed/25601048", "http://www.ncbi.nlm.nih.gov/pubmed/22205877"], "snippets": [{"offsetInBeginSection": 962, "offsetInEndSection": 1209, "text": "Analyses of sequenced bacterial genomes revealed that the cut cluster is present in many human gut bacteria, is predictive of choline utilization in sequenced isolates, and is widely but discontinuously distributed across multiple bacterial phyla.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873372"}, {"offsetInBeginSection": 334, "offsetInEndSection": 577, "text": "Here we reconstructed GEMs for three key species, (Bacteroides thetaiotamicron, Eubacterium rectale and Methanobrevibacter smithii) as relevant representatives of three main phyla in the human gut (Bacteroidetes, Firmicutes and Euryarchaeota).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982459"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 2025, "offsetInEndSection": 2238, "text": "The presence of some bacterial phyla on gut tract suggests that cockroaches could be an interesting model to study the organization of gut bacterial communities during digestion of different lignocellulosic diets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24324923"}, {"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 1517, "offsetInEndSection": 1764, "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 290, "offsetInEndSection": 501, "text": "Here, we review how members of the Bacteroidetes, one of two dominant gut-associated bacterial phyla, process complex glycans using a series of similarly patterned, cell envelope-associated multiprotein systems.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19553672"}, {"offsetInBeginSection": 237, "offsetInEndSection": 393, "text": "Recent evidence suggests that obesity is influenced by specific bacterial phyla present in the human gut that have increased energy harvesting capabilities.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054"}, {"offsetInBeginSection": 240, "offsetInEndSection": 497, "text": "The presence of different and modular bacterial phyla on the cockroach gut tract suggests that this insect could be an interesting model to study the organization of gut bacterial communities associated with the digestion of different lignocellulosic diets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24324923"}, {"offsetInBeginSection": 709, "offsetInEndSection": 1009, "text": "The families Enterobacteriaceae, Ricketsiaceae, Spiroplasmataceae and Bacillaceae, were the main groups responsible for the specificity of the bee gut while the main families responsible for the specificity of the beebread were Neisseriaceae, Flavobacteriaceae, Acetobacteraceae and Lactobacillaceae.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25601048"}]}, {"id": "5ad6e431133db5eb7800000e", "body": "Which test is used for the definition of colour-blindness?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25452008", "http://www.ncbi.nlm.nih.gov/pubmed/26591383", "http://www.ncbi.nlm.nih.gov/pubmed/310055", "http://www.ncbi.nlm.nih.gov/pubmed/314267", "http://www.ncbi.nlm.nih.gov/pubmed/16431664", "http://www.ncbi.nlm.nih.gov/pubmed/22076482", "http://www.ncbi.nlm.nih.gov/pubmed/28274040", "http://www.ncbi.nlm.nih.gov/pubmed/306798", "http://www.ncbi.nlm.nih.gov/pubmed/9893853", "http://www.ncbi.nlm.nih.gov/pubmed/18942220"], "snippets": [{"offsetInBeginSection": 748, "offsetInEndSection": 1082, "text": "The association of colour-blindness with higher socio-economic status is expected given the history of European conquest in the New World, and suggests that the major cause of varying rates of the defect in Latin American populations is socio-economic heterogeneity and by inference different degrees of European-Amerindian admixture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267"}, {"offsetInBeginSection": 993, "offsetInEndSection": 1185, "text": "Percentage was used to calculate the prevalence of colour vision handicap and its effect on matching of shades of teeth as compared to normal vision, which was evaluated using Chi square test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "PURPOSE: X-linked red-green colour blindness is the most common form of colour blindness.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18942220"}, {"offsetInBeginSection": 178, "offsetInEndSection": 295, "text": "The purpose of this study is to determine the prevalence of red-green colour blindness in Singaporean schoolchildren.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18942220"}, {"offsetInBeginSection": 0, "offsetInEndSection": 49, "text": "Colour-blindness and sensitivity to PTC in Hadza.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16431664"}, {"offsetInBeginSection": 1154, "offsetInEndSection": 1339, "text": "Although the Ishihara test proved useful in identifying colour-blind children, other tests are required to accurately classify the types of red-green colour blindness in these children.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18942220"}, {"offsetInBeginSection": 0, "offsetInEndSection": 29, "text": "Colour-blindness in Colombia.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267"}, {"offsetInBeginSection": 1665, "offsetInEndSection": 1794, "text": "CONCLUSION: Colour blindness and colour vision handicap are rare conditions, with the latter being more common in the population.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040"}, {"offsetInBeginSection": 0, "offsetInEndSection": 162, "text": "211 Hadza (Tanzania) males, including members of both western and eastern groups, were tested for red-green colour blindness with the Ishihara non-numeral plates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16431664"}, {"offsetInBeginSection": 1024, "offsetInEndSection": 1179, "text": "With coloured stimuli, the difference between normal and red-green colour-blindness is more clear-cut, and red-blind can be discriminated from green-blind.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/310055"}]}, {"id": "5ab1483bfcf4565872000014", "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26154131", "http://www.ncbi.nlm.nih.gov/pubmed/16772461", "http://www.ncbi.nlm.nih.gov/pubmed/17727851", "http://www.ncbi.nlm.nih.gov/pubmed/21846752", "http://www.ncbi.nlm.nih.gov/pubmed/15474307", "http://www.ncbi.nlm.nih.gov/pubmed/27135263", "http://www.ncbi.nlm.nih.gov/pubmed/7777329", "http://www.ncbi.nlm.nih.gov/pubmed/10640803", "http://www.ncbi.nlm.nih.gov/pubmed/25162450", "http://www.ncbi.nlm.nih.gov/pubmed/22233209"], "snippets": [{"offsetInBeginSection": 1130, "offsetInEndSection": 1484, "text": "In conclusion, we suggest that the difference between the pattern of suckling behavior of kittens of the domestic cat (and other felids) and the domestic dog is not an artifact of domestication, but rather reflects phylogenetic differences between felids and canids as a consequence of their different lifestyles and associated patterns of parental care.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27135263"}, {"offsetInBeginSection": 159, "offsetInEndSection": 338, "text": "Yet, little scientific research has focused on the cognition of the domestic cat, especially in comparison with human's other companion, the domestic dog (Canis lupus familiaris).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Pattern of nipple use by puppies: A comparison of the dingo (Canis dingo) and the domestic dog (Canis familiaris).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27135263"}, {"offsetInBeginSection": 1030, "offsetInEndSection": 1213, "text": "Although native haplotypes were also found in the captive population, the majority (68%) of captive individuals shared a common mtDNA haplotype with the domestic cat (Felis s. catus).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25162450"}, {"offsetInBeginSection": 400, "offsetInEndSection": 570, "text": "In particular, we characterized cestodes from Italian wildcats (Felis silvestris silvestris), free-ranging domestic cats (Felis silvestris catus) and hybrids populations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22233209"}, {"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "The genetic integrity of the ex situ population of the European wildcat (Felis silvestris silvestris) is seriously threatened by introgression from domestic cats (Felis silvestris catus).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25162450"}, {"offsetInBeginSection": 415, "offsetInEndSection": 577, "text": "We asked whether the more \"chaotic\" behavior seen in puppies of the domestic dog (Canis familiaris) could be the result of relaxed selection due to domestication.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27135263"}, {"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "The evolutionary basis for the feeding behavior of domestic dogs (Canis familiaris) and cats (Felis catus).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 130, "offsetInEndSection": 270, "text": "We have previously reported notable differences in the pattern of nipple use by kittens of the domestic cat and puppies of the domestic dog.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27135263"}, {"offsetInBeginSection": 36, "offsetInEndSection": 160, "text": "is a conservation concern largely due to introgressive hybridization with its congener F. s. catus, the common domestic cat.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21846752"}]}, {"id": "5abd31e0fcf456587200002c", "body": "What is ATAC-seq?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28550296", "http://www.ncbi.nlm.nih.gov/pubmed/28075484", "http://www.ncbi.nlm.nih.gov/pubmed/27903897", "http://www.ncbi.nlm.nih.gov/pubmed/29155775", "http://www.ncbi.nlm.nih.gov/pubmed/27832532", "http://www.ncbi.nlm.nih.gov/pubmed/29030848", "http://www.ncbi.nlm.nih.gov/pubmed/28723572", "http://www.ncbi.nlm.nih.gov/pubmed/29052193", "http://www.ncbi.nlm.nih.gov/pubmed/27146274", "http://www.ncbi.nlm.nih.gov/pubmed/25559105"], "snippets": [{"offsetInBeginSection": 631, "offsetInEndSection": 1000, "text": "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775"}, {"offsetInBeginSection": 0, "offsetInEndSection": 168, "text": "Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) is a method used for the identification of open (accessible) regions of chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775"}, {"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "ATAC-seq is a high-throughput sequencing technique that identifies open chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296"}, {"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) is a useful method to map genome-wide chromatin accessibility and nucleosome positioning.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27832532"}, {"offsetInBeginSection": 472, "offsetInEndSection": 645, "text": "The overall goal of this unit is to provide a thorough ATAC-seq data analysis plan, as well as describe how primary human blood samples can be processed for use in ATAC-seq.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484"}, {"offsetInBeginSection": 0, "offsetInEndSection": 226, "text": "The assay for transposase-accessible chromatin using sequencing (ATAC-seq) was recently established as a method to profile open chromatin, which overcomes the sample size limitations of the alternative methods DNase/MNase-seq.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29030848"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "In recent years, the assay for transposase-accessible chromatin using sequencing (ATAC-Seq) has become a fundamental tool of epigenomic research.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27146274"}, {"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Reducing mitochondrial reads in ATAC-seq using CRISPR/Cas9.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296"}, {"offsetInBeginSection": 334, "offsetInEndSection": 578, "text": "We tested two approaches to decrease wasted sequencing in ATAC-seq libraries generated from lymphoblastoid cell lines: targeted cleavage of mitochondrial DNA fragments using CRISPR technology and removal of detergent from the cell lysis buffer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296"}, {"offsetInBeginSection": 368, "offsetInEndSection": 638, "text": "Our aim was to develop a protocol for freezing neuronal cells that is compatible with ATAC-Seq; we focused on a disease-relevant cell type, namely motor neurons differentiated from induced pluripotent stem cells (iMNs) from a patient affected by spinal muscular atrophy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27146274"}]}, {"id": "5abce6acfcf4565872000022", "body": "Please list 7 classes of drugs that interact with Warfarin.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19587643", "http://www.ncbi.nlm.nih.gov/pubmed/21397772"], "snippets": [{"offsetInBeginSection": 395, "offsetInEndSection": 751, "text": "METHODS: We examined the official labeling information approved by the US Food and Drug Administration for the 50 drugs, biologics, and drug classes that were commonly identified by 3 drug information compendia--Clinical Pharmacology, ePocrates(\u00ae), and Micromedex(\u00ae)--and the warfarin US prescribing information (PI) as having an interaction with warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 205, "offsetInEndSection": 395, "text": "OBJECTIVE: The aim of this study was to assess the information regarding warfarin interactions that is included in the official labeling of prescription products that interact with warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 1736, "offsetInEndSection": 2019, "text": "CONCLUSION: This assessment of official US product labeling for 50 drugs, biologics, and drug classes known to interact with warfarin, comprising 73 distinct agents, found that 15% failed to mention the interaction, even though the interaction was mentioned in the warfarin labeling.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 84, "offsetInEndSection": 388, "text": "We assessed three drug information compendia-Clinical Pharmacology, ePocrates, and Micromedex-and the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 611, "offsetInEndSection": 797, "text": "The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 389, "offsetInEndSection": 521, "text": "The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "Interactions of warfarin with other drugs or substances can pose a serious problem.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 1299, "offsetInEndSection": 1399, "text": "Those failing to mention the warfarin interaction were for older generic drugs or influenza vaccine.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 911, "offsetInEndSection": 1075, "text": "This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}]}, {"id": "5ac0aee419833b0d7b000004", "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28916391", "http://www.ncbi.nlm.nih.gov/pubmed/28049830", "http://www.ncbi.nlm.nih.gov/pubmed/28971967", "http://www.ncbi.nlm.nih.gov/pubmed/28239447", "http://www.ncbi.nlm.nih.gov/pubmed/27876396", "http://www.ncbi.nlm.nih.gov/pubmed/28383800", "http://www.ncbi.nlm.nih.gov/pubmed/27355570", "http://www.ncbi.nlm.nih.gov/pubmed/28931684", "http://www.ncbi.nlm.nih.gov/pubmed/28198446", "http://www.ncbi.nlm.nih.gov/pubmed/27647195"], "snippets": [{"offsetInBeginSection": 709, "offsetInEndSection": 996, "text": "Herein, we evaluated the most important human pathological, animal developmental, and neuro-cytotoxic findings released in 2016, and highlighted the original experimental evidence that strengthens the potential link between ZIKV and the high incidence of microcephaly in new-born babies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27876396"}, {"offsetInBeginSection": 0, "offsetInEndSection": 276, "text": "Zika virus (ZIKV), a mosquito-transmitted flavivirus, responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, re-emerged in the last decade causing serious human diseases including microcephaly, congenital malformations, and Guillain-Barr\u00e9 syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684"}, {"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "A recent outbreak of Zika virus (ZIKV) in Brazil is associated with microcephaly in infants born of infected mothers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800"}, {"offsetInBeginSection": 397, "offsetInEndSection": 598, "text": "SELECTION: Studies were included and analyzed if they met all of the following criteria: \"probable or confirmed infant microcephaly\" and \"probable or confirmed ZIKV infection among mothers or infants\".", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27647195"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Accumulating evidence implicates Zika virus (ZIKV) in pathogenesis of microcephaly in newborns and Guillain-Barr\u00e9 syndrome in adults.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28239447"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967"}, {"offsetInBeginSection": 0, "offsetInEndSection": 198, "text": "The growing number of zika virus (ZIKV) infections plus a 20-fold increase in neonatal microcephaly in newborns in Brazil have raised alarms in many countries regarding the threat to pregnant women.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 971, "offsetInEndSection": 1212, "text": "The expression of premembrane protein (prM) resulted in cell-cycle G1 accumulation, whereas membrane-anchored capsid (anaC), membrane protein (M), envelope protein (E), and nonstructural protein 4A (NS4A) caused cell-cycle G2/M accumulation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28049830"}, {"offsetInBeginSection": 75, "offsetInEndSection": 317, "text": "Little is known about how ZIKV causes these conditions or which ZIKV viral protein(s) is responsible for the associated ZIKV-induced cytopathic effects, including cell hypertrophy, growth restriction, cell-cycle dysregulation, and cell death.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28049830"}, {"offsetInBeginSection": 118, "offsetInEndSection": 253, "text": "As this pandemic spreads, rapid scientific investigation is shedding new light on how prenatal infection with ZIKV causes microcephaly.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800"}]}, {"id": "5abcf0b0fcf4565872000024", "body": "What causes leishmaniasis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18457726", "http://www.ncbi.nlm.nih.gov/pubmed/23219435", "http://www.ncbi.nlm.nih.gov/pubmed/23286822", "http://www.ncbi.nlm.nih.gov/pubmed/15071036", "http://www.ncbi.nlm.nih.gov/pubmed/25228325", "http://www.ncbi.nlm.nih.gov/pubmed/26081889", "http://www.ncbi.nlm.nih.gov/pubmed/25988048", "http://www.ncbi.nlm.nih.gov/pubmed/2670376", "http://www.ncbi.nlm.nih.gov/pubmed/15259461", "http://www.ncbi.nlm.nih.gov/pubmed/25116660"], "snippets": [{"offsetInBeginSection": 423, "offsetInEndSection": 506, "text": "Visceral leishmaniasis causes high morbidity and mortality in the developing world.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25116660"}, {"offsetInBeginSection": 409, "offsetInEndSection": 520, "text": "However, in Sri Lanka, L. donovani causes mainly cutaneous leishmaniasis, while visceral leishmaniasis is rare.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}, {"offsetInBeginSection": 491, "offsetInEndSection": 612, "text": "L. (L.)\u00a0donovani usually causes visceral leishmaniasis, but in this case, the patient manifested cutaneous leishmaniasis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228325"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "An imported case of cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Japan.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228325"}, {"offsetInBeginSection": 156, "offsetInEndSection": 331, "text": "The protozoa is obliged intracellularly and causes a wide spectrum of clinical syndromes: VL ('kala azar'), cutaneous leishmaniasis and mucocutaneous leishmaniasis (espundia).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25988048"}, {"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461"}, {"offsetInBeginSection": 0, "offsetInEndSection": 158, "text": "DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036"}, {"offsetInBeginSection": 0, "offsetInEndSection": 183, "text": "Leishmaniasis is a neglected tropical disease caused by Leishmania protozoa and associated with three main clinical presentations: cutaneous, mucocutaneous and visceral leishmaniasis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}, {"offsetInBeginSection": 475, "offsetInEndSection": 613, "text": "We describe a case of disseminated cutaneous leishmaniasis caused by L. donovani in a traveller returning to the United States from Italy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23286822"}, {"offsetInBeginSection": 118, "offsetInEndSection": 339, "text": "Identification of 5 isolates from 4 CL patients by enzyme analysis during 2002 showed that they were all Leishmania donovani zymodeme MON-37, the parasite which also causes visceral leishmaniasis in India and East Africa.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461"}]}, {"id": "5ac138aa95d0062724000001", "body": "Which is the enzymatic activity of nardilysin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/15544571", "http://www.ncbi.nlm.nih.gov/pubmed/21801775", "http://www.ncbi.nlm.nih.gov/pubmed/19234765"], "snippets": [{"offsetInBeginSection": 353, "offsetInEndSection": 499, "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571"}, {"offsetInBeginSection": 1136, "offsetInEndSection": 1286, "text": "Our data are consistent with the notion that the proposed alpha-secretase-enhancing activity of nardilysin might play a role in human brain pathology.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765"}, {"offsetInBeginSection": 431, "offsetInEndSection": 602, "text": "A prerequisite for the alpha-secretase-stimulating effect of nardilysin on the activity of ADAMs in vivo is cellular co-expression of nardilysin with ADAM10 and/or ADAM17.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765"}, {"offsetInBeginSection": 668, "offsetInEndSection": 745, "text": "Here, we show that p42(IP4) enhances the enzymatic activity of NRD 3-4 times.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 208, "offsetInEndSection": 430, "text": "Nardilysin enhances the alpha-secretase activity of the disintegrin and metalloproteases (ADAMs) 10 and 17, thereby possibly contributing to reduced generation of amyloidogenic fragments from the amyloid precursor protein.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765"}, {"offsetInBeginSection": 0, "offsetInEndSection": 191, "text": "Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin \u03b1 1; ADAP1) in neuroblastoma cells.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 0, "offsetInEndSection": 214, "text": "The mainly neuronally expressed protein p42(IP4) (centaurin \u03b11; ADAP1), which interacts with the metalloendopeptidase nardilysin (NRD) was found to be localized in neuritic plaques in Alzheimer disease (AD) brains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 897, "offsetInEndSection": 1135, "text": "Compared to controls, in Alzheimer's disease and in Down syndrome brains there is a decreased cellular expression of all three antigens, and a reduction in the number of those neurons that co-express nardilysin with ADAM10 or with ADAM17.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765"}, {"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "The peptidase nardilysin is involved in degradation of neuropeptides and limited intracellular proteolysis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765"}, {"offsetInBeginSection": 564, "offsetInEndSection": 667, "text": "Some members of this M16 family act bi-functionally, as protease and as non-enzymatic scaffold protein.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}]}, {"id": "5aaef38dfcf456587200000f", "body": "Please list 10 conditions which play a role in causing atrial fibrillation.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19151857", "http://www.ncbi.nlm.nih.gov/pubmed/11978585", "http://www.ncbi.nlm.nih.gov/pubmed/24111315", "http://www.ncbi.nlm.nih.gov/pubmed/12781903", "http://www.ncbi.nlm.nih.gov/pubmed/7759722", "http://www.ncbi.nlm.nih.gov/pubmed/10646954", "http://www.ncbi.nlm.nih.gov/pubmed/16793213", "http://www.ncbi.nlm.nih.gov/pubmed/10535368", "http://www.ncbi.nlm.nih.gov/pubmed/10409531", "http://www.ncbi.nlm.nih.gov/pubmed/12746748"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 402, "text": "OBJECTIVES: (1) To investigate the electrophysiological effects of flecainide and propafenone during atrial fibrillation, and their relation to arrhythmia termination; (2) to investigate the effects of isoprenaline on atrial fibrillation in basal conditions and during treatment with class 1C drugs to evaluate the role of adrenergic stimulation on proarrhythmic events occurring during this treatment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10409531"}, {"offsetInBeginSection": 908, "offsetInEndSection": 1136, "text": "The number of atrial fibrillation and atrial flutter episodes did not differ (23 vs. 39, p = 0.072), but the mean duration of atrial flutter was longer than that of atrial fibrillation (37.0 +/- 10 vs. 6.6 +/- 3.6 h, p = 0.014).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7759722"}, {"offsetInBeginSection": 318, "offsetInEndSection": 639, "text": "Among those with significant coronary artery disease were 49 (66.2%) patients with atrial fibrillation and 88.5% with sinus rhythm (P50%) coronary stenosis were re-evaluated and results compared to the control group which consisted of 108 consecutive patients who were in sinus rhythm at the time of coronary angiography.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10646954"}, {"offsetInBeginSection": 213, "offsetInEndSection": 476, "text": "Despite the inherent difficulty in identifying the causes of postoperative atrial fibrillation, several important observations have been made during the recent past that may play a role in treating or even preventing this common and serious postoperative problem.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10535368"}, {"offsetInBeginSection": 1291, "offsetInEndSection": 1434, "text": "Most of these cytokines play a crucial role in inflammation response that associate with the initiating and maintenance of atrial fibrillation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16793213"}, {"offsetInBeginSection": 0, "offsetInEndSection": 273, "text": "To answer whether atrial ischemia plays an important role in the genesis of atrial fibrillation in patients with coronary artery disease, we analyzed the electrocardiograms obtained at the time of coronary angiography and left ventriculography in 3220 consecutive patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10646954"}, {"offsetInBeginSection": 1127, "offsetInEndSection": 1273, "text": "Specific pharmacotherapy could potentially play a major role in the primary and secondary prevention of atrial fibrillation and its complications.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12781903"}, {"offsetInBeginSection": 120, "offsetInEndSection": 207, "text": "It has been considered that inflammation plays a role in atrial fibrillation, recently.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16793213"}, {"offsetInBeginSection": 210, "offsetInEndSection": 389, "text": "BACKGROUND: Substantial animal data indicate that vagally induced dispersion of atrial refractoriness plays a central role in the induction and maintenance of atrial fibrillation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7759722"}, {"offsetInBeginSection": 1141, "offsetInEndSection": 1457, "text": "CONCLUSIONS: Class 1C drugs are effective at restoring sinus rhythm by increasing the MFF to a much greater extent than observed in self terminating atrial fibrillation episodes, and reversing the spontaneous atrial fibrillation behaviour (progressive shortening of MFF and self perpetuation of atrial fibrillation).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10409531"}]}, {"id": "5ad3aa47133db5eb78000004", "body": "Which organ express and secretes the hormone FGF21?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22917661", "http://www.ncbi.nlm.nih.gov/pubmed/26116622", "http://www.ncbi.nlm.nih.gov/pubmed/25811804", "http://www.ncbi.nlm.nih.gov/pubmed/18467542", "http://www.ncbi.nlm.nih.gov/pubmed/26993043", "http://www.ncbi.nlm.nih.gov/pubmed/26654352", "http://www.ncbi.nlm.nih.gov/pubmed/24432989", "http://www.ncbi.nlm.nih.gov/pubmed/25215270", "http://www.ncbi.nlm.nih.gov/pubmed/28089565", "http://www.ncbi.nlm.nih.gov/pubmed/17623664"], "snippets": [{"offsetInBeginSection": 91, "offsetInEndSection": 199, "text": "The placenta actively synthesizes and secretes many hormones, but it is unknown whether this includes FGF21.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989"}, {"offsetInBeginSection": 0, "offsetInEndSection": 157, "text": "The metabolic stress hormone FGF21 is highly expressed in exocrine pancreas, where its levels are increased by refeeding and chemically induced pancreatitis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089565"}, {"offsetInBeginSection": 1230, "offsetInEndSection": 1385, "text": "FGF21 treatment also reversed GH-induced insulin expression, beta-cell proliferation and GH-impaired glucose-stimulated insulin secretion (GSIS) in islets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25811804"}, {"offsetInBeginSection": 140, "offsetInEndSection": 323, "text": "Fibroblast growth factor 21 (FGF21), a hormone induced by a variety of environmental or metabolic stimuli, plays a crucial role in the adaptive response to these stressful conditions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26116622"}, {"offsetInBeginSection": 232, "offsetInEndSection": 352, "text": "This study aimed to elucidate the physiological role of FGF21 in pancreatic islets using FGF21-knockout (FGF21-KO) mice.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25811804"}, {"offsetInBeginSection": 1303, "offsetInEndSection": 1611, "text": "Furthermore, CoCl(2) increased intracellular triglyceride (TG) accumulation, along with a reduction in mRNA levels of lipid lipase, hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), and an increase of sterol regulatory element-binding protein-1c (SREBP1c) and stearoyl-coenzyme A (SCD1).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661"}, {"offsetInBeginSection": 127, "offsetInEndSection": 263, "text": "FGF21 is mainly expressed in the liver, but is also found in other tissues including the intestine, which expresses \u03b2-klotho abundantly.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661"}, {"offsetInBeginSection": 623, "offsetInEndSection": 764, "text": "Mice carrying an acinar cell-specific deletion of \u03b2-Klotho also accumulate zymogen granules but are refractory to FGF21-stimulated secretion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089565"}, {"offsetInBeginSection": 980, "offsetInEndSection": 1129, "text": "The absence of FGF21 in fetal cord blood suggests that neither placental FGF21 nor maternal circulating FGF21 is secreted into the fetal circulation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989"}, {"offsetInBeginSection": 464, "offsetInEndSection": 622, "text": "Mice lacking FGF21 accumulate zymogen granules and are susceptible to pancreatic ER stress, an effect that is reversed by administration of recombinant FGF21.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089565"}]}, {"id": "5ad4f4f5133db5eb7800000a", "body": "What is the aim of the PhenCode database?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25385275"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 56, "text": "VariSNP, a benchmark database for variations from dbSNP.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}, {"offsetInBeginSection": 265, "offsetInEndSection": 306, "text": "VariSNP datasets are selected from dbSNP.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}, {"offsetInBeginSection": 307, "offsetInEndSection": 473, "text": "These subsets were filtered against disease-related variants in the ClinVar, UniProtKB/Swiss-Prot, and PhenCode databases, to identify neutral or nonpathogenic cases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}, {"offsetInBeginSection": 115, "offsetInEndSection": 264, "text": "Some previously developed datasets are available for this purpose, but newer and larger benchmark sets for benign variants have largely been missing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}, {"offsetInBeginSection": 595, "offsetInEndSection": 729, "text": "The datasets will be updated with automated scripts on a regular basis and are freely available at http://structure.bmc.lu.se/VariSNP.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "For development and evaluation of methods for predicting the effects of variations, benchmark datasets are needed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}, {"offsetInBeginSection": 474, "offsetInEndSection": 594, "text": "All variant descriptions include mapping to reference sequences on chromosomal, genomic, coding DNA, and protein levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}]}, {"id": "5a9d99ac4e03427e73000002", "body": "What is measured with the Proseek panels?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28936257", "http://www.ncbi.nlm.nih.gov/pubmed/28586402", "http://www.ncbi.nlm.nih.gov/pubmed/25987887", "http://www.ncbi.nlm.nih.gov/pubmed/28694499", "http://www.ncbi.nlm.nih.gov/pubmed/19040730", "http://www.ncbi.nlm.nih.gov/pubmed/28437237", "http://www.ncbi.nlm.nih.gov/pubmed/28948068", "http://www.ncbi.nlm.nih.gov/pubmed/28734077"], "snippets": [{"offsetInBeginSection": 474, "offsetInEndSection": 654, "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 863, "offsetInEndSection": 1038, "text": "Our results demonstrate that samples applied to the indicating FTA elute micro card\u2122 are amendable to protein analyses, given that a sensitive protein detection assay is used.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 427, "offsetInEndSection": 556, "text": "PCONCLUSIONS: This study shows that food intake affects several different CVD biomarkers, but the effect is predominantly modest.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402"}, {"offsetInBeginSection": 534, "offsetInEndSection": 701, "text": "RESULTS: Plasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28734077"}, {"offsetInBeginSection": 503, "offsetInEndSection": 757, "text": "Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n\u2009=\u200910) or severe TBI (n\u2009=\u200910) with extra-cranial injury or extracranial injury only (EC) (n\u2009=\u200910), 92 inflammation-associated proteins in serum obtained:", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28694499"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "The indicating FTA elute micro card\u2122 has been developed to collect and stabilize the nucleic acid in biological samples and is widely used in human and veterinary medicine and other disciplines.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 215, "offsetInEndSection": 361, "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402"}, {"offsetInBeginSection": 303, "offsetInEndSection": 448, "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120\u00a0min afterward with the Proseek Multiplex Neurology\u00a0I kit.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948068"}, {"offsetInBeginSection": 293, "offsetInEndSection": 473, "text": "We studied the ability to analyse proteins in human plasma and vaginal fluid as applied to the indicating FTA elute micro card\u2122 using the sensitive proximity extension assay (PEA).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 882, "offsetInEndSection": 1166, "text": "EDTA plasma samples (1\u00a0\u03bcL) obtained from 75 patients with Dukes' staged CRC or unaffected controls (age and sex matched with stringent inclusion/exclusion criteria) were assayed for expression of 92 human proteins employing the Proseek\u00ae Multiplex Oncology I proximity extension assay.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}]}, {"id": "5ad247720340b9f058000017", "body": "What is a fibrocyte?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22043022", "http://www.ncbi.nlm.nih.gov/pubmed/22022512", "http://www.ncbi.nlm.nih.gov/pubmed/18427397", "http://www.ncbi.nlm.nih.gov/pubmed/28915889", "http://www.ncbi.nlm.nih.gov/pubmed/18025235", "http://www.ncbi.nlm.nih.gov/pubmed/24507087", "http://www.ncbi.nlm.nih.gov/pubmed/18052725", "http://www.ncbi.nlm.nih.gov/pubmed/26948996", "http://www.ncbi.nlm.nih.gov/pubmed/24822215", "http://www.ncbi.nlm.nih.gov/pubmed/22796709"], "snippets": [{"offsetInBeginSection": 652, "offsetInEndSection": 950, "text": "Using flow cytometry, immunofluorescent staining, and confocal microscopy, we demonstrate here that the marker protein leukocyte-specific protein 1 (LSP1) is stably expressed by fibrocytes for at least 2 months, whereas other potential fibrocyte markers, such as CD34 and CD45, gradually disappear.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18052725"}, {"offsetInBeginSection": 1093, "offsetInEndSection": 1244, "text": "Endogenous production of CysLTs contributes to basal fibrocyte proliferation, but does not alter fibrocyte responses to basic fibroblast growth factor.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18025235"}, {"offsetInBeginSection": 2272, "offsetInEndSection": 2358, "text": "Fibrocyte inhibition is considered a mechanism of anti-fibrotic action of pirfenidone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24507087"}, {"offsetInBeginSection": 697, "offsetInEndSection": 991, "text": "S-100 is strongly expressed in types I, II, and V fibrocytes, and \u03b11Na,K-ATPase is expressed strongly only in types II and V. By combining caldesmon or aquaporin 1 with S-100 and \u03b11Na,K-ATPase, a ratiometric analysis of immunogold density distinguishes all except type II and type V fibrocytes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022"}, {"offsetInBeginSection": 395, "offsetInEndSection": 555, "text": "FINDINGS: In this report, we show that HMWHA potentiates the differentiation of human monocytes into fibrocytes, while LMWHA inhibits fibrocyte differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 1195, "offsetInEndSection": 1355, "text": "The fibrocyte differentiation-inhibiting factor serum amyloid P (SAP) inhibits HMWHA-induced fibrocyte differentiation and potentiates LMWHA-induced inhibition.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 1245, "offsetInEndSection": 1460, "text": "Although CysLTs can induce the migration of fibrocytes in vitro, they do not appear to be essential for fibrocyte recruitment to the lung in vivo, possibly due to compensatory chemokine-mediated recruitment signals.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18025235"}, {"offsetInBeginSection": 1490, "offsetInEndSection": 1676, "text": "CONCLUSIONS: We hypothesize that hyaluronic acid signals at least in part through CD44 to regulate fibrocyte differentiation, with a dominance hierarchy of SAP>LMWHA\u2265HMWHA>IL-4 or IL-13.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 288, "offsetInEndSection": 462, "text": "Fibrocyte cultures offer one source of transplantable cells, but determining what fibrocyte types they contain and what phenotype transplanted cells may adopt is problematic.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022"}, {"offsetInBeginSection": 556, "offsetInEndSection": 690, "text": "Digestion of HMWHA with hyaluronidase produces small hyaluronic acid fragments, and these fragments inhibit fibrocyte differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}]}, {"id": "5ad255210340b9f058000018", "body": "Is lumican a secreted protein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17050378", "http://www.ncbi.nlm.nih.gov/pubmed/22266188", "http://www.ncbi.nlm.nih.gov/pubmed/15466200", "http://www.ncbi.nlm.nih.gov/pubmed/23480731", "http://www.ncbi.nlm.nih.gov/pubmed/20138170", "http://www.ncbi.nlm.nih.gov/pubmed/27126993", "http://www.ncbi.nlm.nih.gov/pubmed/12381269", "http://www.ncbi.nlm.nih.gov/pubmed/21421073", "http://www.ncbi.nlm.nih.gov/pubmed/12128073", "http://www.ncbi.nlm.nih.gov/pubmed/16259954"], "snippets": [{"offsetInBeginSection": 1211, "offsetInEndSection": 1518, "text": "In conclusion, this study demonstrates a novel out-in signaling circuit in human osteosarcoma cells: secreted to extracellular matrix lumican is an endogenous inhibitor of TGF-\u03b22 activity, resulting in downstream effector modulation including pSmad 2, integrin \u03b21 and pFAK to regulate osteosarcoma adhesion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21421073"}, {"offsetInBeginSection": 969, "offsetInEndSection": 1130, "text": "In\u00a0vitro, mechanical stretch and the proinflammatory cytokine interleukin-1\u03b2 increased lumican mRNA as well as secreted lumican protein from cardiac fibroblasts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23480731"}, {"offsetInBeginSection": 846, "offsetInEndSection": 1014, "text": "Western blot analysis with anti-lumican antibody detected a 42 kDa lumican protein secreted into the culture medium of both wild-type and C/S mutant lumican cell lines.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12381269"}, {"offsetInBeginSection": 1525, "offsetInEndSection": 1785, "text": "CONCLUSIONS: Our results demonstrate that activated pancreatic stellate cells within PDAC secrete lumican under the negative control of TGF-\u03b2; once secreted, the extracellular lumican enhances stellate cell adhesion and mobility in a collagen-rich environment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993"}, {"offsetInBeginSection": 1332, "offsetInEndSection": 1606, "text": "Our data suggest that lumican is a significant proteoglycan component of bone matrix, which is secreted by differentiating and mature osteoblasts only and therefore it can be used as a marker to distinguish proliferating pre-osteoblasts from the differentiating osteoblasts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12128073"}, {"offsetInBeginSection": 375, "offsetInEndSection": 450, "text": "Lumican is a secreted proteoglycan that regulates collagen fibril assembly.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993"}, {"offsetInBeginSection": 154, "offsetInEndSection": 496, "text": "We examined the role of a highly conserved cysteine-containing domain proximal to the N-terminus of lumican in collagen fibrillogenesis using site-specific mutagenesis to prepare plasmid DNA encoding wild-type murine lumican (Cys(37)-Xaa(3)-Cys(41)-Xaa-Cys-Xaa(9)-Cys) and a Cys-->Ser (C/S) mutant (Cys(37)-Xaa(3)-Ser(41)-Xaa-Cys-Xaa(9)-Cys).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12381269"}, {"offsetInBeginSection": 1369, "offsetInEndSection": 1525, "text": "In addition, we found that the ability of HPSCs to produce and secrete extracellular lumican significantly enhances HPSCs adhesion and mobility on collagen.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993"}, {"offsetInBeginSection": 991, "offsetInEndSection": 1246, "text": "HT1080 fibrosarcoma cells stably transfected with the lumican cDNA (HT1080/Lum), which express endogenous MT1-MMP, secreted moderate levels of lumican; however, treatment of HT1080/Lum cells with BB94 resulted in accumulation of lumican in culture medium.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200"}, {"offsetInBeginSection": 410, "offsetInEndSection": 582, "text": "Lumican protein from bovine cornea and recombinant lumican core protein fused to glutathione S-transferase was shown to be cleaved at multiple sites by recombinant MT1-MMP.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200"}]}]}